Capsules

S.No.	Product Name	Composition	Packing	Strength
1	Acebrophylline Capsule	Each hardgelatin capsule contain: Acebrophylline Excipients Approved colour used in emptycapsule shell		100 mg q.s
2	Alpha LipoicAcid, Benfotiamine , Multivitamin & Multimineral Capsules	Each Hard Gelatin CapsuleContains: Mecobalamin Alpha LipoicAcid Benfotiamine Vitamin B6 Calcium Pantothenate Folic Acid Zinc Oxide Chromium Picolinate Inositol Lutein Excipients Approved Colour used.	IP USP IP IP IP IP USP USP USP	1500mcg 100mg 15mg 3mg 25mg 1.5mg 22.5mg 65mcg 10mcg 5mg q.s.
3	Atorvastatin and Aspirin Capsules	Each hard gelatin capsule contains: Atorvastatin Calcium Equ. to Atorvastatin (In IRPellets form) Aspirin (As enteric coated pellets) Excipients Approved Colour used in emptycapsules shells.	IP IP	10mg 75mg
4	Atorvastatin, Clopidogrel and Aspirin Capsules	Each hard gelatin capsule contains: Atorvastatin Calcium Equ. to Atorvastatin (as Pellets) Clopidogrel Bisulphate Equ. to Clopidogrel ( as Pellets) Aspirin (As enteric coated pellets) Excipients Approved Colour used in emptycapsules shells.	IP IP IP	20mg 75mg 75mg
5	B –Complex Capsules	Each hard gelatin capsule contains Vitamin B1 (Thiamine Mononitrate) Vitamin B2 (Riboflavin) Vitamin B6 (Pyridoxine Hydrochloride) Niacin (Nicotinamide) Pantothenic Acid (Calcium D-Pantothenate) Vitamin B12 (Cyanocobalamin) Folic Acid (n-pteroyl L-Glutamic Acid) Zinc (as Zinc Sulphate) Bacillus Coagulans Biotin (D-Biotin) Excipients Approved colour used in emptycapsule shells.	IP IP IP IP IP IP IP IP IP	1.1mg 1.3mg 2mg 14mg 5mg 1mcg 100mcg 10mg 2000 Millions 30mcg q.s
6	B- Complex Capsules	Each hard gelatin capsule contains Thiamine Mononitrate Riboflavin Sodium Phosphate Pyridoxine Hydrochloride Niacinamide Calcium Pantothenate Vitamin B12 Folic Acid Biotin Ascorbicacid Excipients Approved colour used in emptycapsule shells.	IP IP IP IP IP IP IP USP IP	10mg 10mg 3mg 100mg 50mg 15mcg 1.5 mg 100mcg 150mg q.s
7	B-complex with L- Lysine Capsules	Each hard gelatin capsule contains Thiamine Mononitrate Riboflavin Sodium Phosphate Pyridoxine Hydrochloride Niacinamide Calcium Pantothenate Vitamin B12 Folic Acid L-Lysine Mono Hydrochloride Excipients Approved colour used in emptycapsule shells.	IP IP IP IP IP IP IP USP	10mg 10mg 3mg 50mg 20mg 5mcg 1000mcg 150mg q.s
8	Benfotiamine Mecobalamin , Alpha Lipoic acid, Inositol , Pyridoxine Hydrochloride & Folicacid Capsules	Each hard gelatin capsule contains Benfotiamine Mecobalamin Alpha Lipoic acid , Inositol , Pyridoxine Hydrochloride Folic acid Excipients Approved colour used in emptycapsule shells.	IP IP USP IP IP IP	100mg 1000mcg 200mg 100mg 3mg 1.5mg q.s
9	Carbonyl Iron, folic acid, Vitamin B12 and Zinc Sulphate Capsules	Each hardgelatin capsule contain: Carbonyl Iron Equivalent toElemental Iron Folic acid Vitamin B12 Zinc sulphate monohydrate Equivalent to elemental zinc Excipients Approved colour used in emptycapsule shells	IP IP IP	100 mg 1.5 mg 15mcg 22.5 mg q .s.
10	Celecoxib Capsules	Each hard gelatin capsules contains: Celecoxib Excipients Approved colour used in emptycapsule shell.	IP	200mg q.s.
11	Clindamycin Hydrochloride Capsule IP	Each hardgelatin capsule contain: Clindamycin Hydrochloride Equivalent to Clindamycin Excipients Approved colour used in emptyhard gelatin capsule	IP	300 mg
12	Clopidogrel and Aspirin Capsules	Each hard gelatin capsule contains: Clopidogrel Bisulphate Equ. toClopidogrel ( as Pellets) Aspirin (As enteric coated pellets) Excipients Approved Colour used in emptycapsules shells.	IP IP	75mg 75mg
13	Cyclosporine Capsules IP	Each Hard Gelatin Capsule Contains : Cyclosporine Excipients Approved colour used. EmptyCapsule Shells.	IP	250mg q.s.
14	Dexlansoprazole Modified Release Capsule	Each Hard Gelatin Capsules Contains: Dexlansoprazole (as Modified Release Pellets) Approved colour used in Pellets & EmptyCapsule Shells.	IP	60mg
15	Dexlansoprazole Modified Release Capsule	Each Hard Gelatin Capsule Contains: Dexlansoprazole (as modified release pellets) Excipients Approved colour used.	IP	30mg q.s.
16	Dexlansoprazole Modified Release Capsule	Each Hard Gelatin Capsule Contains: Dexlansoprazole (as modified release pellets) Excipients Approved colour used.	IP	60mg q.s.
17	Dexrabeprazole (Enteric Coated) & Domperidone (Sustained Release) Capsule	Each hardgelatin capsule contains : Dexrabeprazole Sodium (as Enteric Coated Pellets) Domperidone (as Sustained Release Pellets) Excipients Approved colour used.	IP	10mg 30mg q.s.
18	Diclofenac Sodium & Thiocolchicoside Capsules	Each hard gelatin capsule contain: Diclofenac Sodium Thiocolchicoside Excipients Approved colour used in emptyhard gelatin capsule	IP IP	50 mg 4 mg q.s.
19	Doxycycline & Lactic Acid Bacillus Capsule	Each hard gelatin capsule contains Doxycycline Lactic Acid Bacillus Excipients Approved colour used in emptycapsule shells.	IP	100mg 5 Million q.s.
20	Doxycycline & Lacticacid Bacillus Capsules	Each hard gelatin capsules contains : Doxycycline Hydrochloride Equ. to Doxycycline Lactic acid Bacillus Excipients Approved Colour used in Emptycapsules Shells.	IP	100mg 5Million q.s
21	Doxycycline Hyclate Capsule USP	Each hard gelatin capsule contains: Doxycycline Hyclate Equ. to Doxycycline Excipients Approved colour used in emptycapsule shells	USP	100mg q.s.
22	Elemental Iron , Elemental zinc &folic Acid Capsules	Each hardgelatin Capsule contains: Elemental Iron (In the form of Carbonyl Iron ) Zinc Sulphate Monohydrate Equ. to Elemental Zinc Folic Acid Excipients Colour: - Approved colour used in hard Gelatin Capsule & shells.	IP IP	50mg 61.8mg 22.5mg 0.5mg
23	Enteric coated Esomeprazole 40mg & Itopride Hydrochloride Sustained Release 150mg Capsules	Each hard gelatin capsule contains: Esomeprazole Magnesium Trihydrate Eq.to Esomeprazole (AsEntericCoated Pellets) Itopride Hydrochloride (In Sustained ReleaseForm) Excipients Approved colour used.	IP IP	40mg 150mg q.s.
24	Esomeprazole (Enteric Coated) & Domperidone Sustained Release Capsules	Each hard gelatin capsule contains:- Esomeprazole Magnesium Trihydrate Equ. to Esomeprazole (Asa enteric coated Pellets) Domperidone (as a Sustainedrelease pellets) Excipients Approved colour used in emptycapsule shells.	IP IP	40mg 30mg q.s
25	Esomeprazole (Enteric-coated) & Levosulpiride(Susta ined-release) Capsules	Each hard gelatin Capsule contains : Esomeprazole Magnesium Trihydrate Equ. to Esomeprazole (as enteric –coated pellets) Levosulpiride (as sustained –release pellets) Excipients Colour: Titanium Dioxide IP is used in pellets & approved colour(s) are used in Emptycapsules shells.	IP	40mg 75mg q.s
26	Ferrous Gluconate, Folic Acid, Vitamin B12, Dibasic Calcium Phosphate & Zinc Sulphate Capsules	Each hard gelatin capsule contains: Ferrous Gluconate Eq. to Elemental Iron Folic Acid Vitamin B12 (As gelatin triturate 0.1%) Dibasic Calcium Phosphate (Dihydrate) Zinc Sulphate Excipients Appropriate overages of vitamins added. Approved colour used in hard gelatin capsule shell.	I.P. I.P. I.P. I.P. I.P.	259mg 30mg 0.5mg 2.5 mcg 100mg 33mg q.s.
27	Fluoxetine Capsules IP	Each hard gelatin Capsule contains : Fluoxetine Hydrochloride Equ. to fluoxetine Excipients Approved colour used	IP	20mg
28	Flupirtine Maleate Capsules	Each hard gelatin capsules contains : Flupirtine Maleate Excipients Approved colour used in EmptyCapsule Shells		100mg q.s.
29	Folic Acid, Methylcobalamin, Pyridoxine Hydrochloride & Docosahexaenoic Acid Capsules	Each hard gelatin capsule contains: Folic Acid Methylcobalamin Pyridoxine Hydrochloride Docosahexaenoic Acid Powder (10%w/w) Appropriate overages of vitamins are added to compensate the loss on storage.	IP IP IP	5mg 1500mcg 1.5mg 200mg q.s.
30	Itopride Hydrochloride Sustained Release Capsule	Each Hard Gelatin Capsule Contains: Itopride Hydrochloride (as Sustained Release Pellets) Excipients Approved colour used in Emptycapsule Shells.		150mg q.s.
31	Itraconazole Capsules	Each hard gelatin capsule contains:- Itraconazole Excipients Approved colour used in emptycapsule shells	BP	100mg q.s
32	Itraconazole Capsules	Each hard gelatin capsule contains:- Itraconazole Excipients Approved colour used in emptycapsule shells.	BP	200mg q.s
33	Itraconazole Capsules	Each hard gelatin capsule contains:- Itraconazole Excipients Approved colour used in emptycapsule shells.	USP	100mg q.s
34	Itraconazole Capsules	Each hard gelatin capsule contains:- Itraconazole Excipients Approved colour used in emptycapsule shells.	USP	200mg q.s
35	Itraconazole Capsules BP	Each HPMC capsules Contains: Itraconazole (as Pellets) Excipients Approved colour used in Empty capsule Shells. (Itraconazole Finished Product and Raw Material in IP 2022)	BP	200mg q.s.
36	Mecobalamin, Alpha LipoicAcid, Folic Acid & Pyridoxine Hydrochloride Capsules	Each hard Gelatin capsule contains : Mecobalamin Alpha LipoicAcid Folic Acid Pyridoxine Hydrochloride Excipients Approved Colour Used	IP USP IP IP	1500mcg 100mg 1.5mg 3mg q.s
37	Methylcobalamin, Alpha Lipoic Acid, Inositol, Folic acid, Chromium Polynicotinate, Selenium Dioxide and Benfotiamine Capsules	Each hard gelatin Capsules contains: Methylcobalamin Alpha LipoicAcid Inositol Folic Acid Chromium Polynicotinate Selenium Dioxide Benfotiamine Excipients Approved colour Used	IP USP BP IP	1500mcg 100mg 100mg 1.5mg 200mcg 55mcg 150mg q.s
38	Methylcobalamine, Alpha Lipoic Acid, Pyridoxine Hydrochloride, Thiamine & Folic Acid Capsules	Each hard gelatin capsule contains:- Methylcobalamin Alpha Lipoic Acid Pyridoxine Hydrochloride Thiamine Mononitrate Folic Acid Excipients Approved colour used in emptycapsule shells.	IP USP IP IP IP	1500 mcg. 100 mg. 3 mg. 10 mg. 1.5 mg. q.s.
39	Multivitamin , Multimineral with LycopeneCapsules	Each hard gelatin capsule contains Lycopene 6% Lutien 8% Beta Carotene (10% Dispersion) Vitamin B6 Vitamin B12 Vitamin D3 Folic Acid Calcium Pantothenate Niacinamide Biotin Lysine Hydrochloride Ferrous Fumarate Dibasic Calcium Phosphate Zinc Sulphate Magnesium Hydroxide Copper Sulphate Manganese Sulphate Chromium Chloride Sodium Selenate Excipients Approved colour used in emptycapsule shells.	USP USP USP IP IP IP IP IP IP USP USP IP IP IP IP USP USP USP	5mg 6mg 10mg 1mg 5mcg 200IU 500mcg 5mg 25mg 10mcg 50mg 45mg 75mg 10mg 10mg 500mcg 500mcg 200mcg 100mcg q.s
40	Omeprazole (Delayed- Release) and Domperidone (Sustained-Release) Capsules	Each capsule contains: Omeprazole (as enteric coated pellets) Domperidone (as sustained Release pellets) Colour : Titanium Dioxide Approved colour used in emptycapsule shel	IP IP	20mg 30mg
41	Omeprazole (EntericCoated) & Domperidone Capsules IP	Each hard gelatin capsule contains:- Omeprazole (As Enteric Coated Pellets) Domperidone Excipients Approved colour used in emptycapsule shells.	IP IP	20 mg 10 mg q.s
42	Omeprazole Capsule IP	Each hard gelatin capsule contains:- Omeprazole (As enteric coated pellets) Excipients Approved colour used in emptycapsule shells.	IP	20mg. q.s.
43	Orlistat Capsules USP	Each Hard Gelatin Capsules Contains: Orlistat ( as Pellets) Excipients Approved colour used in EmptyCapsule Shells	USP	120mg q.s.
44	Oxaceprol Capsules	Each Hard Gelatin Capsules Contains: Oxaceprol Excipients Approved colour used in emptyCapsule Shells		200mg q.s.
45	Pantoprazole Gastro-resistant and Domperidone Prolonged –release Capsules IP	Each hard gelatin capsule contains:- Pantoprazole Sodium Sesquihydrate Equivalent to Pantoprazole (As Enteric Coated Pellets) Domperidone (As Sustained Release Pellets) Excipients Approved colour used in emptycapsule shells.	IP IP	40 mg 30 mg q.s
46	Pantoprazole Gastro-resistant and Domperidone Prolonged –release Capsules IP	Each hard gelatin capsule contains:- Pantoprazole Sodium Sesquihydrate Equivalent to Pantoprazole (As Enteric Coated Pellets) Domperidone (As Prolonged Release Pellets) Excipients Approved colour used in emptycapsule shells.	IP IP	40 mg 30 mg q.s
47	Pantoprazole Sodium (Enteric coated) & Domperidone (Sustained Release) Capsules IP	Each hard gelatin capsule contains:- Pantoprazole Sodium Sesquihydrate Equivalent to Pantoprazole (As Enteric Coated Pellets) Domperidone (As Sustained Release Pellets) Excipients Approved colour used in emptycapsule shells.	IP IP	40 mg 30 mg q.s
48	Pantoprazole Sodium (Enteric Coated) &Itopride Hydrochloride (Sustained Release) Capsule	Each Hard Gelatin Capsule contain: Pantoprazole Sodium Sesquihydrate Equivalent to Pantoprazole (As enteric coated pellets) Itopride Hydrochloride (As sustainedrelease pellets) Excipients Approved colour used in emptycapsule shells	IP	40 mg 150 mg q.s.
49	Pantoprazole Sodium (Enteric Coated)& Levosulpiride (sustained Release) Capsules	Each Hard Gelatin Capsule Contains Pantoprazole Sodium Sesquihydrate Equivalent to Pantoprazole (As a EntericCoated Pellets) Levosulpiride (As Sustained Release Pellets) Excipients Approved colour used in emptycapsule shells	IP	40 mg 75 mg q.s.
50	Pre & Probiotic With L-Glutamine Capsules	Each hard gelatin capsule contains: Fructo oligosaccharide L- Glutamine Bifidobecterium Bifidum Bifidobecterium Longm Lactobaccilus acidophillus Streptococusthermophillus Excipients Approved colour used emptycapsule shells	USP	200 MG 100 mg 150million 150 million 300 million 150 million q.s.
51	Prebiotic & Probiotic Capsules	Each Hard Gelatin Capsule Contains:- Fructooligosaccharides Saccharomyces Boulardii Bifidobacterium Bifidum Bifidobacterium Longum Lactobacillus Acidophillus Streptococcus Thermophillus Excipients Approved colour used in empty capsule shells.		200mg 250 million spores 150 million spores 150 million spores 300 million spores 150 million spores q.s.
52	Pregabalin , Methylcobalamin, Alpha Lipoic Acid Pyridoxine with Folic Acid Capsules	Each hard gelatin capsule contains Pregabalin Methylcobalamin Alpha LipoicAcid Pyridoxine Hydrochloride Folic Acid Excipients Approved colour used in emptycapsule shells.	IP IP USP IP IP	75mg 750mcg 100mg 3mg 1.5mg q.s
53	Pregabalin & Methylcobalamin Capsules IP	Each hard gelatin capsule contains:- Pregabalin Methylcobalamin Excipients Approved colour used in emptycapsule shells.	IP IP	75 mg. 750 mcg. q.s.
54	Pregabalin Capsules IP	Each Hard Gelatin Capsule contains: Pregabalin Excipients Approved colour used in EmptyHard Gelatin Capsule	IP	75mg q.s
55	Pregabalin Capsules IP	Each Hard Gelatin Capsule contains: Pregabalin Excipients Approved colour used in EmptyHard Gelatin Capsule	IP	150mg q.s
56	Pregabalin Capsules IP	Each Hard Gelatin Capsule contains: Pregabalin Excipients Approved colour used in EmptyHard Gelatin Capsule	IP	300mg q.s
57	Pregabalin, Methylcobalamin, Benfotiamine, Pyridoxine Hydrochloride & Folic Acid Capsules	Each Hard Gelatin Capsule Contains : Pregabalin Methylcobalamin Benfotiamine Pyridoxine Hydrochloride Folic Acid Excipients Approved colour used in EmptyCapsule Shells	IP IP IP IP	75mg 750mcg 7.5mg 1.5mg 0.75mg q.s.
58	Probiotic Capsules	Each hard gelatin capsule contains: Streptococcus Faecalis Clostridium Butyricum Bacillus Mesentericus Lactic acid bacillus (Lactobacillus sporogenes) Excipients Approved colour used.		30 Million 2 Million 1 Million 50 Million q.s.
59	Rabeprazole sodium (Enteric coated) & Aceclofenac (Sustained Release) Capsule	Each hardgelatin capsule contains:- Rabeprazole Sodium (Asa enteric coated Pellets) Aceclofenac (as a Sustainedrelease pellets) Excipients Approved colour used in emptycapsule shells	IP IP	20mg 200mg q.s
60	Rabeprazole Sodium (Enteric coated) & Domperidone (Sustained Release) Capsules	Each hard gelatin capsule contains:- Rabeprazole Sodium (As Enteric Coated Pellets) Domperidone (As Sustained Release Pellets) Excipients Approved colour used in emptycapsule shells.	IP IP	20 mg 30 mg q.s
61	Rabeprazole Sodium (Enteric Coated) & Domperidone (Sustained Release) Capsules	Each Hard Gelatin CapsuleContains Rabeprazole Sodium (As a EntericCoated Pellets) Domperidone (10mg Immediate Release Pellets) (20mg Sustained Release Pellets) Excipients Approved colour used in emptycapsule shells	IP IP	20mg 30mg q.s.
62	Rabeprazole sodium (Enteric coated) & Levosulpiride (Sustained release) capsule	Each hard gelatin capsule contains:- Rabeprazole Sodium (AsEntericCoated Pellets) Levosulpiride (AsSustained ReleasePellets) Excipients Approved colour used in emptycapsule shells.	IP IP	20 mg 75 mg q.s
63	Rabeprazole sodium (Enteric coated) And Itopride Hydrochloride (sustained Release) Capsules	Each hard gelatin capsule contains:- Rabeprazole Sodium (Asa enteric coated Pellets) Itopride Hydrochloride (as a Sustainedrelease pellets) Excipients Approved colour used in emptycapsule shells.	IP IP	20 mg 150 mg q.s
64	Rabeprazole Sodium 40mg (EC)& Domperidone 10(IR)20mg(SR) Capsules	Each hard Gelatin Capsules Contains: Rabeprazole Sodium (as enteric coated pellets) Domperidone (as immediaterelease pellets) Domperidone (as sustained Release pellets) Excipients Approved Colour Used in emptyCapsules Shells	IP IP IP	40mg 10mg 20mg
65	Racecadotril Capsules IP	Each Hard Gelatin Capsules Contains: Racecadotril Excipients Approved Colour used	IP	100mg
66	Rosuvastatin , Clopidogrel and Aspirin Capsule	Each hard gelatin Capsule contains : Rosuvastatin Calcium Equ. to Rosuvastatin (as pellets) Clopidogrel Bisulphate Equ. to Clopidogrel (as pellets) Aspirin (as enteric coatedpellets) Excipients Approved colour used in emptycapsule shells.	IP IP IP	20mg 75mg 75mg q.s.
67	Rosuvastatin , Clopidogrel and Aspirin Capsules	Each Hard Gelatin Capsule Contains : Rosuvastatin Calcium Equ. to Rosuvastatin(as pellets) Clopidogrel Bisulphate Equ. to Clopidogrel ( as pellets) Aspirin (as Enteric Coated Pellets) Excipients Approved colour used in emptyCapsule Shells	IP IP IP	10MG 75MG 75MG q.s
68	Rosuvastatin & Clopidogrel capsule	Each hard gelatin capsule contains: Rosuvastatin calcium Equ. To Rosuvastatin (as pellets Form) Clopidogrel Bisulphate Equ. To Clopidogrel (as pellets Form) Excipients Approved colour used in emptycapsule shells.	IP IP	10mg 75mg q.s.
69	Rosuvastatin and Aspirin (EC) Capsules	Each hard gelatin capsule contains: Rosuvastatin Calcium Equ. to Rosuvastatin (In IR Pellets form) Aspirin (As enteric coated pellets) Excipients Approved Colour used in emptycapsules shells.	IP IP	10mg 75mg
70	Rosuvastatin and Aspirin (EC) Capsules	Each hard gelatin capsule contains: Rosuvastatin Calcium Equ. to Rosuvastatin (In IR Pellets form) Aspirin (As enteric coated pellets) Excipients Approved Colour used in emptycapsules shells.	IP IP	20mg 75mg
71	Rosuvastatin and Aspirin Capsules	Each Hard Gelatin Capsule contain: Rosuvastatin calcium Equivalent to Rosuvastatin (As pellets) Aspirin (As enteric coated pellets) Excipients Approved colour used in emptycapsule shells	IP IP	10 mg 75 mg
72	Silodosin Capsules	Each hard gelatin capsules contain: Silodosin Excipients		8 mg q.s.
73	Silodosin Capsules	Each hard gelatin capsules contain: Silodosin Excipients		4 mg q.s.
74	Thiocolchicoside Capsules	Each Hard Gelatin Capsule Contains : Thiocolchicoside Excipients Approved colour used in EmptyCapsule shells	IP	4mg q.s.

Cream

S.No.	Product Name	Composition	Packing	Strength
1	Acetonide Cream	Fluocinolone Acetonide In a cream Base	IP	0.1 mg q.s.
2	Aciclovir Cream IP	Composition :- Aciclovir In a cream Base	IP	5%w/w q.s.
3	Amorolfine Cream 0.25% w/w	Composition : Amorolfine Hydrochloride Equ. to Amorolfine Excipients Cream Base	IP	0.25%w/w q.s.
4	Baclomethasone Dipropionate, Neomycin and Clotrimazole Cream	Composition Baclomethasone Dipropionate Neomycin sulphate Clotrimazole In cream base	strength	0.025 %w/w 0.5 % w/w 1 % w/w q.s.
5	Beclomethasone Dipropionate, Phenylephrine Hydrochloride & Lignocaine Hydrochloride Cream	Composition: Beclomethasone Dipropionate Phenylephrine Hydrochloride Lignocaine Hydrochloride Preservative Chlorocresole Aqueous cream base	IP IP IP IP	0.025%w/w 0.10% w/w 2.50% w/w 0.1% w/w q.s.
6	Ciprofloxacin HCl, Fluocinolone Acetonide , Clotrimazole & Chlorocresol Cream	Composition : Ciprofloxacin Hydrochloride Equ. to Ciprofloxacin Fluocinolone Acetonide Clotrimazole Chlorocresol ( as preservative) Cream Base	IP IP IP IP	0.5%w/w 0.01%w/w 1.0% w/w 0.1%w/w q.s.
7	Ciprofloxacin, Metronidazole, Terbinafine Hydrochloride & Clobetasol PropionateCream	Composition : Ciprofloxacin Hydrochloride equ. to Ciprofloxacin Metronidazole Benzoate equ. to Metronidazole Terbinafine Hydrochloride Clobetasol Propionate Preservatives : Methyl Paraben Propyl Paraben Cream Base	IP IP IP IP IP IP	1.0%w/w 1.0%w/w 1.0%w/w 0.05%w/w 0.16%w/w 0.033%w/w q.s
8	Clobetasol Propionate , Miconazole Nitrate, Neomycin Sulphate Cream	Composition : Clobetasol Propionate Miconazole Nitrate Neomycin Sulphate Equ.toNeomycin Base Chlorocresol (as preservative) Cream base	IP IP IP IP	0.05%w/w 2%w/w 0.5%w/w 0.1%w/w q.s.
9	Clobetasol Propionate &Fusidic Acid Cream	Composition: Clobetasol Propionate Fusidic Acid In a water Miscible Cream Base Preservatives: Butylated Hydroxytoluene Sorbic Acid	IP IP IP IP	0.05%W/W 2.00%W/W 0.005%W/W 0.200%W/W
10	Clobetasol Propionate cream IP	Composition: Clobetasol Propionate Cream Base	IP	0.05%w/w q.s.
11	Clobetasol Propionate, Fusidic Acid,Clotrima zole Cream	Composition: Clobetasol Propionate Fusidic Acid Clotrimazole	USP IP IP	0.05%W/W 2%W/W 1%W/W
12	Clobetasol Propionate, Gentamicin, Tolnaftate, Iodochlorhydroxyq uinoline and Clotrimazole Cream	Composition : Clobetasol Propionate Gentamicin Sulphate Equ. to Gentamicin Tolnaftate Iodochlorhydroxyquinoline Clotrimazole Preservative : Chlorocresol Cream base	IP IP IP IP IP IP	0.05%w/w 0.10%w/w 1.0%w/w 1.0%w/w 1.0%w/w q.s.
13	Clobetasol Propionate, Neomycin Sulphate, Tolnaftate, Iodochlorhydroxyq uinoline and Ketoconazole Cream	Composition Clobetasol Propionate Neomycin Sulphate Tolnaftate Iodochlorhydroxyquinoline Ketoconazole In a Non greasycream base	IP IP IP IP IP	0.05% w/w 0.1% w/w 1.0% w/w 1.0% w/w 2.0% w/w q.s
14	Clobetasol Propionate, Ofloxacin, Itraconazole, Cream	Composition : Ofloxacin Ornidazole Itraconazole Clobetasol Propionate Methylparaben(As preservative) Propylparaben ( As preservative) Cream Base	IP IP USP IP IP IP IP	0.75%w/w 2.0%w/w 1.00%w/w 0.05%w/w 0.20%w/w 0.02%w/w q.s.
15	Clobetasol, Neomycin & Clotrimazole Cream	Composition : Clobetasol Propionate Neomycin Sulphate Clotrimazole Preservatives: Chlorocresol Cream Base	IP IP IP IP	0.05%w/w 0.5%w/w 1.0%w/w 0.1%w/w q.s.
16	Clotrimazole & Beclomethasone Dipropionate Cream	Composition : Clotrimazole Beclomethasone Dipropionate Preservatives: Benzyl Alcohol Methyl Paraben Cream base	IP IP IP IP	1.0%w/w 0.025%w/w 1.0%w/w 0.15%w/w q.s
17	Clotrimazole Cream IP 1%w/w	Composition Clotrimazole Preservatives : Benzyl Alcohal Water Miscible Base	IP IP	1%w/w 1%w/w q.s.
18	Fluticasone Propionate Cream I.P	Each g contains Fluticasone PropionateExcipients	IP	0.05% w/w q.s.
19	Fusidic Acid & Beclomethasone Dipropionate Cream	Composition : Fusidic Acid Beclomethasone Dipropionate Preservatives Chlorocresol In a water Miscible cream Base	IP IP IP	2.00%w/w 0.025%w/w 0.12%w/w q.s
20	Fusidicacid Cream IP	Composition: Fusidic Acid Cream Base	IP	2%w/w q.s.
21	Hydroquinone, Tretinoin & Fluocinolone Acetonide Cream	Each 1gcontain: Hydroquinone Tretinoin Fluocinolone Acetonide In a cream Base	USP USP IP	20 mg 0.25 mg 0.1 mg q.s.
22	Itraconazole & TerbinafineCream	Composition : Itraconazole Terbinafine Hydrochloride Preservative : Methyl Paraben Phenoxyethanol Cream base	BP IP IP IP	1.0%w/w 1.0%w/w 0.16%w/w 0.05%w/w q.s.
23	Itraconazole Cream 1% w/w	Composition Itraconazole Methyl Paraben Propyl Paraben In cream base	BP IP IP	BP IP IP1 % w/w 0.1% w/w 0.05% w/w q.s.
24	Ketoconazole Cream	Composition : Ketoconazole Preservatives: Methyl Paraben Phenoxyethanol Cream Base	IP IP IP	2.0%w/w 0.1%w/w 0.05%w/w q.s
25	Luliconazole cream	Composition:- Luliconazole Preservative Benzyl Alcohal Cream Base	IP IP	1%w/w 1%w/w q.s.
26	Luliconazole Cream 1% w/w	Composition : Luliconazole Preservative Benzyl Alcohol Cream base	IP	1%w/w 1%w/w q.s.
27	Mometasone & Fusidic Acid Cream	Composition:- Mometasone furoate Fusidic Acid Cream Base	IP IP	0.10%w/w 2.00%w/w q.s.
28	Mometasone Furoate & Terbinafine Hydrochloride Cream	Mometasone Furoate Terbinafine Hydrochloride Cream Base	IP IP	0.1% w/w 1% w/w q.s.
29	Mometasone FuroateCream IP	Composition : Mometasone Furoate Cream Base	IP	0.1% w/w q.s.
30	Mometasone, Hydroquinone and Tretinoine Cream	Composition Mometasone furoate Hydroquinone Tretinoine Excipients	IP USP USP	0.1 % w/w 2 % w/w 0.025 %w/w q.s.
31	Neomycin, Miconazole Nitrate & Fluocinolone Acetonide Cream	Composition : Miconazole Nitrate Neomycin Sulphate Equ. to Neomycin Fluocinolone Acetonide Preservatives: Chlorocresol Cream Base	IP IP IP IP	2.0%w/w 0.5%w/w 0.01%w/w 0.1%w/w q.s
32	Ofloxacin, Flucinolone Acetonide, Clotrimazole & Chlorocresol Cream	Composition : Ofloxacin Flucinolone Acetonide Clotrimazole Chlorocresol (as Preservative) Cream Base	IP IP IP IP	0.5%w/w 0.01%w/w 1%w/w 0.1%w/w q.s.
33	Ofloxacin, Ornidazole, Itraconazole and Clobetasole PropionateCream	Composition Ofloxacin Ornidazole Itraconazole Clobetasole Propionate Methyl Paraben (Preservative) Propyl Paraben (Preservative) In cream base	IP IP USP IP IP IP	0.75 % w/w 2.0 % w/w 1 % w/w 0.05 % w/w 0.20% w/w 0.02% w/w q.s.
34	Silver Nitrate, Chlorhexidine Gluconate, Aloevera & Allantoin Cream	Composition : Silver Nitrate Chlorhexidine Gluconate Solution Allantoin AloeVera extract Preservatives: Chlorocresol Cream Base	IP IP IP IP	0.2%w/w 0.2%w/w 0.1%w/w 15.0%w/w 0.1%w/w q.s
35	Silver Sulphadiazine & Chlorhexidine GluconateCream	Composition : Silver Sulphadiazine Chlorhexidine Gluconate solution Equ. to Chlorhexidine Cream base	IP IP	0.5%w/w 0.2%w/w q.s.
36	Tacrolimus cream	Composition:- Tacrolimus Excipients	IP	0.1%w/w q.s.
37	Terbinafine Hydrochloride Cream IP	Composition: Terbinafine Hydrochloride Preservatives Benzyl Alcohol In a Cream Base	IP IP	1%w/w 1%w/w q.s.
38	Troxerutin, Calcium Dobesilate, Zinc, Phenylephrine, Lignocaine with Hydrocortisone Cream	Composition : Troxerutin Calcium Dobesilate Monohydrate Equ. to Anhydrous Calcium Dobesilate Lignocaine Hydrochloride Hydrocortisone Acetate Zinc Oxide Phenylephrine Hydrochloride Cream Base	BP BP IP IP IP IP	2.0%w/w 0.25%w/w 3.0%w/w 0.25%w/w 5.0%w/w 0.1%w/w q.s
39	Urea, Lactic acid, Propylene Glycol & Liquid Paraffin Cream	Composition : Urea Lactic Acid Propylene Glycol Liquid Paraffin Preservatives: Methyl Paraben Propyl Paraben Cream Base	IP IP IP IP IP IP	10%w/w 10%w/w 10%w/w 10%w/w 0.16%w/w 0.04%w/w q.s
40	WhiteSoft Paraffin & Light Liquid Paraffin Cream	Composition : White Soft Paraffin Light Liquid Paraffin Cream Base	IP IP	13.2%w/w 10.2%w/w q.s

External Preparations

S.No.	Product Name	Composition	Packing	Strength
1	Ondansetron Oral Solution IP	Each 5 ml contains: Ondansetron Hydrochloride Equ.to ondansetron Flavoured syrupybase	IP q.s	2 mg q.s.
2	Ondansetron Oral Solution IP	Each 5 ml contains: Ondansetron Hydrochloride Equ. to Ondansetron Flavoured Syrupy Base	IP	4mg q.s.
3	Sodium Picosulfate Oral Solution BP	Each 5 ml contains: Sodium Picosulfate In a flavoured sorbitol base Approved colour used	BP	5 mg q.s.
4	ZincSulphateOral Solution IP	Each 5 ml Contains: Zinc Sulphate Equivalent to elemental zinc In a Flavoured palatable base Approved colour used	IP	20 mg q.s.

Gel

S.No.	Product Name	Composition	Packing	Strength
1	Chlorhexidine Gluconate, Metronidazole & Lignocaine Hydrochloride Gel	Composition :- Chlorhexidine Gluconate Solution Equ. to Chlorhexidine Metronidazole Equ. to Metronidazole Lignocaine Hydrochloride Gel Base	IP IP IP	1%w/w 1%w/w 2%w/w q.s.
2	Choline Salicylate & Lignocaine Hydrochloride Gel	Composition : Choline Salicylate Solution Equ. to Choline Salicylate Lignocaine Hydrochloride Preservative: Benzalkonium Chloride In Pleasant Flavoured Base	BP IP IP	8.7%w/w 2.0%w/w 0.01%w/w q.s
3	Choline Salicylate, Lignocaine Hydrochloride and Benzalkonium Chloride Gel	Composition : Choline Salicylate Solution Equ. to Choline Salicylate Lignocaine Hydrochloride Benzalkonium Chloride In a Flavoured Mucoadhesive gel base	BP IP IP	8.7%w/w 2.0%w/w 0.01%w/w q.s
4	Clindamycin & NicotinamideGel	Composition: Clindamycin Phosphate Equivalent toClindamycin Nicotinamide Gel base	IP IP	1.0% w/w 4.0% w/w q.s.
5	Clindamycin Phosphate & AdapaleneGel	Composition Clindamycin phosphate Equivalent to clindamycin Adapalene Gel base	IP IP	1 % w/w 0.1%w/w q.s.
6	Clindamycin PhosphateGel	Composition:- Clindamycin Phosphate Equivalent toClindamycin Benzoyl PeroxideAnhydrous Gel Base	IP IP	1.00% w/w 2.50% w/w
7	Diclofenac Diethyl amine, methyl Salicylate, linseed Oil &Menthol Gel	Composition:- Diclofenac Diethyl amine Equ. toDiclofenacSodium 1.0%w/w) Linseed Oil Methyl Salicylate Menthol Benzyl Alcohol Excipients	IP BP IP IP IP	1.16%w/w 3.0%w/w 10.0%w/w 5.0%w/w 1.0%w/w q.s.
8	Diclofenac Diethylamine , Thiocolchicoside, Virgin Linseed Oil, Methyl Salicylate & Menthol Gel	Composition : Diclofenac Diethylamine Equ. to Diclofenac Sodium Thiocolchicoside Virgin Linseed Oil Menthol Methyl Salicylate Preservative : Benzyl Alcohol Gel Base	IP IP BP IP IP IP	1.16%w/w 1.00%w/w 0.125%w/w 3.0%w/w 5.0%w/w 10%w/w 1.0%w/w q.s.
9	Diclofenac, Methyl Salicylate & Menthol Topical Gel	Diclofenac Diethylamine Eq. to Diclofenac Sodium Methyl Salicylate Menthol Benzyl Alcohol (As Preservative) Gel Base	IP IP IP IP IP	2.32% w/w 2% w/w 10% w/w 5% w/w 1% w/w q.s
10	Etoricoxib,Linse ed Oil,Methyl Salicylate & Menthol Gel	Etoricoxib Linseed Oil Methyl Salicylate Menthol	IP BP IP IP	1.0% W/W 3.0% W/W 10.0% W/W 5.0% W/W q.s.
11	Fluoride Medicated Oral Gel	Composition : Sodium Monofluorophosphate In a Flavoured Gel base Approved Colour used	USP	0.35%w/w q.s
12	Itraconazole Gel	Composition Itraconazole Methyl Paraben Propyl Paraben In Gel base	BP IP IP	1 % w/w 0.1% w/w 0.05% w/w q.s.
13	Lipid Based Amphotericin B Gel 0.1% w/w	Each g contains: Amphotericin B Base	IP	1.0mg q.s.
14	Virgin Linseed Oil, Diclofenac Diethylamine, Methyl Salicyclate, Menthol& Capsaicin Gel	Composition: Virgin Linseed Oil Diclofenac Diethylamine Equ. to Diclofenac Sodium Methyl Salicyclate Menthol Capsaicin Preservative : Benzyl Alcohol Gel Base	BP IP IP IP USP IP	3.00%w/w 1.16%w/w 1.00%w/w 10.00%w/w 5.00%w/w 0.025%w/w 1.00%w/w q.s.

Lotion

S.No.	Product Name	Composition	Packing	Strength
1	Calamine & Liquid Paraffin Lotion	Composition : Calamine Liquid Paraffin Lotion Base	IP IP	8.0%w/w 10%w/w q.s.
2	Ketoconazole Lotion	Composition : Ketoconazole In a perfumed conditioner Lotion Base Approved Colour used	IP	2.0%W/V q.s
3	Luliconazole Lotion	Composition : Luliconazole Lotion Base		1.0%w/v q.s
4	Mometasone Furoate& Salicylic Acid Lotion	Composition : Mometasone Furoate Salicylic Acid In an Emollient Base Containing Hexylene Glycol Preservatives : Methylparaben Propylparaben	IP IP IP IP	0.10%w/w 3.50%w/w 0.20%w/w 0.02%w/w
5	Permethrin Lotion	Composition : Permethrin Base		5.0%w/v q.s

mouth wash

S.No.	Product Name	Composition	Packing	Strength
1	Chlorhexidine Gluconate, Sodium Fluoride & Zinc Chloride Mouthwash	Composition : Chlorhexidine Gluconate (as Chlorhexidine Gluconate Solution IP) Sodium Fluoride ZincChloride Base Colour: Brilliant Blue FCF	IP IP	0.2%w/v 0.05%w/v 0.09%w/v q.s
2	Chlorhexidine mouth wash IP	Chlorhexidine Gluconate Solution diluted to Chlorhexidine Gluconate In a flavoured Aqueous base Approved colour used.	IP	0.2% w/v q.s.
3	Thymol, Menthol, Eucalyptol & Ethanol Mouthwash	Composition : Thymol Menthol Eucalyptol Ethanol(95%) Approved Colour Used	IP IP IP	0.06%w/v 0.04%w/v 0.09%w/v 21.6%v/v

Oil

S.No.	Product Name	Composition	Packing	Strength
1	Aceclofenac along with Linseed oil, Menthol, Methyl Salicylate & Capsaicin	Composition :- Aceclofenac Linseed Oil Menthol Methyl Salicyclate Capsaicin Banzyl Alcohol (as Preservative) Gel base	IP BP IP IP USP IP	1.5%w/w 3%w/w 5%w/w 10%w/w 0.010%w/w 1%w/w q.s.
2	Simethicone , Dill Oil & Fennel Oil Drops	Each ml contains: Simethicone Dill Oil Fennel Oil Flavoured palatable base. Approved colour used	IP BP IP	40mg 0.005ml 0.0007ml q.s.

Ointment

S.No.	Product Name	Composition	Packing	Strength
1	Clobetasol Propionate & Salicylic Acid Ointment	Composition: Clobetasol Propionate Salicylic acid Excipients In Ointment Base	IP IP	0.05%w/w 6.0%w/w q.s.
2	Metronidazole and Povidone –Iodine Ointment	Composition : Metronidazole Povidone–Iodine (Available Iodine 1.0%w/w) Water Soluble Ointment Base	IP IP	2.0%w/w 10.0%w/w q.s
3	Mometasone FuroateOintment	Each g contains Mometasone Furoate Excipients	IP	0.1% w/w q.s.
4	Mupirocin ointment IP	Composition :- Mupirocin Topical Ointment Base	IP	2.0%w/w q.s.
5	Neomycin and Polymyxin B Sulfate and Bacitracin Zinc Ointment USP	Composition : Each gm Contains : Polymyxin B Sulfate Equ. to Polymyxin Bacitracin Zinc Equ. to Bacitracin Neomycin Sulphate Equ. to Neomycin Preservative: Benzyl Alcohol Ointment Base	USP IP IP IP	5000 units 400units 3400units 0.1%w/w q.s
6	Povidone –Iodine & Ornidazole Ointment	Composition : Povidone Iodine (0.5% w/w Available Iodine) Ornidazole In an Ointment base	IP IP	5.0%w/w 1.0%w/w q.s
7	Povidone Iodine ointment	Composition :- Povidone Iodine Excipients	IP	5%w/w q.s.
8	Povidone iodine, Metronidazole and Aloevera Ointment	Composition Povidoneiodine (AvailableIodine0.5% w/w) Metronidazole Aloevera Water Soluble ointment base. (Banned drug 12/08/2024)	IP IP IP	5 % w/w 1 % w/w 1.50%w/w q.s.
9	Povidone Iodine& Metronidazole, Sucralfate Ointment.	Composition : Povidone Iodine (available Iodine 0.5%w/w) Metronidazole Sucralfate In a water soluble Ointment base.	IP IP USP	5.0 %W/W 1.0% W/W 7.0% W/W q.s.

Oral Liquids

S.No.	Product Name	Composition	Packing	Strength
1	Ambroxal Hydrochloride Drops	Each ml contains: Ambroxal Hydrochloride In a flavoured base Approved colour used	IP	7.5mg q.s.
2	Ambroxol HCl, Levosalbutamol & Guaiphenesin Drops	Each ml Contains : Ambroxol Hydrochloride Levosalbutamol Sulphate Equ. to Levosalbutamol Guaiphenesin In a Flavoured SyrupyBase Colour : Ponceau 4R	IP IP IP	7.5mg 0.25mg 12.5 mg q.s
3	Chlorhexidine GluconateSolution & Cetrimide Antiseptic Liquid	Composition: ChlorhexidineGluconate solution Cetrimide Solution Base	IP IP	0.3% v/v 0.6% w/v q.s.
4	Cyproheptadine Hydrochloride & Tricholine Citrate Drops	Each ml contains : Cyproheptadinehydrochloride Equ. toanhydrous Cyproheptadine Hydrochloride Tricholine Citrate In a Flavoured palatable Base Approved colour used	IP	1.5mg 55mg q.s.
5	Dicyclomine Hydrochloride& Simethicone Oral Drops	Each ml contains : Dicyclomine Hydrochloride Simethicone In a flavoured syrupybase Approved Coloured used	IP IP	10mg 40mg q.s
6	Digestive Enzyme Drops.	Each ml contains: Alpha amylase (1:800) Pepsin Dil oil Anise oil Carawayoil Flavored syrupy base ApprovedColour Used	IP IP BP BP BP	20mg 10mg 2mg 2mg 2mg q.s
7	Multivitamin, Iron, folic acid & Lysine Drops	Each ml contains: Vitamin A(as Palmitate) Vitamin D3 Ferric Ammonium citrate (eq.to Element iron) Vitamin B12 Folic acid Lysine Monohydrochloride Thiamine Hydrochloride Vitamin B2 Vitamin B6 D-Panthenol Niacinamide Flavoured syrupy base Approved Colour Used	IP IP IP IP IP USP IP IP IP IP IP	5000IU 400IU 25mg 5mcg 0.2mg 100mg 1mg 1mg 1mg 3mg 10mg q.s
8	Paracetamol Oral Drops	Each ml Contains: Paracetamol Flavoured Palatable base	IP	100mg q.s
9	Paracetamol, Chlorpheniramine Maleate & Phenylephrine HCl Drops	Each ml contains Paracetamol Chlorpheniramine Maleate Phenylephrine Hydrochloride Flavoured Palatable Base Approved Colour Used	IP IP IP	125mg 1mg 2.5mg
10	Phenylephrine Hydrochloride and Chlorpheniramine Maleate Drops IP	Each ml contains : Phenylephrine Hydrochloride Chlorpheniramine Maleate In a flavoured syrupyBase. Approved colour used.	IP IP	5mg 2mg q.s.
11	Vitamin D3 oral solution	Each 5 ml contains: Cholecalciferol (In Nano Droplet form) In a flavoured sugar free syrupybase. Approved colour used.	IP	60000IU q.s

Powder

S.No.	Product Name	Composition	Packing	Strength
1	A Balanced Protein Supplement Fortified with Essential Vitamins , Minerals & DHA	Each 30g contains: Protein Hydrolysate 20% DHA 10 % Pyridoxine Hydrochloride Cyanocobalamin Vitamin D3 Folic Acid Niacinamide Calcium (as Dibasic Calcium Phosphate Dihydrate IP) Manganese Sulphate Zinc (as ZincSulphate Heptahydrate IP) Iron (as Ferric Ammonium Citrate IP) Magnesium Oxide Cupric Sulphate Chromium (as Chromium Chloride USP) Selenium Dioxide Monohydrate Potassium Chloride Sodium Chloride Iodine (as Potassium Iodide IP) Excipients	IP IP IP IP IP USP IP USP USP IP IP	5 g 25 mg 0.5 mg 1 mcg 100 IU 0.3 mg 15 mg 200 mg 1.5 mcg 1.5 mg 10 mg 4 mg 2.5 mg 25 mcg 20 mcg 5 mg 33 mg 100 mcg q.s.
2	ABalanced Protein Supplement Fortified with Essential Vitamins & Minerals	Each 30gmpowder Contains Whey Protein 30% Docosa HexaenoicAcid 10 % Pyridoxine Hydrochloride Cyanocobalamin Vitamin D3 Folic Acid Niacinamide Calcium (as Dibasic Calcium Phosphate Dihydrate IP) Manganese Sulphate Zinc (as ZincSulphate Heptahydrate IP) Iron (as Ferric Ammonium Citrate IP) Magnesium Oxide Cupric Sulphate Chromium (as Chromium Chloride USP) Selenium Dioxide Monohydrate Potassium Chloride Sodium Chloride Iodine (as Potassium Iodide IP) Excipients	IP IP IP IP IP USP IP USP USP IP IP	10 g 25 mg 0.5 mg 1 mcg 100 IU 300 mcg 15 mg 200 mg 1.5 mcg 1.5 mg 10 mg 4 mg 2.5 mg 25 mcg 20 mcg 5 mg 33 mg 100 mcg q.s.
3	Clotrimazole DustingPowder	Composition : Each 100gm contains Clotrimazole Excipients	IP	1gm q.s
4	Miconazole Nitrate Topical Powder USP	Composition : Miconazole Nitrate Talc	IP IP	2%w/w q.s
5	Protein Hydrolysate, Calcium, Phosphorus, Vitamin B6, Cyanocobalamin Vitamin D3, Niacinamide, Folic Acid, Zinc & Iron	Each 30g contains: Protein hydrolysate 20% Calcium (as Dibasic Calcium Phosphate) Phosphorus (as Dibasic Calcium Phosphate) Vitamin B6 (Pyridoxine Hydrochloride) Vitamin B12 (Cyanocobalamin) Vitamin D3 Niacinamide Folic Acid Zinc (as ZincSulphate Heptahydrate IP) Iron (as Ferric Ammonium Citrate IP) Excipients	IP IP IP IP IP IP IP	5 g 225 mg 174 mg 0.5 mg 1 mcg 100 IU 15 mg 300 mg 5 mg 7.5 mg q.s.

Products

S.No.	Product Name	Composition	Packing	Strength
1	Chlorzoxazone, Diclofenac Potassium, Paracetamol	Each film coated tablet contains: Chlorzoxazone Diclofenac Potassium Paracetamol Excipients Approved colour used.	USP BP IP	250mg 50mg 325mg q.s.
2	Cholecalciferol oral solution USP	Each ml Contains: Cholecalciferol (Vitamin D3) In a pleasantlyflavoured palatable Base Approved Colour used.	IP	400IU q.s.
3	Levofloxacin Oral Solution IP	Each 5 ml contains: Levofloxacin Hemhydrate Eq.to Levofloxacin Excipients Approved colour used.	IP	125mg q.s.
4	Metronidazole Oral solution	Each 5ml contains : Metronidazole Benzoate Equ. to Metronidazole In a flavoured Syrupy Base. Colour : Approved Coloured Used	IP	250mg q.s
5	Minoxidil Topical solution USP	Each ml contains: Minoxidil Excipients Approved colour used	IP	20mg q.s
6	Oral Rehydrat ion Salts IP	Each Pack contains: Sodium Chloride Potassium Chloride Sodium Citrate Dextrose Anhydrous Excipients	IP IP IP IP	0.52g 0.30g 0.58g 2.70g q.s.
7	Oral Rehydration Salt IP	Composition: Each sachet(21.8gm) contains: Dextrose (Anhydrous) Potassium Chloride Sodium Chloride Sodium Citrate Excipients	IP IP IP IP	13.5gm 1.5gm 2.6gm 2.9gm q.s
8	Potassium Citrate and Citric Acid Oral Solution USP	Each 5ml contains : Potassium Citrate Citric Acid Monohydrate Flavoured Sorbitol Base. Approved Colour Used	IP IP	1100mg 334mg q.s
9	Povidone Iodine GermicideGargle	Composition: Povidone Iodine (0.2%w/vAvailable Iodine) Absolute alcohol contain In amint Flavour aqueous base	IP	2.0% w/v 8.38% v/v q.s.
10	Povidone Iodine Solution IP	Composition : Povidone Iodine (available Iodine0.5%w/v) Purified Water	IP IP	5%w/v q.s
11	Ursodeoxycholic Oral Acid Suspension	Each 5ml Contains : Ursodeoxycholic Acid Excipients Approved colour used	IP	125mg q.s.

Sachet

S.No.	Product Name	Composition	Packing	Strength
1	Cholecalciferol GranulesSachet	Each sachet of1gmContains: Cholecalciferol Excipients	IP	60000 IU q.s
2	L-Arginine & Proanthocynadine Granules Sachet	Each 5 gm sachet contain: L-Arginine Proanthocynadine Excipients Approved colour used	IP	3.0 gm 75 mg q.s.
3	Pre & Probiotic With ZincSachet	Each 1 gm sachet contain: Lactobacillus acidophilus Lactobacillus rhamnosus Lactobacillus casei Lactobacillus plantarum Lactobacillus bulgaricus Bifidobacterium Longum Bifidobacterium infantis Bifidobacterium breve Streptococcus Thermophillus Fructo oligosaccharide Zinc Sulphate Monohydrate Eq. to elemental zinc Saccharomyces boulardil Excipients Containspermitted synthetic flavours	USP	350 million 200 million 150 million 150 million 150 million 150 million 150 million 150 million 200 million 100 mg 10mg 0.05 billion q.s.

Shampoo

S.No.	Product Name	Composition	Packing	Strength
1	Ketoconazole Anti- Dandruff Shampoo	Composition: Ketoconazole Conditioner Shampoo Base	IP	2.0%w/v q.s
2	Ketoconazole Zinc Pyrithione Shampoo	Composition : Ketoconazole Zinc Pyrithione (ZPTO) Conditioner Shampoo Base Colour: Erythrosine	IP	2.0%w/v 1.0%w/v q.s

Suspension

S.No.	Product Name	Composition	Packing	Strength
1	Aceclofenac & Paracetamol Suspension	Each 5ml contains: Aceclofenac Paracetamol In a Flavoured SyrupyBase. Approved colour used	IP IP	100mg 250mg q.s.
2	Acetaminophen, Dextromethorphan, Guaiphenesin, Phenylephrine HCl, Chlorpheniramine Maleate & Menthol Suspension	Each 5ml Contains : Acetaminophen Dextromethorphan Hydrobromide Guaiphenesin Phenylephrine Hydrochloride Chlorpheniramine Maleate Menthol In a flavoured Suspension Base Colour: Sunset Yellow FCF	USP BP BP BP BP BP	250mg 10mg 50mg 5mg 2mg 1mg q.s
3	Albendazole & Ivermectin suspension	Each 5 ml contains: Albendazole Ivermectin Flavoured syrupybase	IP IP	200 mg 1.5 mg
4	Albendazole Oral Suspension IP	Each ml Contains: Albendazole In flavoured Syrupybase Approved colour used	IP	200 mg q.s.
5	Albendazole Oral Suspension IP	Each 5ml contains: Albendazole Excipients Approved colour used	IP	200mg q.s.
6	Aluminium , Magnesium & simethicone oral Suspension IP	Each 10ml contains : Aluminiumhydroxide Gel Equ. to Dried Aluminium Hydroxide Gel Magnesium Hydroxide Paste Equ. to Magnesium Hydroxide Simethicone In a flavoured Palatable Base Colour :Erythrosine & Tartrazine	IP IP IP	250mg 250mg 50mg q.s
7	Aluminium Hydroxide, Magnesium Hydroxide & Oxetacaine Oral Suspension	Each 5 ml contains: Aluminium Hydroxide (Added Aluminium Hydroxide paste Eq. to dried aluminium hydroxide gel ) Magnesium Hydroxide (Added as magnesium Hydroxide Paste) Oxetacaine Flavoured palatable base	IP IP IP BP	0.291 g 0.380 g 98 mg 10 mg q.s.
8	Azithromycin Oral Suspension IP	Each 5 ml contains Azithromycin Dihydrate eq. toAnhydrousAzithromycin In a flavoured Syrupybase. Approved Colour Used	IP	200mg q.s.
9	Azithromycin Suspension IP	Each 5 ml contain: Azithromycin Dihydrate Equivalent to Azithromycin Anhydrous In flavoured Syrupybase Approved colour used	IP	100 mg q.s
10	Calcitriol & Calcium Citrate Suspension	Each 5ml contains: Calcitriol Calcium Citrate Equ. To Elemental CalciumIn a Flavoured syrupyBase.Approved colour used.	IP USP	0.0625mcg 100mg q.s.
11	Calcium Carbonate, & Vitamin D3 Suspension	Each 5ml Contains : Calcium Carbonate 625mg (Derived from Oyster Shell) Equ. to elemental Calcium Vitamin D3 Flavoured SyrupyBase ApprovedColour Used	IP IP	250mg 125IU q.s.
12	Calcium Carbonate, Magnesium Hydroxide, Zinc & Vitamin D3 Suspension	Each 5ml contains: Calcium Carbonate Eq. toElementalCalcium Magnesium Hydroxide Eq. toElemental Magnesium Zinc Gluconate Eq. toElemental zinc Vitamin D3 In a Flavoured syrupybase Approved colour used	IP IP USP IP	625 mg 250 mg 180 mg 75 mg 14 mg 2 mg 200 IU
13	Calcium Carbonate, Vitamin d3 Magnesium& Zinc Suspension.	Each 5ml contains: Calciumcarbonate (eq. toElemental calcium150mg) Vitamin D3 Magnesium Hydroxide (Eq.to Elemental magnesium) Zinc Gluconate Eq.to Elemental zinc In flavored syrupybase ApprovedColour Used	IP IP IP IP	375mg 200IU 25mg 10.45mg 1.5mg q.s.
14	Calcium Phosphorus, Magnesium, Zinc& Vitamin D3 Suspension	Each 10ml (2Teaspoonful) Contains: Calcium Phosphate Equ. To Elemental Calcium Equ. ToElemental PhosphorusMagnesium Hydroxide Equ. ToElemental MagnesiumZinc Gluconate Equ. ToElemental ZincVitamin D3 In a Flavoured Palatable Base Approved colour used.	IP IP USP IP	300mg 150mg 75mg 4mg 400IU q.s.
15	Calcium, Vitamin D3, Vitamin B12 & Lysine Hydrochloride Suspension	Each 5ml contains: Calciumcarbonate Equ. toElemental Calcium Vitamin D3 Vitamin B12 Lysine Hydrochloride Flavoured sorbitol base. Approved colour used.	IP IP IP USP	150mg 200IU 2.5mcg 25mg q.s.
16	Deflazacort Oral Suspension	Each 5ml contain: Deflazacort In flavoured Syrupybase Approved colour used		6 mg q.s.
17	Dicyclomine Hydrochloride & Simethicone Suspension	Each 5ml contains: Dicyclomine Hydrochloride Simethicone Emulsion USP Eq. to Simethicone In a flavoured syrupy base Approved colour used.	IP USP	10mg 40mg q.s.
18	Dried Aluminium Hydroxide , Magnesium Hydroxide, Simethicone & Sorbitol Oral Suspension	Each 5ml contains : Dried Aluminium Hydroxide Gel Magnesium Hydroxide Activated Simethicone Sorbitol Solution (Non Crystallizing 70%) In a flavoured non syrupy base. Approved colour used	IP IP IP IP	250mg 250mg 50mg 1.25gm q.s.
19	Dried Aluminium Hydroxide Gel , Magnesium Hydroxide Gel, Oxetacaine & Activated Dimethicone oral Suspension	Each 5ml contains : Dried Aluminium Hydroxide Gel Magnesium Hydroxide Gel Oxetacaine Activated Dimethicone In a Flavoured non syrupybase Approved colour used	IP IP IP IP	300mg 250mg 10mg 50mg q.s.
20	Dried Aluminium Hydroxide Gel, Magnesium hydroxide, Oxetacaine and Simethicone Suspension	Each 5ml contain: Dried Aluminium Hydroxidegel Magnesium hydroxide Oxetacaine Simethicone In a flavoured sorbitol base Approved colour used	IP IP BP IP	600 mg 300mg 10 mg 25 mg q.s.
21	Ferrous Ascorbate & Folic Acid Suspension	Each 5ml contains:- Ferrous Ascorbate eq. toElemental Iron Folic Acid Excipients In flavored syrupybase ApprovedColour Used	IP	30mg 550mcg q.s.
22	Ferrous Ascorbate, Folic Acid, Methylcobalamin Suspension	Each 5ml contains : Methylcobalamin Ferrous Ascorbate Equ. toElemental Iron Folic Acid In a flavoured syrupyBase Approved colour used.	IP IP	500mcg 30mg 0.5mg q.s.
23	Ibuprofen & Paracetamol Suspension	Each 5ml Contains Ibuprofen Paracetamol Flavoured Palatable base Colour : Sunset Yellow FCF	IP IP	100mg 162.5mg q.s
24	Levocarnitine Oral Solution U.S.P.	Each 5ml contains: Levocarnitine In a flavoured syrupy base Approved colour used.	I.P.	500mg
25	Levocetirizine & Montelukast Suspension	Each 5ml Contains : Levocetirizine Hydrochloride Montelukast Sodium Equ. to Montelukast In a flavoured syrupybase. Approved colour used	IP IP	2.5mg 4mg q.s.
26	Levocloperastine Fendizoate Oral Suspension	Each 5ml Contains : Levocloperastine Fendizoate Equ. To Levocloperastine HClIn a Flavoured Syrupy Base Approved colour used		35.4mg 20mg q.s.
27	Levofloxacin & Ornidazole Oral Suspension	Each 5ml Contains : Levofloxacin Hemihydrate Equ. to Levofloxacin Ornidazole In a flavoured SyrupyBase. Approved colour used	IP IP	125mg 125mg q.s.
28	Liquid Paraffin & Milk of Magnesia Suspension	Each15 ml (tablespoonful 133pprox..)Contains: Liquid Paraffin Milk ofMagnesia flavoured syrupy base Approvedcolour used	IP IP	3.75ml 11.25ml q.s.
29	Magaldrate & Simethicone Oral Suspension IP	Each 5ml contains : Magaldrate (as anhydrous) Simethicone In a Flavored Syrupybase Approved colour used.	IP IP	400mg 60mg q.s
30	Magaldrate, Simethicone & Domperidone Oral Suspension	Each 5ml contains: Magaldrate Simethicone Domperidone Sorbitol Solution (70%) (Non-Crystallizing) Approved colour used	IP IP IP IP	480mg 20mg 10mg q.s.
31	Magaldrate, Simethicone & Oxetacaine Suspension	Each 5ml contains: Magaldrate Simethicone Oxetacaine Excipients Approved colour used	IP IP BP	480mg 20mg 10mg q.s.
32	Magaldrate, Simethicone & Oxetacaine Suspension.	Each 5ml contains: Magaldrate Simethicone Oxetacaine Excipients Approved colour used.	IP IP BP	540mg 50mg 10mg q.s.
33	Magaldrate& Simethicone Oral Suspension	Each 5ml contains: Magaldrate Simethicone Sorbitol Solution (70%) (Non Crystallising) In a flavoured sugar freeBase. Approved Colour Used.	IP IP	400mg 20mg q.s.
34	Mefenamic Acid & Paracetamol Suspension	Each 5mlContains:- Mefenamic Acid Paracetamol In flavoured Palatablebase Approved colour used	IP IP	100 mg 250 mg q.s.
35	Mefenamic Acid Oral Suspension	Each 5ml contains: Mefenamic Acid In a Flavoured SyrupyBase Approved colour used	IP	100mg q.s.
36	Milk of Magnesia, Liquid Paraffin & Sodium Picosulphate Suspension	Each 5 ml contain: Milk of Magnesia Liquid Paraffin Sodium Picosulphate Excipients In a Flavoured Sorbitol base Approved colour used	IP IP BP	3.75ml 1.25ml 3.33 mg q.s.
37	Milk of Magnesia, Liquid Paraffin and Sodium Picosulfate Suspension	Each 5ml contains: Liquid Paraffin Milk of Magnesia Sodium Picosulphate Flavoured Non SyrupyBase Approved colour used	IP IP BP	1.25ml 3.75ml 3.33mg q.s.
38	Multivitamin Multimineral & Antioxidant suspension	Each 5ml contains: Cholecalciferol (as Stabilized) Pyridoxine HCL Niacinamide Cyanocobalamin Zinc (as Zinc Gluconate ) B-Carotene Dispersion 2.5% Manganese (as Manganese Chloride Tetrahydrate) Molybdenum (as Sodium Molybdate Dihydrate ) Selenium (as Sodium Selenate) Lysine Hydrochloride Iodine(as Potassium Iodide ) Biotin Chromiume (as Chromium Chloride Hexahydrate) Inositol Excipients In a flavoured syrupy base Approved colour used.	IP IP IP IP USP USP BP BP IP USP USP USP	200IU 1mg 15mg 1mcg 3mg 38mg 0.8mg 8mcg 10mcg 30mg 50mcg 10mcg 10mcg 10mg q.s.
39	Nitazoxanide for Oral Suspension	Composition : Each 5ml of reconstituted suspension contains Nitazoxanide Excipients Approved Colour used		100mg q.s
40	Ofloxacin & Metronidazole Suspension	Each 5ml contains : Ofloxacin Metronidazole Benzoate Equ. to Metronidazole In a Flavoured SyrupyBase Colour : Sunset Yellow FCF	IP IP	50mg 100mg q.s
41	Ofloxacin & Metronidazole Suspension	Each 5ml contains : Ofloxacin Metronidazole Benzoate Equ. to Metronidazole Flavoured Syrupy base Approved colour used.	IP IP	50mg 120mg q.s
42	Ofloxacin & Metronidazole Suspension	Each 5ml contains : Ofloxacin Metronidazole Benzoate Equ. To Metronidazole In a Flavoured Palatable Base Colour: - Approved colour used.	IP IP	100mg 200mg q.s.
43	Ofloxacin oral suspension IP	Each 5ml ofsuspension contains Ofloxacin In a flavoured Syrupybase. Approved Colour Used.	IP	100mg q.s.
44	Ofloxacin Oral Suspension IP	Each 5 ml contains: Ofloxacin Excipients Approved colour used	IP	50 mg
45	Ofloxacin, Metronidazole Benzoate & Simethicone Suspension	Each 5ml Contains:- Ofloxacin MetronidazoleBenzoate Equivalent toMetronidazole Simethicone In flavoured Syrupybase Approved colour used	IP IP IP	50 mg 120mg 10 mg q.s.
46	Paracetamol , Phenylephrine Hydrochloride &Cetirizine Dihydrochloride suspension	Each 5ml contains: Paracetamol Phenylephrine Hydrochloride Cetirizine Dihydrochloride In a flavoured base Approved colour used (Banned drug 12/08/2024)	IP IP IP	250mg 2.5mg 2.5mg q.s
47	Paracetamol & Domperidone MaleateSuspension	Each 5ml contains : Paracetamol Domperidone Maleate Flavoured Palatable Base Colour : Sunset Yellow FCF	IP IP	125mg 5mg q.s
48	Paracetamol & Domperidone Suspension	Each 5ml contains: Paracetamol Domperidone In a Flavoured syrupyBase Approved colour used	IP IP	250mg 5mg q.s.
49	Paracetamol & Mefenamic Acid Suspension	Each 5ml Contains Paracetamol Mefenamic Acid In flavoured Palatable base Approved colour used	IP IP	125mg 50mg q.s.
50	Paracetamol & Phenylephrine & Chlorpheniramine maleate Suspension	Each 5 ml contains :- Paracetamol Phenylephrine HCl Chlorpheniramine maleate In flavoured syrupyBase. Approved Colour Used.	IP IP IP IP	250mg 5mg 2mg q.s.
51	Paracetamol Paediatric Oral Suspension IP	Each 5ml contains: Paracetamol In a Flavoured SyrupyBase. Approved colour used	IP	240mg q.s.
52	Paracetamol Paediatric Oral Suspension IP	Each 5ml contains: Paracetamol In a Flavoured SyrupyBase Approved colour used	IP	120mg q.s.
53	Paracetamol Suspension IP	Each 5ml Contains Paracetamol Excipients Approved colour used	IP	125mg q.s.
54	Paracetamol Suspension IP	Each 5ml Contains Paracetamol In flavoured Palatablebase Approved colour used	IP	250mg q.s.
55	Paracetamol, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Suspension	Each 5ml contains Paracetamol Chlorpheniramine Maleate Phenylephrine Hydrochloride Flavoured Palatable Base Approved Colour Used.	IP IP IP	125mg 1mg 2.5mg
56	Paracetamol, Dextromethorph nHBr,Cetirizine HCL, ,Phenylephrine HCL, Sodium Citrate & Menthol Suspension	Each 5ml Contains: Paracetamol Dextromethorphan HBr Cetirizine HCL Phenylephrine HCL Sodium Citrate Menthol Ina flavoured syrupy base Approved colour use	IP IP IP IP IP IP	250mg 5mg 2.5mg 5mg 25mg 1mg q.s
57	Paracetamol, Phenylephrine HCL, & Chlorpheniramine MaleateSuspension	Each 5ml Contains:- Paracetamol Phenylephrine HCL Chlorpheniramine Maleate In flavoured Palatablebase Approved colour used	IP IP IP	125 mg 5 mg 1 mg q.s.
58	Paracetamol, Phenylephrine HCL, Chlorpheniramine Maleate, Sodium Citrate & Menthol Suspension	Each 5ml Contains:- Paracetamol Phenylephrine HCL Chlorpheniramine Maleate Sodium Citrate Menthol In flavoured Syrupybase Approved colour used	IP IP IP IP IP	250 mg 5 mg 0.5 mg 60 mg 1 mg q.s.
59	Paracetamol, Phenylephrine HCL, Chlorpheniramine Maleate, Sodium Citrate & Menthol Suspension	Each 5ml Contains:- Paracetamol Phenylephrine HCL Chlorpheniramine Maleate Sodium Citrate Menthol In flavoured Syrupybase Approved colour used	IP IP IP IP IP	125 mg 5 mg 0.5 mg 60 mg 1 mg q.s.
60	Paracetamol, Phenylephrine Hydrochloride & Cetirizine Dihydrochloride Suspension	Each 5ml contains: Paracetamol Phenylephrine Hydrochloride Cetirizine Dihydrochloride In a flavoured Syrupy Base. Approved colour used. (Banned drug 12/08/2024)	IP IP IP	125mg 5mg 2mg q.s.
61	Paracetamol, Phenylephrine Hydrochloride & Cetirizine Hydrochloride Suspension	Each 5ml contains: Paracetamol Phenylephrine Hydrochloride Cetirizine Hydrochloride In a flavoured SyrupyBase. Approved colour used. (Banned drug 12/08/2024)	IP IP IP	125mg 2.5mg 2.5mg q.s.
62	Paracetamol& Dicyclomine Hydrochloride Suspension	Each 5ml contains: Paracetamol Dicyclomine Hydrochloride Flavoured Palatable Base Colour: Sunset YellowFCF	IP IP	125mg 5mg q.s
63	Posaconazole oral Suspension	Each ml contains: Posaconazole Excipients Approved Colour Used	IP	40mg q.s
64	Potassium Citrate, Magnesium Citrate & Vitamin B6 Oral Suspension	Each 5ml contains : Potassium Citrate Magnesium Citrate Pyridoxine Hydrochloride In a Flavoured SyrupyBase Approved colour used	IP USP IP	1100mg 375mg 20mg q.s.
65	Rifaximin & Metronidazole Suspension	Each 5 ml contains: Rifaximin Metronidazole Benzoate Eq. to Metronidazole In a flavoured base Excipients Approved colour used.	I.P. I.P.	100mg 200mg q.s.
66	Rifaximin Oral Suspension	Each 5ml contains: Rifaximin Excipients Approved Colour Used.		100mg q.s.
67	Simethicone, Norfloxacin & Metronidazole Suspension	Each 5ml contains : Simethicone Norfloxacin Metronidazole Benzoate Equ. to Metronidazole In a flavoured SyrupyBase Approved colour used	IP IP IP	10mg 125mg 125mg q.s.
68	Sodium Alginate, Sodium Bicarbonate & Calcium Carbonate Oral Suspension	Each 5 ml contains: Sodium Alginate Sodium Bicarbonate Calcium Carbonate In a flavoured base. Approved colour used	IP IP IP	250mg 133.5mg 80mg q.s.
69	Sucralfate & Oxetacaine Oral suspension	Each 10ml Contains:- Sucralfate Oxetacaine In palatable sorbitol Base Approved Colour Used.	USP BP	1g. 20mg. q.s.
70	Sucralfate & Oxetacaine Suspension	Each 5ml contains: Sucralfate Oxetacaine In a flavoured syrupyBase. Approved colour used.	USP BP	500mg 10mg q.s.
71	Sucralfate & Oxetacaine Suspension	Each 10ml contains: Sucralfate Oxetacaine In a flavoured palatable base Approved colour used	IP BP	1g 10 mg q.s.
72	Sucralfate & Oxetacaine Suspension	Each 5ml contains: Sucralfate Oxetacaine In a flavoured palatable base Approved colour used	USP BP	1g 10 mg q.s.
73	Sucralfateand Oxetacaine Suspension	Each 10ml contain: Sucralfate Oxetacaine In a flavoured sorbitol base Approved colour used	IP BP	IP BP
74	Ursodeoxycholic Oral Acid Suspension	Each 5ml Contains : Ursodeoxycholic Acid Excipients Approved colour used	IP	250mg q.s.
75	ZincGluconate Suspension	Each 5ml contains: Zinc Gluconate Equ. to Elemental Zinc In a flavoured SyrupyBase Colour: Ponceau 4R	USP	20mg q.s

Syrup

S.No.	Product Name	Composition	Packing	Strength
1	Acebrophylline , Terbutaline Sulphate & Guaiphenesin Syrup	Each 5ml contains : Acebrophylline Terbutaline Sulphate Guaiphenesin In a flavoured Syrupybase. Approved Colour Used.	IP IP	50mg 1.25 50mg q.s.
2	Alpha-Amylase & Papain Syrup	Each 5ml contains: Alpha-Amylase (Bacterial 1:800) Papain In a flavoured non-syrupy base Approved colour used.	I.P. I.P.	100mg 50mg q.s.
3	Ambroxal Hydrochloride Syrup	Each 5ml contains: Ambroxal Hydrochloride In a flavoured base Approved colour used	IP	30mg q.s.
4	Ambroxol HCl , Terbutaline Sulphate, Guaiphenesin and Menthol Syrup	Each 5ml contains : Ambroxol Hydrochloride Terbutaline Sulphate Guaiphenesin Menthol In a flavoured syrupybase. Approved colour used.	IP IP IP IP	15mg 1.5mg 50mg 2.5mg q.s.
5	Ambroxol HCL, Cetirizine HCL, Phenylephrine HCL, Guaiphenesin & Menthol Syrup	Each 5ml Contains: Ambroxol Hydrochloride Cetirizine Hydrochloride Phenylephrine Hydrochloride Guaiphenesin Menthol In flavoured Palatable base Approved colour used	IP IP IP IP IP	4 mg 2.5 mg 5 mg 50 mg 1 mg q.s.
6	Ambroxol Hcl, Levosalbutamol & Guaiphenesin Syrup	Each 5ml Contains : Ambroxol Hydrochloride Levosalbutamol Sulphate Equ. to Levosalbutamol Guaiphenesin In a Flavoured SyrupyBase Colour : Ponceau 4R	IP IP IP	15mg 0.5mg 50mg q.s
7	Ambroxol HCL, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup	Each 5ml contains: Ambroxol HCL Terbutaline Sulphate Guaiphenesin Menthol In a flavoured sugar free base	IP IP IP IP	15mg 1.25mg 50mg 1mg q.s.
8	Ambroxol Hydrochloride , Phenylephrine Hydrochloride ,Chlorpheniramine Maleate, Guaiphenesin & Menthol Syrup	Each 5ml. contains : Phenylephrine HCL Ambroxol Hydrochloride Guaiphenesin Chlorpheniramine Maleate Menthol In a Flavoured syrupybase Approved colour used.	IP IP IP IP IP	5mg 15mg 50mg 2mg 1.5mg q.s.
9	Ambroxol Hydrochloride & Cetirizine Hydrochloride Syrup	Each 5ml contains : Ambroxol Hydrochloride Cetirizine Hydrochloride In a Flavoured SyrupyBase. Approved colour used	IP IP	30mg 5mg q.s.
10	Ambroxol Hydrochloride Syrup	Each 5ml contains : Ambroxol Hydrochloride In a Flavoured SyrupyBase Approved colour used	IP	30mg q.s.
11	Ambroxol Hydrochloride Terbutaline Sulphate, Guaiphenesin & Menthol Syrup	Each 5ml. contains : Ambroxol Hydrochloride Terbutaline Sulphate Guaiphenesin Menthol In a Sorbitol Solution (70%) (Non-Crystallising) Approved colour used	IP IP IP IP	15mg 1.25mg 50mg 2.5mg q.s.
12	Ambroxol Hydrochloride, Levosalbutamol Sulphate & Guaiphenesin Syrup	Each 5ml Contains Ambroxol Hydrochloride Levosalbutamol Sulphate Eq. to Levosalbutamol Guaiphenesin In flavoured Syrupybase Approved colour used	IP IP IP	30 mg 1 mg 50mg q.s.
13	Ambroxol Hydrochloride, Terbutaline Sulphate & Guaiphenesin oral Drops	Each ml(Approx. 20drops) contains : Ambroxol Hydrochloride Terbutaline Sulphate Guaiphenesin In a flavoured syrupyBase. Approved colour used.	IP IP IP	7.5mg 0.5mg 12.5mg q.s.
14	Ambroxol Terbutaline Guaiphenesin with Menthol Syrup	Each 5ml Contains :- Ambroxol Hydrochloride Terbutaline Sulphate Guaiphenesin Menthol In flavoured syrupyBase Approved Colour Used.	IP IP IP IP	15mg 1.25mg 50mg 2.5mg q.s.
15	Ambroxol Terbutaline Guaiphenesin with Menthol Syrup	Each 5ml Contains :- Ambroxol Hydrochloride Terbutaline Sulphate Guaiphenesin Menthol In flavoured syrupyBase Approved Colour Used.	IP IP IP IP	30mg 2.5mg 100mg 2.5mg q.s.
16	B-Complex with L- Lysine Syrup	Each 5ml contains : L-Lysine Monohydrochloride Vitamin B1 Vitamin B2 Vitamin B6 Methylcobalamin Niacinamide Zinc Sulphate Ina pleasantlySyrupyBase Colour : Tartrazine FCF	USP IP IP IP IP IP IP	25mg 1.5mg 1.0mg 0.5mg 2mcg 15mg 2.0mg q.s
17	B-Complex with Lysine Syrup	Each 5ml contains :- Lysine Hydrochloride Pyridoxinehydrochloride Niacinamide Cyanocobalamin D- Panthenol Zinc SulphateMonohydrate Equ. toElemental zinc In flavored syrupybase ApprovedColour Used	USP IP IP IP IP IP	200mg 1.5mg 25mg 7.5mcg 5mg 16.5mg q.s.
18	Bromhexine Hydrochloride, Terbutaline Sulphate, Guaiphenesin &Menthol Syrup	Each 5ml contains : Bromhexine Hydrochloride Terbutaline Sulphate Guaiphenesin Menthol In a flavoured SyrupyBase. Approved colour used.	IP IP IP IP	4mg 1.25mg 50mg 2.5mg q.s
19	Cetirizine Dihydrochloride, Dextromethorphan Hydrobromide & Phenylephrine Hydrochloride Syrup	Each 5ml contains : Dextromethorphan Hydrobromide Cetirizine Dihydrochloride Phenylephrine Hydrochloride In a flavoured SyrupyBase Approved colour Used	IP IP IP	10mg 5mg 5mg q.s.
20	Cetirizine Hydrochloride Syrup IP	Each 5 ml contains: Cetirizine Hydrochloride In a flavoured syrupybase Approved colour base	IP	5 mg q.s.
21	Chlorpheniramine Maleate, Phenylephrine Hydrochloride & Dextromethorphan Hydrobromide Syrup	Each 5ml contains : Chlorpheniramine Maleate Phenylephrine Hydrochloride Dextromethorphan Hydrobromide In a flavoured palatable base Approved colour used.	IP IP IP	2mg 5mg 15mg q.s.
22	Citicoline & Piracetam Syrup	Each 5ml contains: Citicoline sodium Equ. to Citicoline Piracetam Flavoured Syrupybase Approved colour used	IP IP	500mg 400mg q.s
23	Cyproheptadine Hydrochloride & Tricholine Citrate Syrup	Each 5ml Contains:- Cyproheptadine Hydrochloride Tricholine Citrate (65%) Sorbitol Solution (70%) In flavoured Syrupy base Approved colour used	IP IP	2 mg 275 mg q.s.
24	Cyproheptadine, B- Complex & Zinc Syrup	Each 5ml contains : Cyproheptadine Hydrochloride Vitamin B1 Vitamin B6 Vitamin B12 Niacinamide D-Panthenol ZincSulphate Equ.ToElemental Zinc In a Flavoured SyrupyBase Approved colour used.	IP IP IP IP IP IP IP	2mg 1mg 1.5mg 1mcg 15mg 1.5mg 1.8mg q.s.
25	Desloratadine, Ambroxol Hydrochloride, Guaiphenesin & Menthol Syrup	Each 5ml contains: Desloratadine Ambroxol Hydrochloride Guaiphenesin Menthol Flavoured syrupybase. Approved colour used.	BP IP IP IP	2.5mg 30mg 50mg 1mg q.s.
26	Dextromethorphan HBR, Ambroxol HCL, Chlorpheniramine Maleate, Phenylephrine HCL & Menthol Syrup	Each 5 ml contains: Dextromethorphan Hydrobromide Ambroxol Hydrochloride Chlorpheniramine Maleate Phenylephrine Hydrochloride Menthol Flavoured syrupy base Approved colour used	IP IP IP IP IP	10 mg 15 mg 2 mg 5 mg 1.5 mg q.s
27	Dextromethorphan HBR, Ambroxol HCL, Chlorpheniramine Maleate, Phenylephrine HCL & Menthol Syrup	Each 5 ml contains: Dextromethorphan Hydrobromide Ambroxol Hydrochloride Chlorpheniramine Maleate Phenylephrine Hydrochloride Menthol Flavoured syrupy base Approved colour used	IP IP IP IP IP	10 mg 15 mg 4 mg 5 mg 1 mg q.s
28	Dextromethorphan HBR, Bromhexine HCL & Phenylephrine HCL Syrup	Each 5 ml Contains: Dextromethorphan Hydrobromide Bromhexine Hydrochloride Phenylephrine Hydrochloride In a flavoured syrupybase Approved colour base	IP IP IP	5 mg 4 mg 5 mg q.s.
29	Dextromethorphan HBR, Phenylephrine HCL & Chlorpheniramine Maleate Syrup	Each 5ml Contains:- Dextromethorphan Hydrobromide Phenylephrine Hydrochloride Chlorpheniramine Maleate In flavoured Syrupybase Approved colour used	IP IP IP	10 mg 5 mg 2mg q.s.
30	Dextromethorphan Hydrobromide & Chlorpheniramine maleate Syrup	Each 5 ml contains :- Dextromethorphan Hydrobromide Chlorpheniramine maleate In flavoured syrupyBase Approved Colour Used.	IP IP	10mg 2mg q.s.
31	Dextromethorphan Hydrobromide & Chlorpheniramine maleate Syrup	Each 5 ml contains :- Dextromethorphan Hydrobromide Chlorpheniramine maleate In flavoured syrupyBase Approved Colour Used.	IP IP	10mg 4mg q.s.
32	Dextromethorphan Hydrobromide, Cetirizine Hydrochloride, Ammonium Chloride, Ambroxol Hydrochloride & Menthol Syrup	Each 5ml contains : Dextromethorphan Hydrobromide Cetirizine Hydrochloride Ammonium Chloride Ambroxol Hydrochloride Menthol In a flavoured SyrupyBase Approved colour used.	IP IP IP IP IP	10mg 2.5mg 100mg 30mg 1mg q.s.
33	Dicyclomine Hydrochloride & Activated Dimethicone Drops	Each ml contains: Dicyclomine Hydrochloride Activated Dimethicone Flavoured syrupybase. Approved colour used.	IP IP	10mg 40mg q.s.
34	Digestive Enzyme syrup	Each 5 ml Contains :- Alpha Amylase(1:1200) (Fungal digest derived from Asper gillous oryzaedigest not less than 60gm of cooked starch) Pepsin (1:3000) (Digest not lessthan 30gm of coagulated eggalbumen) In a Flavoured syrupybase. Approved Colour Used	IP IP	50mg 10mg q.s.
35	Diphenhydramine HCl, Ammonium Chloride, Sodium Citrate &Menthol Syrup	Each 5ml contains : Diphenhydramine HCl Ammonium Chloride Sodium Citrate Menthol Flavoured SyrupyBase Approved colour used.	IP IP IP IP	14.08mg 138mg 57.03mg 1.14mg q.s.
36	Disodium Hydrogen Citrate Syrup	Each 5 ml contains :- Disodium Hydrogen Citrate In flavoured syrupyBase Approved Colour Used.	BP	1.37gm. q.s.
37	Ferric Ammonium Citrate, Folic Acid, Vit. B12 & Zinc Syrup	Each 15ml contains : Ferric Ammonium Citrate Equ. to Elemental Iron Cyanocobalamin Folic Acid ZincSulphate In a Flavoured SyrupyBase. Approved Colour Used	IP IP IP IP	200mg 41mg 7.5mcg 0.5mg 7mg q.s.
38	Fungal Diastase & Pepsin Drops	Each ml contains: Diastase (1: 1200) (Fungal Diastase derived from Aspergillus oryzae, digest not less than 40g cooked starch) Pepsin (1: 3000) (Digest not less than 15g of coagulated egg Albumin) Flavoured syrupybase Approved colour used	IP IP	33.33mg 5mg q.s.
39	Fungal Diastase & Pepsin Syrup	Each 15ml contains : Fungal Diastase(1:1200) Pepsin (1:3000) In a flavoured syrupyBase Approved colour used	IP IP	50mg 10mg q.s.
40	Granisetron Syrup	Each 5ml contains : Granisetron Hydrochloride Equ. to Granisetron In a Flavoured SyrupyBase.	BP	1mg q.s
41	Iron &FolicAcid Syrup	Each 15ml Contains : Iron(III) Hydroxide Polymaltose Complex Equ. to Elemental Iron Folic Acid In a Flavoured SyrupyBase Approved colour used.	IP	50mg 0.5mg q.s.
42	L- Lysine with Multivitamin & Multimineral Syrup	Each 5ml contains : ZincSulphate Nicotinamide L-Lysine Hydrochloride D- Panthenol Thiamine Hydrochloride Riboflavin Sodium Phosphate Pyridoxine Hydrochloride Copper Sulphate Potassium Iodide Sodium Selenite Pentahydrate Equ. to Selenium Cyanocobalamin Vitamin “A”(as Palmitate ) Cholecalciferol Vitamin “E” Acetate PleasantlyFlavoured SyrupyBase. Approved colour used.	IP IP USP IP IP IP IP BP IP IP IP IP IP	22.5mg 7.5mg 5mg 1.25mg 0.75mg 0.75mg 0.5mg 100mcg 50mcg 10mcg 0.5mcg 1250IU 100IU 2.5IU q.s.
43	Lactulose Solution USP	Each 15 ml contain: Lactulose In flavoured Syrupybase Approved colour used	USP	10 gm. q.s.
44	LactuloseSolution USP	Each 15ml contain: Lactulose In flavoured Syrupybase Approved colour used	USP	10 mg q.s.
45	Levocetirizine Dihydrochloride & Montelukast Sodium Syrup	Each 5ml Contains:- LevocetirizineDihydrochloride Montelukast Sodium Equivalent to Montelukast In flavoured Syrupybase Approved colour used	IP IP	2.5 mg 4 mg q.s.
46	Levocetirizine Dihydrochloride Syrup	Each 5 ml contains: LevocetirizineDihydrochloride In a flavoured syrupy base Approved colour base	IP	2.5 mg q.s.
47	Levocetirizine Dihydrochloride& Ambroxol Hydrochloride Syrup	Each 5ml Contains: LevocetirizineDihydrochloride Ambroxol Hydrochloride Flavoured Syrupy Base Colour : Tartrazine	IP IP	2.5mg 30mg q.s
48	Levocetirizine HCl, Ambroxol HCl, Guaiphenesin & Menthol Syrup	Each 5ml Contains : Levocetirizine Hydrochloride Ambroxol Hydrochloride Guaiphenesin Menthol In a Flavoured syrupyBase. Approved Colour Used	IP IP IP IP	2.5mg 15mg 50mg 1mg q.s.
49	Levocetirizine Hydrochloride & Ambroxol Hydrochloride Syrup	Each 5ml contains: Ambroxol Hydrochloride Levocetirizine Hydrochloride In a flavoured Syrupy Base Approved colour Used.	IP IP	30mg 5mg q.s.
50	Levodropropi zine Syrup	Each 5ml contains: Levodropropizine In a flavoured sugar freebase Approved colour used	IP	30mg q.s.
51	Levodropropizine & Chlorpheniramine maleate Syrup	Each 5ml contains:- Levodropropizine Chlorpheniramine maleate In a flavoured syrupy base Approved colour used .	IP IP	30mg 2mg q.s.
52	Levosalbutamol Syrup 1mg/5ml	Each 5ml contains: Levosalbutamol Sulphate Equ. to Levosalbutamol In a Flavoured SyrupyBase Approved colour used.	IP	1mg q.s.
53	Levosalbutamol Syrup 2mg/5ml	Each 5ml contains: Levosalbutamol Sulphate Equ. To Levosalbutamol In a Flavoured SyrupyBase Approved colour used.	IP	2mg q.s.
54	Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup	Each 5ml Contains : Levosalbutamol Sulphate Equ. to Levosalbutamol Ambroxol Hydrochloride Guaiphenesin Flavoured SyrupyBase Colour: Tartrazine	IP IP IP	0.5mg 15mg 50mg q.s
55	Lycopene with Anti-oxidant , Multivitamin & Multimineral Syrup	Each 10ml Contains:- Lycopene 6% Vitamin A Concentrate (oily form) ( as Palmitate) Ascorbic Acid (Vitamin C) Vitamin E acetate Selenium (Assodium Selenate) Zinc (As zinc Gluconate) Manganese(as Manganese Gluconate) Iodine (as Potassium Iodide ) Copper (as cupric Sulphate) Thiamine hydrochloride Riboflavin sodium phosphate Pyridoxinehydrochloride In a Flavoured syrupybase. Approved Colour Used	IP IP IP USP USP IP USP IP IP IP	1000mcg 2500IU 50mg 10IU 35mcg 3mg 2mcg 100mcg 500mcg 2mg 3mg 1.5mg q.s
56	Lycopene with Vitamins & Minerals Syrup	Each 10ml contains : Lycopene(10% ) Dispersion Niacinamide Pyridoxine Hydrochloride Cyanocobalamin Folic Acid Sodium Selenate Equ. toElemental Selenium Zinc Gluconate Equ. toElemental Zinc Potassium Iodide Equ. toavailable Iodine Cupric Sulfate Equ. to Elemental Copper In a Flavoured SyrupyBase. Approved Colour used.	USP IP IP IP IP USP IP USP	2000mcg 25mg 1.5mg 1mcg 100mcg 35mcg 3mg 100mcg 500mcg q.s.
57	Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine MaleateSuspension	Each 5ml Contains: Paracetamol Phenylephrine Hydrochloride Chlorpheniramine Maleate In a Flavoured Syrupy Base Colour: Sunset Yellow FCF	IP IP IP	125mg 2.5mg 1mg q.s
58	Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup	Each 5ml contains : Phenylephrine hydrochloride Chlorpheniramine Maleate Flavoured syrupybase. Approved colour used	IP IP	5mg 2mg q.s
59	Phenylephrine Hydrochloride and Chlorpheniramine Maleate Drops IP	Each ml contains : Phenylephrine Hydrochloride Chlorpheniramine Maleate In a flavoured syrupy Base. Approved colour used.	IP IP	2.5mg 1mg q.s.
60	Phenylephrine Hydrochloride, Paracetamol & Cetirizine Hydrochloride Syrup	Each 5ml Contains : Phenylephrine Hydrochloride Paracetamol Cetirizine Hydrochloride Flavoured Syrupy Base Colour : Sunset Yellow FCF (Banned drug 12/08/2024)	IP IP IP	5mg 125mg 5mg q.s.
61	Potassium Citrate, Magnesium Citrate & Vitamin B6 Oral Solution	Each 5ml contains : Potassium Citrate Magnesium Citrate Pyridoxine Hydrochloride In a Flavoured SyrupyBase Approved colour used	IP USP IP	1100mg 375mg 20mg q.s.
62	PromethazineSyrup	Each 5ml Contains : Promethazine Hydrochloride Excipients Colour : Approved Colour Used	IP	5mg
63	Ranitidine Oral Solution IP	Each 5ml Contains : Ranitidine Hydrochloride Equ. to Ranitidine In a Flavoured SyrupyBase Approved colour used	IP	75mg q.s.
64	Silymarin, L-Ornithine Laspartate, with B-Complex syrup	Each 5ml contains : Silymarin (80%) L-Ornithine L- aspartate Sorbitol solution (70%) Vitamin B1 Vitamin B2 Vitamin B6 Vitamin B12 Niacinamide Calcium D-Pantothenate Flavoured Syrupy Base. Approved Colour Used	IP IP IP IP IP IP IP	40mg 150mg 500mg 2.5mg 2.5mg 1.5mg 5mcg 25mg 5mg q.s
65	Sodium Feredetate,Folic Acid,Cyanocoba lamin Syrup	Each 5ml Contains: SodiumFeredetate (Eq. to33 mg.elemental Iron) Folic Acid Cyanocobalamin Ina flavoured syrupy base Approved colour use	BP IP IP	231mg 1.5mg 15mcg
66	Syrup of Iron, Folic Acid & Vitamin B12 with Minerals	Each 15ml contains : Ferric Ammonium Citrate Cyanocobalamin Folic Acid Copper Sulphate Manganese Sulphate In a Flavoured Syrupybase. Approved colour Used.	IP IP IP BP BP	160mg 7.5mcg 7.5mg 30mcg 30mcg q.s.
67	Syrup of vitamin iron ,folicacid, zinc with Cyanocobalamin.	Each 15ml contains: FerricAmmonium citrate (equivalent to32.25mgElemental Iron) Cyanocobalamin Folic acid ZincSulphate (equivalent to7.5mg ofElement Zinc ) Flavored syrup base Approved Colour Used	IP IP IP IP	150mg 15mcg 1.5mg 33mg q.s.
68	Terbutaline , Bromhexine, Guaiphenesin and Menthol Syrup	Each 5ml contains : Terbutaline Sulphate Bromhexinehydrochloride Guaiphenesin Menthol In a Flavoured SyrupyBase Approved colour used	IP IP IP IP	1.25mg 2mg 50mg 0.5mg
69	Terbutaline Sulphate & Bromhexine Hydrochloride Syrup	Each 5ml contains : Terbutaline Sulphate Bromhexine Hydrochloride In a Flavoured palatable base. Approved colour used	IP IP	2.5mg 8mg q.s.
70	Terbutaline Sulphate & Choline Theophyllinate Syrup	Each 5ml contains : Terbutaline Sulphate CholineTheophyllinate In a flavoured SyrupyBase. Approved colour Used.	IP BP	1.25mg 50mg q.s.
71	Terbutaline Sulphate, Ambroxol HCl, Guaiphenesin & Menthol Expectorant	Each 5ml contains : Terbutaline Sulphate Ambroxol Hydrochloride Guaiphenesin Menthol Flavoured SyrupyBase Approved colour used.	IP IP IP IP	1.5mg 15mg 50mg 1.5mg q.s.
72	Terbutaline Sulphate, Ambroxol HCl, Guaiphenesin & Menthol Expectorant	Each 5ml contains : Terbutaline Sulphate Ambroxol Hydrochloride Guaiphenesin Menthol Flavoured SyrupyBase Approved colour used.	IP IP IP IP	1.5mg 15mg 50mg 1.5mg q.s.
73	Terbutaline Sulphate, Bromhexine HCL, Guaiphenesin & Menthol Syrup	Each 5ml Contains Terbutaline Sulphate Equivalent to Terbutaline Bromhexine Hydrochloride Guaiphenesin Menthol In flavoured Syrupybase Approved colour used	IP IP IP IP	1.25 mg 2 mg 50mg 0.5 mg q.s.
74	Terbutaline Sulphate, Guaiphenesin, Ambroxol Hydrochloride & Menthol Syrup	Each 5ml contains : Terbutaline Sulphate Guaiphenesin Ambroxol Hydrochloride Menthol In a Flavoured syrupyBase Approved colour used	IP IP IP IP	1.25mg 50mg 15mg 0.5mg q.s.
75	Tricholine Citrate & Sorbitol Solution Syrup	Each 10 ml contains: Tricholine Citrate Sorbitol Solution (70%) (Non-Crystallising) Excipients Approved colour used.	IP	0.55gm 7.150gm q.s.
76	Vitamin B6, Nicotinamide, Vitamin B12 & Lysine Syrup	Each 5ml contains : Pyridoxine Hydrochloride Nicotinamide Cyanocobalamin L-Lysine Hydrochloride Sorbitol Solution (70%) (Non-Crystallizing) Colour: Caramel	IP IP IP USP IP	0.75mg 15mg 2mcg 37.5mg q.s
77	Vitamin D3 oral Drops	Each ml contains: Cholecalciferol (Vitamin D3 as stabilized) In a flavoured syrupybase Approved colour used.	IP	800IU q.s.
78	Zinc Acetate Oral Solution USP	Each 5 ml contains: Zinc Acetate (as Dihydrate) Eq.to Elemental Zinc In a Mentholated Syrupy base. Approved colour used.	USP	20mg q.s.
79	Zinc Acetate Syrup	Each 5ml contains : Zinc Acetate (as Dihydrate) Equ. to Elemental Zinc In a Mentholated SyrupyBase. Approved Colour used.	USP	20mg q.s.
80	Zinc gluconate Oral Solution	Each 5ml contains: Zinc gluconate Eq. to elemental zinc In a flavoured syrupy base Approved colour used.	USP	20mg q.s

Tablets

S.No.	Product Name	Composition	Packing	Strength
1	Acebrophylline & Acetylcysteine Tablets	Each film coated Tablet Contains: Acebrophylline Acetylcysteine Excipients Approved colour used.	BP	100mg 600mg q.s.
2	Acebrophylline & N- Acetyl L- Cysteine Tablets	Each film coated Tablet Contains: Acebrophylline N- Acetyl L-Cysteine Excipients Approved colour used	BP	100mg 600mg q.s.
3	Acebrophylline & N- Acetyl L- Cysteine Tablets	Each film coatedBilayered Tablet Contains: Acebrophylline N- Acetyl L-Cysteine Excipients Approved colour used	BP	100mg 600mg q.s.
4	Acebrophylline Sustained Release Tablets	Each film coated sustained release Tablet contains : Acebrophylline Excipients Approved colour used		200mg q.s.
5	Acebrophylline Sustained Release Tablets	Each film coated sustained release Tablet contains : Acebrophylline Excipients Approved colour used		200mg q.s.
6	Aceclofenac & DrotaverineTablets	Each FilmCoated Tablet Contains: Aceclofenac Drotaverine Hydrochloride Excipients Colour : ApprovedColour Used	IP IP	100mg 80mg q.s.
7	Aceclofenac & Paracetamol Tablets	Each Uncoated Tablets Contains: Aceclofenac Paracetamol Excipients Approved colour used	IP IP	100 mg 325 mg q.s.
8	Aceclofenac & Serratiopeptidase Tablets	Each filmcoated tablet contain: Aceclofenac Serratiopeptidase ( Eq. to enzyme activityof 20000 units of enteric coated granules) Excipients Approved colour used	IP IP	100 mg 10 mg q.s.
9	Aceclofenac & Serratiopeptidase Tablets	Each film coated Tablet Contains: Aceclofenac Serratiopeptidase (Eq. to enzyme activityof 30000 units of enteric coated granules) Excipients Approved colour used.	IP IP	100mg 15mg q.s.
10	Aceclofenac & Thiocolchicoside Tablets	Each FilmCoated Tablet Contains: Aceclofenac Thiocolchicoside Excipients Colour : ApprovedColour Used	IP IP	100mg 4mg q.s.
11	Aceclofenac & Thiocolchicoside Tablets	Each FilmCoated Tablet Contains: Aceclofenac Thiocolchicoside Excipients Colour : ApprovedColour Used	IP IP	100mg 8mg q.s.
12	Aceclofenac Sustained Release Tablets	Each FilmCoatedTablet Contains: Aceclofenac (AsSustained Release) Excipients Colour : ApprovedColour Used	IP	200mg q.s.
13	Aceclofenac Tablets	Each film coated Tablets Contains : Aceclofenac Excipients Approved colour used.	IP	100mg q.s.
14	Aceclofenac, Paracetamol & Chlorzoxazone Tablet	Each FilmCoatedTablet Contains Aceclofenac Paracetamol Chlorzoxazone Excipients Approved colour used	IP IP USP q.s.	100 mg 325 mg 250 mg
15	Aceclofenac, Paracetamol & Chlorzoxazone Tablets	Each Film coated Tablet Contains: Aceclofenac Paracetamol Chlorzoxazone Excipients Approved colour used	IP IP USP	100mg 325mg 500mg q.s.
16	Aceclofenac, Paracetamol & Chymotrypsin Tablets	Each Film coatedTabletsContains: Aceclofenac Paracetamol Trypsin Chymotrypsin 50000 Armour unit of enzymaticactivity (Supplied bya purified concentrate which has specific Trypsin and chymotrypsin activity in ratio of Approximate six to one) Excipients Approved colour used	IP IP	100 mg 325 mg 50000AU q.s.
17	Aceclofenac, Paracetamol & Serratiopeptidase Tablets	Each film coatedTablet Contains: Aceclofenac Paracetamol Serratiopeptidase (Eq. toenzyme activityof 30000 units of enteric coated granules) Excipients Approved Colour Used	IP IP IP	100mg 325mg 15mg q.s.
18	Aceclofenac, Paracetamol & Serratiopeptidase Tablets	Each film coated Tablet Contains: Aceclofenac Paracetamol Serratiopeptidase (Eq. to 20,000 Serratiopeptidase units) Excipients Approved Colour Used.	IP IP IP	100mg 325mg 10mg q.s.
19	Aceclofenac, Paracetamol & Thiocolchicoside Tablet	Each FilmCoatedTablet Contains Aceclofenac Paracetamol Thiocolchicoside Excipients Approved colour used	IP IP q.s.	100 mg 325 mg 4 mg
20	Aceclofenac, Paracetamol & Thiocolchicoside Tablet	Each Film Coated Tablet Contains Aceclofenac Paracetamol Thiocolchicoside Excipients Approved colour used	IP IP q.s.	100 mg 325 mg 8 mg q.s.
21	Aceclofenac, Paracetamol Tablets	Each FilmcoatedTabletsContains: Aceclofenac Paracetamol Excipients Approved colour used	IP IP	100 mg 325 mg q.s.
22	Aceclofenac,Par acetamol, Phenylephrine HCL,Cetirizine HCL&Caffeine Tablets	Each uncoated tablet contains: Aceclofenac Paracetamol Phenylephrine HCL Cetirizine HCL Caffeine Anhydrous	IP IP IP IP IP	100mg 325mg 10mg 5mg 25mg q.s.
23	Aceclofenac,Paracetamol, Caffeine, Phenylephrine HCL& Cetirizine Hydrochloride Tablets	Each uncoated tablet contains: Aceclofenac Paracetamol Phenylephrine Hydrochloride Cetirizine Hydrochloride Caffeine (Anhydrous) Excipients Approved colour used	IP IP IP IP IP	100 mg 325 mg 5 mg 10 mg 25 mg q.s.
24	Aciclovir Dispersible Tablet IP	Each uncoated tablet contains: Aciclovir Excipients Approved colour used	IP	800 mg
25	Aciclovir Tablet IP	Each uncoated tablet contain: Aciclovir Excipients Approved colour used	IP	800 mg q.s.
26	Acyclovir Dispersible Tablets IP	Each uncoatedTabletsContains: Acyclovir Excipients Approved colour used	IP	400 mg q.s.
27	Albendazole & Ivermectin Tablet	Each Uncoated tablet contains: Albendazole Ivermectin Excipients Colour :-Approved colour used	IP IP	400mg 6mg q.s.
28	Albendazole Tablet IP	Each Uncoated Chewable Tablet Contains:- Albendazole Excipients Colour:-Approved Colour used	IP	400mg q.s.
29	Allopurinol Tablets IP	Each uncoated tablets contains: Allopurinol Excipients Approved colour used	IP	100 mg q.s.
30	Allopurinol Tablets IP	Each uncoated tablets contains: Allopurinol Excipients Approved colour used	IP	300 mg q.s.
31	Alprazolam Tablets IP	Each uncoated tablet contains: Alprazolam Excipients Approved colour used	IP	0.25 mg q.s
32	Alprazolam Tablets IP	Each uncoated tablet contains: Alprazolam Excipients Approved colour used	IP	0.5 mg q.s
33	Ambroxol Hydrochloride (SR)& Levocetirizine hydrochloride Tablets	Each Filmcoated Tablet Contains:- Ambroxol Hydrochloride (As sustained Release) Levocetirizinehydrochloride Excipients Approved colour used	P IP	75 mg 5mg q.s.
34	Amisulpride Tablets IP	Each Uncoated Tablet Contains: Amisulpride Excipients Approved colour used.	IP	100mg q.s.
35	Amitriptyline Hydrochloride Tablets IP	Each film coated tablet contains:- Amitriptyline Hydrochloride Excipients Colour:- Approved Colour used	IP	10 mg q.s
36	Amitriptyline Hydrochloride Tablets IP	Each film coated tablet contains:- Amitriptyline Hydrochloride Excipients Colour:- Approved Colour used	IP	25 mg q.s.
37	Amitriptyline Hydrochloride Tablets IP	Each film coated tablet contains:- Amitriptyline Hydrochloride Excipients Colour:- Approved Colour used	IP	50 mg q.s.
38	Amlodipine & AtenololTablets	Each uncoated tablet contains:- Amlodipine Besylate Equivalent to Amlodipine Atenolol Excipients Colour:-Approved colour used	IP IP	5 mg 50 mg q.s.
39	Amlodipine Tablets IP	Each uncoated tablet contains:- Amlodipine Besylate Equivalent to Amlodipine Excipients Colour : Approved Coloured Used	IP	5 mg q.s
40	AmlodipineTablets IP	Each uncoated tablet contains:- Amlodipine Besylate Equivalent to Amlodipine Excipients Colour : Approved Coloured Used	IP	10 mg q.s
41	AmlodipineTablets IP	Each uncoated Tablet contains: Amlodipine Besylate Equ. to Amlodipine Excipients Approved colour used	IP	2.5mg q.s.
42	Artemether & Lumifantrine Tablets	Each uncoatedTabletsContains: Artemether Lumifantrine Excipients Approved colour used	IP	80 mg 480 mg q.s.
43	Ascorbic Acid (Vitamin C ), Sodium Ascorbate & Zinc Chewable Tablets	Each uncoated Tablet Contains: Ascorbic Acid Sodium Ascorbate Equ. to Ascorbicacid Zinc Excipients Approved Colour Used	IP IP	100mg 450mg 400mg 5mg q.s
44	Ascorbicacid Tablet IP	Each Uncoated ChewableTablet Contains Ascorbic acid Excipients Colour : ApprovedColour Used	IP	500mg
45	Atenolol Tablets IP	Each Uncoated Tablet Contains: Atenolol Excipients Colour : Approved Coloured Used	IP	50mg q.s
46	Atenolol Tablets IP	Each Uncoated Tablet Contains: Atenolol Excipients Colour : Approved Coloured Used	IP	100mg q.s
47	Atorvastatin & FinofibrateTablets	Each filmcoated tablet contain Atorvastin Calcium Eq.to Atorvastin Finofibrate Excipients Approved colour used	IP IP	10 mg 160 mg q.s.
48	Atorvastatin Tablets IP	Each film coated tablet contains:- Atorvastatin Calcium Eq. toAtorvastatin Excipients Colour:-Approved colour used	IP	10 mg q.s.
49	Atorvastatin Tablets IP	Each film coated tablet contains:- Atorvastatin Calcium Eq. toAtorvastatin Excipients Colour:-Approved colour used	IP	20 mg q.s.
50	Atorvastatin Tablets IP	Each film coated tablet contains:- Atorvastatin Calcium Eq. toAtorvastatin Excipients Colour:-Approved colour used	IP	40 mg q.s.
51	Atorvastatin Tablets IP	Each film coated tablet contains:- Atorvastatin Calcium Eq. toAtorvastatin Excipients Colour:-Approved colour used	IP	80 mg q.s.
52	Azathioprine Tablets IP	Each uncoated tablet contains: Azathioprine Excipients Approved colour used.	IP	50mg q.s.
53	Azithromycin & Lacticacid Bacillus Tablet	Each film coated tablet contains: Azithromycin Dihydrate Equ. toAzithromycin Anhydrous Lactic acid Bacillus Excipients Approved colour used	IP	250mg 60 million spores q.s
54	Azithromycin & Lacticacid Bacillus Tablet	Each film coated tablet contains: Azithromycin Dihydrate Equ. toAzithromycin Anhydrous Lactic acid Bacillus Excipients Approved colour used	IP	500mg 60 million spores q.s
55	Azithromycin Dispersible Tablet	Each uncoated dispersible Tablet Contains : Azithromycin Dihydrate Equ. to Azithromycin anhydrous Excipients Colour : Approved Coloured Used	IP	100mg
56	Azithromycin Tablet IP	Each film coated tablet contains: Azithromycin Dihydrate Equivalent to Azithromycin anhydrous Excipients Approved colour used	IP	250 mg q.s.
57	Azithromycin Tablet IP	Each film coated tablet contains: Azithromycin Dihydrate Equivalent to Azithromycin anhydrous Excipients Approved colour used	IP	500 mg q.s.
58	Baclofen Tablets IP	Each uncoated tablet contains: Baclofen Excipients Approved colour used.	IP	10mg q.s.
59	Baclofen Tablets IP	Each uncoated tablet contains:- Baclofen Excipients Approved colour used.	IP	25mg q.s
60	Betahistine Tablet (SR) IP	Each uncoated sustainedrelease tablet contain: Betahistine Hydrochloride Excipients Approved colour used	IP	24 mg q.s.
61	Betahistine Tablet IP	Each Uncoated Tablet Contains:- Betahistine hydrochloride Excipients Approved colour used	IP	8mg q.s
62	Betahistine Tablet IP	Each Uncoated Tablet Contains:- Betahistine hydrochloride Excipients Approved colour used	IP	16 mg q.s.
63	Betahistine Tablets IP	Each uncoated tablets contains: Betahistine Hydrochloride Excipients Approved colour used	IP	8 mg q.s.
64	Betahistine Tablets IP	Each uncoated tablets contains: Betahistine Hydrochloride Excipients Approved colour used	IP	16 mg q.s.
65	Betahistine Tablets IP	Each uncoated Tablet contains: Betahistine Hydrochloride Excipients Approved colour used.	IP	24mg q.s.
66	Betamethasone Tablets IP	Each uncoated tablet contains:- Betamethasone Excipients Colour : Approved Coloured Used	IP	0.5mg q.s.
67	Bilastine & Montelukast Tablets	Each Film Coated bilayered tablet Contains: Montelukast Sodium eq. to Montelukast Bilastine Excipients Approved colour used.	IP	10mg 20mg q.s.
68	Bilastine Tablets	Each Film Coated Tablet Contains: Bilastine Excipients Approved colour used		20mg q.s.
69	Biotin & FolicAcid Tablets	Each film coated Tablet contains: Biotin Folic Acid Excipients Approved Colour used	USP IP	5mg 5mg q.s
70	Biotin Tablets USP	Each Film coated Tablet Contains : Biotin Excipients Approved colour used	USP	10mg q.s.
71	Bisacodyl Tablets IP	Each enteric coated tablet contains: Bisacodyl Excipients Approved colour used	IP	5mg q.s.
72	Bisoprolol Fumarate Tablets	Each film coated tablet contains: Bisoprolol Fumarate Excipients Approved colour used.	IP	2.5mg q.s.
73	Bisoprolol Fumerate Tablets	Each film coated tablet contains: Bisoprolol Fumerate Excipients Approved colour used.	IP	5mg q.s.
74	Calcium Carbonate & Vitamin D3 Tablets	Each film coated Tablet contains: Calcium Carbonate (Derived from an organic source oyster shell) Equ. to Elemental Calcium Vitamin D3 Excipients Approved colour used	IP IP	1250mg 500mg 500IU q.s.
75	Calcium Carbonate, Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5- Phosphate Tablets	Each Film Coated Tablet Contains : Calcium Carbonate( from Oyster shell) Equ. to Elemental Calcium Vitamin D3 Methylcobalamin L- Methylfolate Calcium Pyridoxal-5- Phosphate Excipients Approved colour used.	IP IP	1250mg 500mg 2000IU 1500mcg 1mg 20mg q.s.
76	Calcium Citrate Maleate, Calcitriol , Folic Acid , Zinc & Vitamin K2-7 Tablets	Each Film Coated Tablet Contains: Calcium Citrate Maleate Equ. toElemental Calcium Calcitriol Folic Acid Zinc Sulphate Monohydrate Equ. to Zinc Vitamin K2-7 Excipients Approved colour used	IP IP IP	250mg 0.25mcg 100mcg 7.5mg 50mcg q.s.
77	Calcium Citrate Maleate, Methylcobalamin, Vitamin D3, Vitamin K2-7, Magnesium Oxide & Zinc Oxide Tablets	Each film coated tablet contains: Calcium Citrate Maleate Methylcobalamin Vitamin D3 Vitamin k2-7 Zinc Oxide Magnesium Oxide Excipients Approved colour used	IP IP IP IP	1250mg 1500mcg 1000IU 90mcg 15mg 50mg q.s.
78	Calcium Citrate Maleate& Vitamin D3 Tablets	Each film coated Tablet Contains: Calcium Citrate Maleate Equ.ToElemental CalciumVitamin D3 Excipients Approved colour used	USP IP	1250mg 250mg 450IU q.s.
79	Calcium Citrate, Calcitriol , Zinc & Manganese Tablets	Each film coated tablet contains: Calcium Citrate Calcitriol Zinc Sulphate Monohydrate Eq. to elemental Zinc Manganese (as Manganese Sulphate) Excipients Approved colour used.	USP BP IP IP	1000 mg 0.25 mcg 7.5 mg 40 mg q.s.
80	Calcium Citrate, Magnesium, Zinc With Vitamin D3 Tablets	Each film coatedTablet Contains: Calcium Citrate Magnesium Hydroxide Zinc SulphateMonohydrate Equ. to Elemental Zinc Vitamin D3 Excipients Approved Colour Used.	USP IP IP IP	1000mg 100mg 4mg 200IU q.s.
81	Calcium Orotate & Vitamin D3 Tablets	Each film coated tablet contains: Calcium Orotate Vitamin D3 (Stabilized) Excipients Approved colour used. Appropriate overages of vitamin added to compensate the loss on storage.	I.P.	740mg 1000 IU q.s.
82	Calcium Pantothenate Tablets I.P. 200mg	Each film coated tablet contains: D-Calcium Pantothenate Excipients Approved colour used.	I.P.	200mg q.s.
83	Calcium,Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5- Phosphate Tablets	Each film coated tablet contains: Calcium Carbonate eq.to Elemental Calcium Vitamin D3 Mecobalamin (Methylcobalamin) L-Methylfolate calcium Pyridoxal-5-Phosphate Excipients Approved colour used.	IP IP IP	1250mg 500mg 2000 I.U. 1500mcg 1mg 20mg q.s.
84	Calcium&Vitamin D3 Tablets IP	Each Film coated Tablet Contains: Calcium Carbonate Equ.toElemental Calcium Vitamin D3 Excipients Approved Colour Used.	IP IP	500mg 250IU q.s.
85	Carbamazepine Tablets IP	Each uncoated tablet contains:- Carbamazepine Excipients Colour:- Approved Colour used	IP	200 mg q.s.
86	Carbimazole Tablets IP	Each Film coated Tablet Contains : Carbimazole Excipients Approved colour used	IP	5mg q.s.
87	Carisoprodol Tablets IP	Each Uncoated tablet contains:- Carisoprodol Excipients Colour:- Approved Colour used	IP	350 mg q.s
88	Carvedilol Tablets IP	Each film coated Tablet contains: Carvedilol Excipients Approved colour used	IP	3.125mg q.s.
89	Carvedilol Tablets IP	Each uncoated Tablet Contains: Carvedilol Excipients Approved colour used	IP	12.5mg q.s.
90	Carvedilol Tablets IP	Each Uncoated Tablet contains: Carvedilol Excipients Approved colour used	IP	6.25mg q.s.
91	Carvedilol Tablets IP	Each Uncoated Tablet contains: Carvedilol Excipients Approved colour used	IP	3.125mg q.s.
92	Cetirizine HCl, Phenylephrine HCl & Paracetamol Tablets	Each film coated tablet contains: Cetirizine HCl Phenylephrine HCl Paracetamol Excipients Approved colour used. (Banned drug 12/08/2024)	IP IP IP	5mg 5mg 325mg q.s.
93	Cetirizine Hydrochloride & Ambroxol Hydrochloride Tablets	Each film coated tablet contains: Cetirizine Hydrochloride Ambroxol Hydrochloride Excipients Approved colour used.	I.P. I.P.	5mg 60mg q.s.
94	Cetirizine Hydrochloride Tablets IP	Each uncoated tablet contains:- Cetirizine Hydrochloride Excipients Colour:- Approved Colour used	IP	10 mg q.s.
95	Chlordiazepoxide & Clidinium Bromide Tablet	Each FilmCoated tablet contains Chlordiazepoxide Clidinium Bromide Excipients Approved Colour used	IP IP	5mg 2.5mg q.s
96	Chlorpheniramine Maleate tablet IP	Each Uncoated Tablet Contains: Chlorpheniramine Maleate Equ. to Chlorpheniramine Excipients	IP	4mg q.s.
97	Chlorpromazine Hydrochloride Tablets IP	Each film coated tablet contains:- Chlorpromazine Hydrochloride Excipients Colour:- Approved Colour used	IP	50 mg q.s.
98	Chlorpromazine Hydrochloride Tablets IP	Each film coated tablet contains:- Chlorpromazine Hydrochloride Excipients Colour:- Approved Colour used	IP	100 mg q.s.
99	Chlorpromazine Hydrochloride Tablets IP	Each film coated Tablet Contains: Chlorpromazine Hydrochloride Excipients Approved colour used.	IP	50mg q.s.
100	Cholecalciferol Tablet IP	Each uncoated chewable tablet contains Cholecalciferol (Stabilized) Excipients Colour :- Approved colour used	IP	60000IU q.s.
101	Cholecalciferol, Ferrous Ascorbate, Folic Acid & Cyanocobalamin Tablets	Each film coated Tablet Contains: Cholecalciferol Ferrous Ascorbate Equ. toElemental Iron Folic Acid Cyanocobalamin Excipients Approved colour used	IP IP IP	1000IU 100mg 1mg 7.5mcg q.s.
102	Cilnidipine Tablet	Each film coated tablet contains Cilnidipine Excipients Colour :- Approved Colour Use	IP	10mg q.s
103	Cilnidipine Tablets IP	Each film coated tablet contains: Cilnidipine Excipients Approved colour used.	IP	5mg q.s.
104	Cilnidipine Tablets IP	Each film coated tablet contains: Cilnidipine Excipients Approved colour used.	IP	5mg q.s.
105	CilnidipineTablets IP	Each film coated Tablet contains: Cilnidipine Excipients Approved colour used.	IP	20mg q.s.
106	Cilostazol Tablets IP	Each uncoated tablet contains: Cilostazol Excipients Approved colour used.	IP	50mg q.s.
107	Cilostazol Tablets IP	Each uncoated tablet contains: Cilostazol Excipients Approved colour used.	IP	100mg q.s.
108	Cinnarizine (SR)Tablet IP	Each uncoatedtablet contain: Cinnarizine (AsSustained Release) Excipients Approved colour used	IP	75 mg q.s.
109	Cinnarizine and Dimenhydrinate Tablets	Each uncoated Tablet contains: Cinnarizine Dimenhydrinate Excipients Approved Colour used	IP BP	20mg 40mg q.s
110	Cinnarizine Tablet IP	Each uncoated tablet contain: Cinnarizine Excipients Approved colour used	IP	25 mg q.s.
111	Cinnarizine Tablets IP	Each uncoated Tablet contains Cinnarizine Excipients Approved Coloured used	IP	75mg q.s
112	Cinnarizineand Domperidone Tablets	Each uncoatedTabletsContains: Cinnarizine Domperidone Excipients Approved colour used	IP IP	20 mg 15 mg q.s.
113	Ciprofloxacin and Tinidazole Tablets	Each film coated Tablet contains: Ciprofloxacin Hydrochloride Equ. to Ciprofloxacin Tinidazole Excipients Approved colour used	IP IP	250mg 300mg q.s
114	Ciprofloxacin Tablets IP	Each film coated tablet contains:- Ciprofloxacin Hydrochloride Eq. tociprofloxacin Excipients Colour:-Approved colour used	IP	250 mg q.s.
115	Ciprofloxacin Tablets IP	Each film coated tablet contains:- Ciprofloxacin Hydrochloride Eq. tociprofloxacin Excipients Colour:-Approved colour used	IP	500 mg q.s.
116	Citicoline & PiracetamTablets	Each FilmcoatedTabletsContains: Piracetam Citicoline sodium Equivalent toCiticoline Excipients Approved colour used	IP IP	800 mg 500 mg q.s.
117	CiticolineTablets	Each FilmcoatedTabletsContains: Citicoline sodium Equivalent toCiticoline Excipients Approved colour used	IP	500 mg q.s.
118	Clarithromycin Tablet IP	Each film coated tablet Contains:- Clarithromycin Excipients Colour :-Approved colour used	IP	250mg q.s
119	Clarithromycin Tablet IP	Each film coatedtablet contain: Clarithromycin Excipients Approved colour used	IP	500 mg q.s
120	Clomifene Tablets IP	Each uncoated tablet contains: Clomifene Citrate Excipients Approved colour used.	IP	50mg q.s.
121	Clomiphene Citrate Tablets IP	Each Uncoated Tablet Contains: Clomiphene Citrate Excipients	IP	50mg q.s.
122	Clomiphene Tablet IP	Each uncoated Tablet Contains :- Clomiphene Citrate Excipients Colour :- Approved colour used	IP	50mg q.s
123	Clonazepam Tablet IP	Each uncoated Tablet contains: Clonazepam Excipients Approved colour used	IP	0.25mg q.s
124	Clonazepam Tablet IP	Each uncoated Tablet contains: Clonazepam Excipients Approved colour used	IP	0.5mg q.s
125	Clopidogrel Bisulphate Tablet	Each film coated Tablet Contains: Clopidogrel Bisulphate Equ. toClopidogrel Excipients Colour : Approved Coloured Used	IP	75mg q.s
126	Combikit of Azithromycin Tablet IP, Fluconazole Tablet IP & Secnidazole Tablet IP	Each Combikit Contain: A) Azithromycin Tablet IP(1Tablet) Each film coated tablet contain: Azithromycin Dihydrate Equivalent to Azithromycin anhydrous Approved colour used B) FluconazoleTablet IP (1Tablet) Each uncoated tablet contain: Fluconazole Approved colour used C) SecnidazoleTablet IP(2Tablet) Each film coated tablet contain: Secnidazole Approved colour used	IP IP IP	1 gm 150 mg 1 gm
127	Cyproheptadine Hydrochloride Tablet IP	Each uncoated tablet contains : - Cyproheptadine Hydrochloride (as anhydrous) Excipients Colour : Approved Colour Used	IP	4mg q.s
128	Cyproheptadine Tablet IP	Each uncoated tablet contains: Cyproheptadine Hydrochloride (Anhydrous) Excipients Approved colour used	IP	4 mg
129	Dapagliflozin & Metformin HCl (ER) Tablets	Each film coated Tablet Contains : Dapagliflozin Propanedial Monohydrate Equ. To Dapagliflozin Metformin Hydrochloride (as Extended Release) Excipients Approved colour used	IP	10mg 1000mg q.s.
130	Dapagliflozin 10mg & Metformin HCl (ER) 500mg Tablets	Each film coated Tablet Contains : Dapagliflozin Propanedial Monohydrate Equ. to Dapagliflozin Metformin Hydrochloride (as Extended Release) Excipients Approved colour used	IP	10mg 500mg q.s.
131	Dapagliflozin Tablet	Each film coated tablet contain: Dapagliflozin propanediol monohydrate Eq. to Dapagliflozin Excipients Approved colour used		10 mg q.s
132	Dapagliflozin Tablets	Each film coated tablet contain: Dapagliflozin propanediol monohydrate Eq. to Dapagliflozin Excipients Approved colour used		5 mg q.s
133	Dapoxetine Tablets IP	Each film coated tablet contains: Dapoxetine Hydrochloride Equ. to Dapoxetine Excipients Approved colour used	IP	30 mg q.s
134	Dapoxetine Tablets IP	Each film coated tablet contains: Dapoxetine Hydrochloride Equ. to Dapoxetine Excipients Approved colour used	IP	60 mg q.s
135	Deflazacort Tablets	Each Uncoated Tablet Contains: Deflazacort Excipients Approved Colour used		18mg q.s
136	Deflazacort Tablets	Each uncoated tablet contains: Deflazacort Excipients Colour:- Approved colour used	IP	12 mg q.s.
137	DeflazacortTablet	Each uncoated tablet contain: Deflazacort Excipients Approved colour used		30 mg q.s.
138	DeflazacortTablets	Each uncoated tablet contains:- Deflazacort Excipients Colour:-Approved colour used	IP	6 mg q.s.
139	Desloratadine Tablet	Each film coated Tablet Contains:- Desloratadine Excipients Approved colour used	BP	5 mg q.s.
140	Dexamethasone Tablets IP	Each uncoated tablet contains:- Dexamethasone Excipients Colour : Approved Coloured Used	IP	0.5 mg q.s.
141	Dexketoprofen Tablet	Each film coated Tablet Contains: Dexketoprofen trometamol Equ. to Dexketoprofen Excipients Colour : Approved Coloured Used		25mg q.s
142	Dextromethorphan HBR, Chlorpheniramine Maleate, Phenylephrine HCL Tablets	Each uncoated tablet Contains: Dextromethorphan Hydrobromide Chlorpheniramine Maleate Phenylephrine Hydrochloride Excipients Approved colour used	IP IP IP	10 mg 2 mg 5 mg q.s.
143	Dextromethorphan Hydrobromide, Phenylephrine hydrochloride & Chlorpheniramine Maleate Tablets	Each uncoated tablet contains : Dextromethorphan Hydrobromide Phenylephrine Hydrochloride Chlorpheniramine Maleate Excipients Colour: Tartrazine	IP IP IP	10mg 5mg 2mg q.s
144	Diacerein , Glucosamine & Methylsulfonylmet hane Tablets	Each film coated tablets contains: Diacerein GlucosamineSulphate potassium chloride Eq.to glucosamine Methylsulfonylmethane Excipients Approved colour used	IP USP USP	50mg 750mg 446mg 250mg
145	Diclofenac & TolperisoneTablets	Each uncoated sustained releaseTablet contains: Tolperisone Hydrochloride Diclofenac Sodium Excipients Approved colour used	IP	450mg 100mg q.s.
146	Diclofenac Paracetamol & Chlorzoxazone Tablets	Each uncoated tablet contains:- Paracetamol Diclofenac Potassium Chlorzoxazone Excipients Colour:-Approved colour used	IP BP USP	325 mg 50 mg 250mg q.s.
147	Diclofenac Potassium , Paracetamol & Serratiopeptidase Tablets	Each film coatedTablet Contains: Diclofenac Potassium Paracetamol Serratiopeptidase ( Eq. to enzyme activityof 20000 units of enteric coated granules) Excipients Approved Colour Used	BP IP IP	50mg 325mg 10mg q.s.
148	Diclofenac Potassium , Paracetamol & Serratiopeptidase Tablets	Each film coatedTablet Contains: Diclofenac Potassium Paracetamol Serratiopeptidase ( Eq. to enzyme activityof 20000 units of enteric coated granules) Excipients Approved Colour Used.	BP IP IP	50mg 325mg 10mg q.s.
149	Diclofenac Potassium , Paracetamol & Serratiopeptidase Tablets	Each film coated Tablet Contains: Diclofenac Potassium Paracetamol Serratiopeptidase ( Eq. to enzyme activityof 30000 units of enteric coated granules) Excipients Approved Colour Used	BP IP IP	50mg 325mg 15mg q.s.
150	Diclofenac Potassium & Metaxalone Tablets	Each uncoated Tablet contains: Diclofenac Potassium Metaxalone Excipients Approved colour used	BP	50mg 400mg q.s.
151	Diclofenac Potassium & Paracetamol Tablets	Each film coated Tablet Contains: Diclofenac Potassium Paracetamol Excipients Approved colour used	BP IP	50mg 325mg q.s.
152	Diclofenac Potassium & Paracetamol Tablets	Each film coated Tablet Contains: Diclofenac Potassium Paracetamol Excipients Approved colour used	BP IP	50mg 325mg q.s.
153	Diclofenac Potassium & Serratiopeptidase Tablets	Each film coated Tablet contains: Diclofenac Potassium Serratiopeptidase (Eq. toenzyme activityof 30000units of enteric coated granules) Excipients Approved colour used	BP IP	50mg 15mg q.s.
154	Diclofenac Potassium & Serratiopeptidase Tablets	Each film coated tablet contains : Diclofenac Potassium Serratiopeptidase (as enteric coated 20,000 unit of activated enzymatic activity of Serratiopeptidase ) Excipients Approved colour used.	BP IP	50mg 10mg q.s.
155	Diclofenac Potassium & Thiocolchicoside Tablets	Each enteric coated tablet contains: Diclofenac Potassium Thiocolchiside Excipients Approved colour used.	I.P. I.P.	50mg 4mg q.s.
156	Diclofenac Potassium Sustained Release Tablets	Each film coated sustainedrelease tablet contains: Diclofenac Potassium Excipients Approved colour used	BP	100 mg q.s.
157	Diclofenac Potassium Tablets IP	Each Filmcoated Tablet contains: Diclofenac Potassium Excipients Approved colour used	IP	25mg q.s.
158	Diclofenac Potassium, Paracetamol & Chlorzoxazone Tablets	Each film coated Tablet Contains: Diclofenac Potassium Paracetamol Chlorzoxazone Excipients Approved colour used	BP IP IP	50mg 325mg 500mg q.s.
159	Diclofenac potassium, Paracetamol & Chymotrypsin Tablets (Discontinue AFTER GETTING APPROVAL AS PER S.No.892 which is in enteric coated formulation).	Each Film coated TabletsContains: Diclofenac potassium Paracetamol Trypsin Chymotrypsin 50000 Armour unit of enzymatic activity (Supplied by a purified concentrate which has specific Trypsin and chymotrypsin activity in ratio of Approximate six to one) Excipients Approved colour used	BP IP	50 mg 325 mg 50000AU q.s.
160	Diclofenac Potassium, Paracetamol & Trypsin Chymotrypsin Tablets	Each enteric coated tablet contains: Diclofenac Potassium Paracetamol Trypsin Chymotrypsin 50000 Armour unit of enzymatic activity. Excipients Approved colour used.	BP IP BP	50mg 325mg 50000AU q.s.
161	Diclofenac Sodium , Paracetamol & Chlorzoxazone Tablets	Each uncoated tablet contains:- Paracetamol Diclofenac Sodium Chlorzoxazone Excipients Colour:-Approved colour used	IP IP USP	325 mg 50 mg 250mg q.s.
162	Diclofenac Sodium & Paracetamol Tablets	Each film coated tablets contains: Diclofenac Sodium (as Enteric coated) Paracetamol Excipients Approved colour used	IP IP	50mg 325mg
163	Diclofenac Sodium & Paracetamol Tablets IP	Each Uncoated Bilayered tablet contains : Diclofenac Sodium Paracetamol Excipients Approved colour used.	IP IP	50mg 325mg q.s.
164	Diclofenac Sodium & Serratiopeptidase Tablets	Each film coatedTablet Contains: Diclofenac Sodium Serratiopeptidase (Eq. toenzyme activityof 20000 units of enteric coated granules) Excipients Approved Colour Used.	IP IP	50mg 10mg q.s.
165	Diclofenac Sodium SR Tablet IP	Each film coated Sustained Release tablet Contains Diclofenac Sodium Excipients Colour :-Approved colour used	IP	100mg q.s
166	Diclofenac Sodium Tablets IP	Each Enteric Coated Tablet Contains: Diclofenac Sodium Excipients Approved Colour Used	IP	50mg q.s
167	Diclofenac, Paracetamol and Serratiopeptidase Tablets	Each film coated tablet contains:- Diclofenac Sodium Paracetamol Serratiopeptidase (Eq.toEnzyme activity30000 Units of enteric coated granules) Excipients Colour:-Approved colour used	IP IP IP	50 mg 325 mg 15 mg q.s.
168	Dicyclomine Hydrochloride& Paracetamol Tablets	Each uncoated Tablet contains: Dicyclomine Hydrochloride Paracetamol Excipients Approved colour used	IP IP	20mg 500mg q.s.
169	Digoxin Tablets IP	Each Uncoated Tablet Contains: Digoxin Excipients	IP	0.25mg q.s.
170	Digoxin Tablets IP	Each uncoated Tablet Contains: Digoxin Excipients Approved colour used	IP	0.25mg q.s.
171	Disulfiram Tablets	Each Uncoated Tablet Contains:- Disulfiram Excipients Colour :- Approved colour used	IP	200mg q.s
172	Domperidone DispersibleTablets	Each uncoated dispersible tablet contains: Domperidone Excipients Approved colour used	IP	10mg q.s
173	Doxofylline ( Sustained Release) & Montelukast Tablets	Each Filmcoated Bilayered Tablet Contains : Doxofylline (as Sustained Release) Montelukast Sodium Equ. to Montelukast Excipients Approved colour used	IP IP	400mg 10mg q.s.
174	Doxofylline & Ambroxol Hydrochloride Tablets	Each Film coated Tablet Contains : Doxofylline Ambroxol Hydrochloride Excipients Approved colour used	IP IP	400mg 30mg q.s.
175	Doxofylline Modified Release Tablets	Each uncoated Modified Release Tablet contains : Doxofylline Excipients	IP	650mg q.s.
176	Doxofylline Tablets IP	Each filmCoatedTablet Contains:- Doxofylline Excipients Colour :-Approved colour used	IP	400mg q.s.
177	Doxofylline Tablets IP	Each uncoated Tablet Contains :- Doxofylline Excipients	IP	400mg q.s.
178	Doxofylline(SR) & Montelukast Sodium Tablets	Each uncoated tablet contains: Doxofylline (As sustainedrelease) Montelukast Sodium Eq. to Montelukast Excipients Approved colour used	IP IP	400 mg 10 mg q.s.
179	Doxycycline & Lactic Acid Bacillus Tablets	Each Film coated Tablet Contains : Doxycycline Hyclate Equ. To DoxycyclineLactic Acid Bacillus Excipients Approved colour used	IP	100mg 5 Billion Spores q.s.
180	Doxycycline Hyclate Tablets	Each film coated Tablet Contains: Doxycycline Hyclate Equ. to Doxycycline Excipients Approved colour used.	IP	100mg q.s.
181	Doxylamine Succinate & Pyridoxine HCl Tablets	Each enteric coated tablet contains : Doxylamine Succinate Pyridoxine Hydrochloride Excipients Approved colour used	USP IP	10mg 10mg q.s
182	Doxylamine succinate, Pyridoxine hydrochloride & Folicacid Tablets	Each enteric coated tablets contains: Doxylamine succinate Pyridoxinehydrochloride Folic acid Excipients Approved colour used	USP IP IP	20 mg 20 mg 5 mg q.s.
183	Doxylamine succinate, Pyridoxine hydrochloride & FolicacidTablets	Each entericcoatedtablets contains: Doxylamine succinate Pyridoxinehydrochloride Folic acid Excipients Approved colour used	BP IP IP	10 mg 10 mg 2.5 mg q.s.
184	Dried Aluminium Hydroxide, Magnesium Aluminium Silicate Hydrate, Magnesium Hydroxide & Simethicone Chewable Tablets	Each uncoated Chewable Tablet Contains: Dried Aluminium Hydroxide Magnesium Aluminium Silicate Hydrate Magnesium Hydroxide Simethicone Excipients Colour: Erythrosine & Ponceau 4R	IP IP IP	300mg 50mg 25mg 25mg q.s
185	Drotaverine hydrochloride & Mefenamic Acid Tablets	Each film coated tablets: Drotaverine hydrochloride Mefenamic Acid Excipients Approved colour used	IP IP	80 mg 250 mg q.s.
186	Drotaverine Hydrochloride Tablet IP	Each film coated tablet Contains:- Drotaverine Hydrochloride Excipients Colour :-Approved colour used	IP	40mg q.s.
187	Drotaverine Hydrochloride Tablets IP	Each uncoated Tablet contains Drotaverine Hydrochloride Excipients Approved Coloured used	IP	80mg q.s
188	Drotaverine Hydrochloride Tablets IP	Each Film coated Tablet contains Drotaverine Hydrochloride Excipients Colour : Approved Coloured used	IP	80mg q.s
189	Duloxetine Gastro- resistant Tablets IP	Each enteric coated Tablet contains : Duloxetine Hydrochloride Equ. to Duloxetine Excipients Approved Colour used.	IP	20mg q.s.
190	EbastineTablet IP	Each film coated tablet contains: Ebastine Excipients Approved colour used	IP	10 mg q.s
191	EbastineTablet IP	Each film coated tablet contains: Ebastine Excipients Approved colour used	IP	20 mg q.s
192	Empagliflozin & Linagliptin Tablets	Each film coated tablet contains:- Empagliflozin Linagliptin Excipients Approved colour used .		10mg 5mg q.s.
193	Empagliflozin & Linagliptin Tablets	Each film coated tablet contains:- Empagliflozin Linagliptin Excipients Approved colour used .		25mg 5mg q.s.
194	Ergotamine Tartrate, Caffeine, Paracetamol & Prochlorperazine Maleate Tablets	Each uncoated tablet contain: Ergotamine Tartrate Caffeine (Monohydrate) Paracetamol Prochlorperazine Maleate Excipients Approved colour used (Banned drug 12/08/2024)	IP IP IP IP	1 mg 100 mg 250 mg 2.5 mg q.s
195	Erythromycin StearateTablet IP	Each film coated Tablet Contains: Erythromycin Stearate Equ. toErythromycin Excipients Colour:- Approved colour used	IP	250mg
196	Escitalopram Oxalate & Clonazepam Tablet IP	Each film coated Tablet Contains:- Escitalopram Oxalate Equivalent toEscitalopram Clonazepam Excipient Approved colour used	IP IP	10 mg 0.5 mg q.s.
197	Escitalopram Oxalate Tablet	Each film coated Tablet Contains: Escitalopram oxalate Equ. toEscitalopram Excipients Colour : Approved Coloured Used	IP	10mg q.s
198	Esomeprazole Gastro–resistant Tablet IP	Each Enteric coated Tablet contains :- Esomeprazole magnesium Trihydrate Equ. to Esomeprazole Excipients Colour : Approved Coloured Used	IP	40mg q.s.
199	Etizolam Tablets	Each film coated tablet contains: Etizolam Excipients Approved colour used		0.25 mg q.s
200	Etizolam Tablets	Each film coated tablet contains: Etizolam Excipients Approved colour used		0.5 mg q.s
201	Etodolac Extended Release Tablets USP	Each Film Coated Extended Release Tablet contains : Etodolac Excipients Approved colour used	IP	600mg q.s.
202	Etodolac Tablets IP	Each Film Coated Tablet contains: Etodolac Excipients Approved colour used	IP	400mg q.s.
203	Etodolac Tablets IP	Each Film Coated Tablet contains: Etodolac Excipients Approved colour used	IP	300mg q.s.
204	Etophylline & Theophylline Prolonged Release Tablet IP	Each Film coated prolonged release Tablet contains Etophylline Theophylline Anhydrous Equ. to Theophyllinehydrate Excipients Colour : Approved Coloured Used	IP IP	115mg 35mg q.s
205	Etoricoxib & Paracetamol Tablets	Each film coated tablet Contains:- Etoricoxib Paracetamol Excipients Colour :-Approved colour used	IP IP	60mg 325mg q.s
206	Etoricoxib & Thiocolchicoside Tablets	Each film coated tablet Contains:- Etoricoxib Thiocolchicoside Excipients Colour :-Approved colour used	IP IP	60mg 4mg q.s
207	Etoricoxib and Pregabalin (Prolonged Release) Tablets	Each uncoated bilayered tablet contains: Etoricoxib Pregabalin (As prolonged release) Excipients Approved colour used.	IP IP	60 mg 75 mg q.s.
208	Etoricoxib tablets IP	Each film coated tablet contains:- Etoricoxib Excipients Colour:-Approved Colour Used	IP	90 mg q.s.
209	Etoricoxib tablets IP	Each film coated tablet contains:- Etoricoxib Excipients Colour:-Approved Colour Used	IP	60 mg q.s.
210	Etoricoxib tablets IP	Each film coated tablet contains:- Etoricoxib Excipients Colour:- Approved Colour Used	IP	120 mg q.s.
211	Febuxostat Tablet	Each film coated tablet contains: Febuxostat Excipients Approved colour used		120 mg q.s
212	FebuxostatTablets	Each film coated tablet contains:- Febuxostat Excipients Colour:-Approved colour used		40 mg q.s.
213	FebuxostatTablets	Each film coated tablet contains:- Febuxostat Excipients Colour:-Approved colour used		80 mg q.s.
214	Ferrous Ascorbate , Folic Acid & Zinc Tablet	Each film coatedTablet Contains: Ferrous Ascorbate Equ. toElemental Iron Folic Acid Zinc SulphateMonohydrate Equ. to Elemental Zinc Excipients Approved Colour Used.	IP IP	100mg 1.5mg 22.5mg q.s.
215	Ferrous Ascorbate , Folic Acid, Methylcobalamin & Zinc Sulphate Monohydrate Tablet	Each FilmCoated Tablet Contains: Ferrous Ascorbate Equ. ToElemental IronFolic Acid Methylcobalamin Zinc Sulphate Monohydrate Equ. To Elemental Zinc Excipients Approved Colour Used	IP IP IP IP	100mg 1.1mg 1.5mg 22.5mg q.s.
216	Ferrous Ascorbate (SR) and L-Methylfolate Tablets	Each film coated tablet contains: Ferrous Ascorbate Eq. to Elemental Iron (In sustained release form) Calcium L-5 Methyltetrahydrofolate Eq. to L-Methylfolate Excipients Approved colour used. Appropriate overages of L-Methylfolate added to compensate loss on storage.	I.P. U.S.P q.s.	100mg 0.5mg
217	Ferrous Ascorbate & Folic Acid Tablets	Each film coated tablet contains:- Ferrous Ascorbate Eq.toElementalIron Folic Acid Excipients Colour:-Approved colour used	IP	100 mg 1.5 mg q.s.
218	Ferrous Ascorbate, Folic Acid & Methylcobalamin Tablets	Each film coated tablets contains: Ferrous Ascorbate Eq. to Elemental Iron Folic Acid Methylcobalamin Excipients Approved Colour used. Appropriate overages of vitamins added to compensate the loss on storage.	I.P. I.P.	100mg 1.5mg 1500 mcg qs
219	Ferrous Ascorbate, Folic acid, Cyanocobalamin & Zinc Tablet	Each film coatedtablet contain: Ferrous Ascorbate Equ. toElmental Iron Folic acid Zinc Sulphate Monohydrate Equ. to Elmental Zinc Cyanocobalamin Excipients Approved colour used	IP IP IP	100 mg 1.5mg 22.5mg 15mcg q.s
220	Fexofenadine & Montelukast ChewableTablets	Each Uncoated Chewable Tablet Contains : Fexofenadine Hydrochloride Montelukast Sodium Equ. to Montelukast Excipients	IP IP	120mg 10mg q.s.
221	Fexofenadine & MontelukastTablet	Each uncoatedTablet contains Fexofenadine Hydrochloride Equ. to Fexofenadine Montelukast Sodium Equ. toMontelukast Excipients Colour : ApprovedColour Used	IP IP	120mg 10mg q.s.
222	Fexofenadine Hydrochloride & Montelukast Tablets	Each film coated tablet contains: Fexofenadine Hydrochloride Montelukast sodium Equ. to Montelukast Excipients Approved colour used.	IP IP	120mg 10mg q.s.
223	Fexofenadine Hydrochloride Tablet IP	Each uncoatedTablet contains Fexofenadine Hydrochloride Equ. to Fexofenadine Excipients Colour : ApprovedColour Used	IP	120mg q.s
224	Fexofenadine Hydrochloride Tablets IP	Each FilmcoatedTabletsContains: Fexofenadine Hydrochloride Excipients Approved colour used	IP	180 mg q.s.
225	Fexofenadine Hydrochloride Tablets IP	Each film coated tablet contains: Fexofenadine Hydrochloride Excipients Approved colour used.	IP	120mg q.s
226	Flavoxate Tablet IP	Each film coated tablet contains: Flavoxate Excipients Approved colour used	IP	200 mg q.s
227	Fluconazole Tablet IP	Each Uncoated Tablet Contains: - Fluconazole Excipients Colour : -ApprovedColour used	IP	150mg q.s.
228	Fluconazole Tablets IP	Each uncoated tablet Contains: Fluconazole Excipients Approved colour used	IP	400mg q.s.
229	FluconazoleTablets IP	Each uncoated tablets contains: Fluconazole Excipients Approved colour used	IP	200 mg q.s.
230	Flunarizine Tablets	Each Uncoated Tablet Contains: Flunarizine (as Flunarizine Dihydrochloride) Excipients Approved colour used	BP	5mg q.s.
231	Flunarizine Tablets IP	Each uncoated Tablet contains Flunarizine Hydrochloride Excipients Approved Coloured used	BP	10mg q.s
232	Fluoxetine & Alprazolam Tablets	Each uncoated tablet contains: Fluoxetine Hydrochloride Eq. to fluoxetine Alprazolam Excipients Approved colour used	IP IP	20 mg 0.25 mg q.s
233	FluoxetineTablet IP	Each film coated tablet Contains:- Fluoxetine Hydrochloride Equ. toFluoxetine Excipients Colour :-Approved colour used	IP	20mg q.s.
234	Flupentixol Dihydrochloride & Melitracen Hydrochloride Tablets	Each film coated tablet contains : Flupentixol Dihydrochloride Equ. to Flupentixol Melitracen Hydrochloride Equ. to Melitracen Excipients Approved colour used.	BP	0.5mg 10mg q.s
235	Folic Acid Tablets IP	Each uncoated Tablet Contains: Folic Acid Excipients Approved Colour used	IP	5mg q.s
236	Folic Acid Tablets IP	Each uncoated Tablet Contains: Folic Acid Excipients Approved Colour used	IP	10mg q.s
237	Frusemide Tablets IP	Each uncoated tablet contains: Frusemide Excipients Approved colour used.	IP	40mg q.s.
238	Furosemide Tablets IP	Each Uncoated Tablet Contains: Furosemide Excipients	IP	40mg q.s.
239	Gabapentin & Methylcobalamin Tablet	Each film coated tablet contains; Gabapentin Methylcobalamine Excipients Approved colour used	IP IP	300mg 500mcg q.s
240	Gabapentin & Methylcobalamin Tablets	Each film coated Tablet Contains: Gabapentin Methylcobalamin Excipients Approved colour used.	IP IP	100mg 500mcg q.s.
241	Gabapentin and Nortriptyline Tablets	Each film coated Tablet contains: Gabapentin Nortriptyline Hydrochloride Equ. to Nortriptyline Excipients Approved colour used	IP IP	300mg 10mg q.s
242	Gabapentin Tablet IP	Each film coated tablet contains: Gabapentin Excipients Approved colour used	IP	100 mg q.s
243	Gabapentin Tablet IP	Each film coated tablet contains: Gabapentin Excipients Approved colour used	IP	400 mg q.s
244	Gabapentin Tablet IP	Each film coated tablet contains: Gabapentin Excipients Approved colour used	IP	800 mg q.s
245	Gliclazide & Metformin Hydrochloride(SR) Tablets	Each Uncoated Bilayered Tablet Contains: Gliclazide Metformin Hydrochloride (as Sustained Release) Excipients Colour : Approved Coloured used	IP IP	80mg 500mg q.s.
246	Glimepiride & Metformin Hydrochloride (SR) Tablets	Each uncoated Bilayered Tablet contains: Glimepiride Metformin Hydrochloride (as Sustained Release form) Excipients Approved colour used	IP IP	3mg 500mg q.s.
247	Glimepiride & Metformin Hydrochloride (SR) Tablets	Each uncoated Bilayered Tablet contains: Glimepiride Metformin Hydrochloride (as Sustained Release form) Excipients Approved colour used	IP IP	4mg 1000mg q.s.
248	Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets	Each uncoated Bilayered Tablet contains: Glimepiride Metformin Hydrochloride ( as Sustained Release) Excipients Approved colour used.	IP IP	3mg 1000mg q.s.
249	Glimepiride and Metformin Hydrochloride (Sustained Release) Tablets IP	Each uncoated Bilayered tablet contains: Glimepiride Metformin Hydrochloride (as sustained release) Excipients Approved colour used.	IP IP	1mg 1000mg q.s.
250	Glimepiride, Metformin Hydrochloride (ER) & Voglibose Tablets	Each uncoated Bilayered Tablet Contains : Glimepiride Metformin Hydrochloride (as Extended Release) Voglibose Excipients Approved colour used	IP IP IP	1mg 500mg 0.3mg q.s.
251	GlimepirideTablet IP	Each uncoated tablet contains: Glimepiride Excipients Approved colour used	IP	1 mg q.s.
252	GlimepirideTablet IP	Each uncoated tablet contains: Glimepiride Excipients Approved colour used	IP	2 mg q.s.
253	Griseofulvin Tablets IP	Each uncoated Tablet Contains: Griseofulvin Excipients Approved Colour Used	IP	250mg q.s
254	Griseofulvin Tablets IP	Each Uncoated Tablet Contains: Griseofulvin Excipients	IP	500mg q.s.
255	Haloperidol Tablet IP	Each Uncoated Tablet Contains: Haloperidol Excipients	IP	5mg q.s.
256	Hydoxychloroquine Tablets IP	Each film coatedtablets contain: Hydroxychloroquine Sulphate Excipients	IP	200 mg q.s.
257	Hydoxychloroquine Tablets IP	Each film coatedtablets contain: Hydroxychloroquine Sulphate Excipients	IP	400 mg q.s.
258	Hydrochlorothiazid e tablet IP	Each film coated tablet contains:- Hydrochlorothiazide Excipients Colour : Approved Colour Used	IP	25mg q.s
259	Hydrochlorothiazid e tablet IP	Each film coated tablet contains:- Hydrochlorothiazide Excipients Colour : Approved Colour Used	IP	50mg q.s
260	Hydroxyzine Hydrochloride Tablet	Each uncoated tablet contains Hydroxyzine Hydrochloride eq. to Hydroxyzine Excipients Colour :- Approved Colour Used	IP	10mg q.s.
261	Hydroxyzine Hydrochloride Tablet	Each uncoated tablet contains Hydroxyzine Hydrochloride eq. to Hydroxyzine Excipients Colour :- Approved Colour Used	IP	25mg q.s.
262	Hydroxyzine Hydrochloride Tablets IP	Each Film Coated Tablet Contains: Hydroxyzine Hydrochloride Excipients Approved colour used.	IP	25mg q.s
263	Hyoscine Butylbromide IP	Each Film coated Tablet Contains : Hyoscine Butylbromide Excipients Approved colour used.	IP	10mg q.s.
264	Ibuprofen & Paracetamol Tablets	Each uncoated Tablet Contains Ibuprofen Paracetamol Excipients Approved Colour Used	IP IP	400mg 325mg q.s
265	Ibuprofen Tablets IP	Each film coated Tablet contains: Ibuprofen Excipients Approved colour used	IP	200mg
266	Ibuprofen Tablets IP	Each film coated Tablet contains: Ibuprofen Excipients Approved colour used	IP	400mg
267	Isosorbide Dinitrate Tablets IP	Each Uncoated Tablet Contains: Isosorbide Dinitrate Excipients Approved colour used	IP	5mg q.s.
268	Isoxsuprine Tablets (Sustained Release)	Each uncoated Sustained Release Tablet Contains Isoxsuprine Hydrochloride Excipients Approved colour used	IP	40mg q.s
269	Ivermactin Tablet IP	Each uncoated tablet contains: Ivermactin Excipients Approved colour used	IP	6 mg q.s
270	Ivermactin Tablet IP	Each uncoated tablet contains: Ivermactin Excipients Approved colour used	IP	12 mg q.s
271	Ivermectin & Albendazole Tablets	Each uncoated tablet contains: Ivermactin Albendazole Excipients Approved colour used	IP IP	12 mg 400mg q.s
272	Ketoconazole Tablet IP	Each uncoated tablet contain: Ketoconazole Excipients Approved colour used	IP	200 mg q.s
273	Ketrolac Tromethamine DispersibleTablets	Each uncoated dispersible tablets contains: Ketrolac Tromethamine Excipients Approved colour used	IP	10 mg q.s.
274	L- Carnitine , L- Tartrate, Folic Acid & Methylcobalamin Tablets	Each film coated Tablet contains: L-Carnitine L-Tartrate Equ. to L-Carnitine Methylcobalamin Folic Acid Excipients Approved colour used	IP IP	500mg 1500mcg 1.5mg q.s.
275	L-Carnitine L- Tartrate, Methylcobalamin and Folic Acid Tablets	Each FilmCoated Tablet Contains: L-Carnitine L-Tartrate Methylcobalamin FolicAcid Excipients Approved colour used.	IP IP	500mg 1500mcg 1.5mg q.s.
276	L-Mehtylfolate, Methylcobalamin & Pyridoxal-5-Phosphate Tablets	Each film coated tablet contains: Calcium L-5 Methyltetrahydrofolate Equivalent to L-Methylfolate Methylcobalamin Pyridoxal-5-Phosphate Excipients Approved colour used Appropriate overages of vitamins added to compensate the possible loss on storage.	U.S.P. I.P.	5 mg 1500 mcg 0.5 mg q.s.
277	L-methylfolate Calcium, Methylcobalamin, Pyridoxal-5-Phosphate Tablets	Each film coated tablet contains:- L-methylfolate Methylcobalamin Pyridoxal-5-Phosphate Excipients Approved colour used .	IP	1mg 1500mcg 0.5mg q.s.
278	Labetalol Tablets IP	Each film coated Tablet Contains: Labetalol Hydrochloride Excipients Approved colour used.	IP	50mg q.s
279	Labetalol Tablets IP	Each film coated Tablet Contains: Labetalol Hydrochloride Excipients Approved colour used.	IP	100mg q.s
280	Lansoprazole orally Disintegrating Tablets	Each uncoated tablet contains: Lansoprazole (as enteric coated pellets) Excipients Approved colour used	IP	15 mg q.s.
281	Lansoprazole Orally Disintegrating Tablets 30mg	Each uncoated orallyDisintegrating tablet contains: Lansoprazole (As enteric coated pellets) Excipients Approved colour used.	IP	30mg q.s.
282	Leflunomide Tablet IP	Each film coated Tablet Contains: Leflunomide Excipients Colour : Approved Coloured Used	IP	20mg q.s
283	Leflunomide Tablet IP	Each film coated Tablet Contains: Leflunomide Excipients Colour : Approved Coloured Used	IP	10mg q.s
284	Letrozole Tablets USP	Each film coated Tablet contains: Letrozole Excipients Approved colour used.	USP	2.5mg q.s.
285	Levetiracetam Tablet IP	Each film Coated Tablet Contains :- Levetiracetam Excipients Colour :- Approved colour used	IP	250mg q.s
286	Levetiracetam Tablet IP	Each film Coated Tablet Contains :- Levetiracetam Excipients Colour :- Approved colour used	IP	500mg q.s
287	Levocetirizine Dihydrochloride & Montelukast DispersibleTablets	Each uncoated dispersible Tablet contains : Levocetirizine Dihydrochloride Montelukast sodium Equ. to Montelukast Excipients	IP IP	2.5mg 4mg q.s
288	Levocetirizine Dihydrochloride Tablets IP	Each Uncoated Tablet Contains:- Levocetirizine Dihydrochloride Excipients Colour :-Approved colour used	IP	5mg q.s.
289	Levocetirizine Dihydrochloride Tablets IP	Each film Coated Tablet Contains : Levocetirizine Dihydrochloride Excipients Approved colour used.	IP	5mg q.s.
290	Levocetirizine Dihydrochloride, Phenylephrine Hydrochloride & Paracetamol Tablets	Each uncoated Tablet contains : Levocetirizine Dihydrochloride Phenylephrine Hydrochloride Paracetamol Excipients (Banned drug 12/08/2024) (Banned drug 12/08/2024)	IP IP IP	2.5mg 10mg 500mg q.s.
291	Levocetirizine Hydrochloride & Ambroxol Hydrochloride Tablet	Each film coated Tablet contains: Levocetirizine Hydrochloride Ambroxol Hydrochloride Excipients Approved colour used.	IP IP	5mg 60mg q.s.
292	Levocetirizine Hydrochloride Tablets IP	Each Film coated Tablet Contains : Levocetirizine Hydrochloride Excipients Approved colour Used.	IP	10mg q.s.
293	Levodopa & Carbidopa Tablets IP	Each Uncoated Tablet Contains: Carbidopa Equ.ToCarbidopa AnhydrousLevodopa Excipients Approved colour used	IP IP	25mg 250mg q.s.
294	Levofloxacin & OrnidazoleTablets	Each film coated tablets contains: Levofloxacin hemihydrate Equivanent to Levofloxacin anhydrous Ornidazole Excipients Approved colour used	IP IP	250 mg 500 mg q.s.
295	Levofloxacin Tablets IP	Each film coated tablet contains:- Levofloxacin Hemihydrate Equivalent to Levofloxacin Excipients Colour:-Approved colour used	IP	250 mg. q.s.
296	Levofloxacin Tablets IP	Each film coated tablet contains:- Levofloxacin Hemihydrate Equivalent to Levofloxacin Excipients Colour:-Approved colour used	IP	500 mg. q.s.
297	Levofloxacin Tablets IP	Each film coated tablet contains:- Levofloxacin Hemihydrate Equivalent to Levofloxacin Excipients Colour:-Approved colour used	IP	750 mg. q.s.
298	Levosulpiride Tablets	Each Uncoated Tablet Contains: Levosulpiride Excipients		25mg q.s.
299	Levothyroxine sodium Tablets USP	Each uncoated Tablet Contains: Levothyroxine Sodium Equ. to Anhydrous Levothyroxine Sodium Excipients	USP	50mcg q.s.
300	LinezolidTablet IP	Each film coated tablet contains:- Linezolid Excipients Colour:-Approved colour used	IP	600 mg q.s.
301	Lithium Carbonate Prolonged – Release Tablets IP	Each uncoated Prolonged-Release tablet contains: Lithium Carbonate Excipients Approved colour used.	IP	450mg q.s.
302	Loperamide Hydrochloride Tablets IP	Each uncoated tablet contains:- Loperamide Hydrochloride Excipients Colour : Approved Coloured Used	IP	2 mg q.s.
303	Loratadine Tablet USP	Each uncoated table contains:- Loratadine Excipients Approved colour used	USP	10 mg q.s.
304	Lornoxicam & Paracetamol Tablets	Each film coatedTablet Contains:- Lornoxicam Paracetamol Excipients Colour :-Approved colour used	IP IP	4mg 325mg q.s.
305	Lornoxicam & Paracetamol Tablets	Each film coatedTablet Contains:- Lornoxicam Paracetamol Excipients Colour :-Approved colour used	IP IP	8mg 325mg q.s.
306	Losartan Potassium & Amlodipine Besilate Tablet IP	Each film coated tablet contains: Losartan Potassium Amlodipine Besilate Eq. to Amlodipine Excipients Approved colour used	IP IP	50 mg 5 mg q.s.
307	Losartan Potassium & Hydrochlorothiazid e Tablet IP	Each film coated tablet contains: Losartan Potassium Hydrochlorothiazide Excipients Approved colour used	IP IP	50 mg 12.5 mg q.s.
308	Losartan Potassium Tablet IP	Each film coated tablet contains: Losartan Potassium Excipients Approved colour used	IP	50 mg
309	Losartan potassium Tablets IP	Each film coated tablet contains: Losartan potassium Excipients Approved colour used.	IP	25mg q.s
310	Mecobalamin Tablets	Each film coated Tablet contains: Mecobalamin Excipients Approved colour used.	IP	1500mcg q.s.
311	Mecobalamin, Alpha Lipoic Acid, Benfotiamine, Folic acid,Chromium Picolinate,Inositol, Pyridoxine HCL, Vitamin D3, & Calcium Carbonate Tablets	Each film coated tablet contains: Mecobalamin Alpha Lipoic Acid Benfotiamine Folic acid Chromium Picolinate Inositol, Pyridoxine HCL Vitamin D3 Calcium Carbonate Excipients Approved colour used	IP IP IP IP IP IP IP IP	1500 mcg 100 mg 150 mg 1.5 mg 200 mcg 100 mg 3 mg 1000 IU 500mg q.s.
312	Mefenamic Acid & Dicyclomine HCl Tablets	Each uncoated Tablet contains: Mefenamic Acid Dicyclomine HCl Excipients	IP IP	250mg 20mg q.s
313	Mefenamic Acid & Dicyclomine Tablets IP	Each uncoated tablet contains:- Mefenamic Acid Dicyclomine Hydrochloride Excipients Colour:-Approved Colour used	IP IP	250 mg 10 mg q.s.
314	Mefenamic Acid & Paracetamol Tablet	Each uncoated tablet contain: Mefenamic Acid Paracetamol Excipients Approved colour used	IP IP	500 mg 325 mg q.s.
315	Mefenamic Acid & Paracetamol Tablets	Each uncoated tablet contains: Mefenamic Acid Paracetamol Excipients Approved Colour used	IP IP	250mg 325mg q.s.
316	Memantine Hydrochloride & Donepezil Hydrochloride Tablets	Each film coated tablet contains: Memantine Hydrochloride Donepezil Hydrochloride Excipients Approved colour used.	IP IP	5mg 5mg q.s.
317	Mesalamine Prolonged-release Tablets IP	Each enteric coated Prolonged-release tablet contains:- Mesalamine Excipients Approved colour used .	IP	1200mg q.s.
318	Metformin Hydrochloride (Prolong Release) and Glimepiride Tablet IP	Each uncoated bilayer tablet contains:- Metformin Hydrochloride (Prolonged Release) Glimepiride Excipients Colour:- Approved Colour Used	IP IP	500 mg 1 mg q.s.
319	Metformin Hydrochloride (Prolong Release) and Glimepiride Tablet IP	Each uncoated bilayer tablet contains:- Metformin Hydrochloride (Prolonged Release) Glimepiride Excipients Colour:- Approved Colour Used	IP IP	500 mg 2 mg q.s.
320	Metformin Hydrochloride (SR) & Glimepiride Tablets IP	Each Uncoated Bilayered Tablet Contains: Glimepiride Metformin Hydrochloride (as Sustained Release) Excipients Approved colour used.	IP IP	2mg 500mg q.s.
321	Metformin Hydrochloride (Sustained Release) , Gliclazide (Sustained Release) & Pioglitazone Tablets	Each uncoated Bilayered Tablet Contains: Metformin Hydrochloride (as Sustained Release) Gliclazide (as Sustained Release) Pioglitazone Hydrochloride Equ. to Pioglitazone Excipients Approved colour used.	IP IP IP	500mg 30mg 15mg q.s.
322	Metformin Hydrochloride (Sustained Release) & Glimepiride Tablets IP	Each Uncoated Bilayered Tablet Contains: Glimepiride Metformin Hydrochloride (as Sustained Release) Excipients Approved colour used.	IP IP	1mg 500mg q.s.
323	Metformin Hydrochloride & GliclazideTablets	Each uncoated tablets contains: Metformin hydrochloride Gliclazide Excipients Approved colour used	IP IP	500 mg 80 mg
324	Metformin Hydrochloride Prolonged Release & Glimepiride Tablets IP	Each uncoated Bilayered tablet contains : Metformin Hydrochloride (as Prolonged Release) Glimepiride Excipients Approved colour used	IP IP	1000mg 2mg q.s
325	Metformin Hydrochloride Sustained-Release Tablets	Each uncoated Sustained Release Tablet Contains : Metformin Hydrochloride Excipients	IP	500mg q.s.
326	Metformin Hydrochloride Sustained-Release Tablets	Each uncoated Sustained Release Tablet Contains : Metformin Hydrochloride Excipients	IP	850mg q.s.
327	Metformin Hydrochloride Sustained-Release Tablets	Each uncoated Sustained Release Tablet Contains : Metformin Hydrochloride Excipients	IP	1000mg q.s.
328	Metformin Hydrochloride Tablets IP	Each uncoated sustainedrelease tablet contains: Metformin Hydrochloride Excipients Approved colour used	IP	500 mg q.s.
329	Metformin hydrochloride,(ER) Pioglitazone and GlimepirideTablets	Each uncoated Bilayered tablets contain: Metformin hydrochloride (as Extended release) Pioglitazone Hydrochloride Eq.to Pioglitazone Glimepiride Excipients Approved colour used	IP IP IP	500 mg 15 mg 2 mg q.s
330	Metformin hydrochloride,(ER) Pioglitazone and Glimipride Tablets	Each uncoated Bilayered tablets contain: Metformin hydrochloride (as Extended release) Pioglitazone Hydrochloride. Eq.to Pioglitazone Glimepiride Excipients Approved colour used	IP IP IP	500 mg 15 mg 1 mg q.s
331	Methotrexate Tablets IP	Each uncoated tablet contains: Methotrexate Excipients Approved colour used.	IP	2.5mg q.s.
332	Methylcobalamin Sublingual Tablets	Each uncoated sublingual tablet contains : Methylcobalamin Excipients	IP	1500mcg q.s.
333	Methylcobalamin Tablets	Each film coated Tablet Contains: Methylcobalamin Excipients Approved colour used.		1500mcg q.s.
334	Methylcobalamin, Alpha Lipoic Acid, Pyridoxine Hydrochloride,Thia mine Mononitrate & Folic Acid Tablets	Each film coated tablet contains: Methylcobalamin Alpha Lipoic Acid Pyridoxine Hydrochloride Thiamine Mononitrate Folic Acid Excipients Approved colour used	IP USP IP IP IP	1500mcg 100mg 3mg 10mg 1.5mg q.s.
335	Methylcobalamin, Calcium Citrate, Calcitriol, Folic Acid & Pyridoxine Hydrochloride Tablets	Each film coated Tablet Contains: Methylcobalamin Calcium Citrate Calcitriol Folic Acid Pyridoxine Hydrochloride Excipients Approved colour used	IP USP IP IP IP	1500mcg 750mg 0.25mcg 1.5mg 3mg q.s.
336	Methylcobalamin, L-Methylfolate & Pyridoxine HCl Tablets	Each film coated Tablet Contains : Methylcobalamin L-Methylfolate Pyridoxine HCl Excipients Approved Colour Used	IP IP	1500mcg 1MG 0.5mg q.s
337	Methylcobalamin, L-Methylfolate, Pyridoxal-Phosphate, Vitamin D3 & Docosahexaenoic Acid (DHA) Tablets	Each film coated tablet contains: Methylcobalamin L-Methylfolate Pyridoxal Phosphate Vitamin D3 Docosahexaenoic Acid (DHA) Excipients Approved colour used. Appropriate overages of vitamins added to compensate the loss on storage.	I.P. I.P. I.P. I.P.	1500 mcg 1.0 mg 0.5 mg 1000 IU 100 mg q.s.
338	Methylcobalamine, Alpha Lipoic Acid Vitamin D3,Pyridoxine Hydrochloride ,FolicAcid Tablets	Each film coatedTablet Contains: Methylcobalamine Alpha LipoicAcid Vitamin D3 Pyridoxine Hydrochloride Folic Acid Excipients Approved Colour Used.	IP USP IP IP IP	1500mcg 100mg 1000IU 3mg 1.5mg q.s.
339	Methylprednisolone Tablets	Each uncoated tablet contains:- Methylprednisolone Excipients Colour :- Approved Colour Used	IP	8 mg q.s.
340	Methylprednisolone Tablets IP	Each uncoated tablet contains:- Methylprednisolone Excipients Colour :- Approved Colour Used	IP	4 mg q.s.
341	Methylprednisolone Tablets IP	Each uncoated tablet contains:- Methylprednisolone Excipients Colour :- Approved Colour Used	IP	2 mg q.s.
342	Methylprednisolone Tablets IP	Each uncoated tablet contains:- Methylprednisolone Excipients Colour :- Approved Colour Used	IP	16 mg q.s.
343	Methylprednisolone Tablets IP	Each uncoated tablet contains:- Methylprednisolone Excipients Colour :- Approved Colour Used	IP	16 mg q.s.
344	Metoprolol Succinate (ER) & Hydrochlorothiazid e Tablets	Each uncoated Bilayered tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Hydrochlorothiazide Excipients Approved colour used	IP IP	47.5 mg 50 mg 12.5 mg q.s.
345	Metoprolol Succinate (ER) & Hydrochlorothiazid e Tablets	Each uncoated Bilayered tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Hydrochlorothiazide Excipients Approved colour used	IP IP	23.75 mg 25 mg 12.5 mg q.s.
346	Metoprolol Succinate (ER) Tablets IP	Each film coated tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Excipients Approved colour used	IP	47.5 mg 50 mg q.s.
347	Metoprolol Succinate Prolonged release Tablets IP	Each film coated ProlongedreleaseTablet Contains Metoprolol succinate Equ. toMetoprolol Tartrate Excipients Colour :-Approved colour used	IP	23.75mg 25mg q.s
348	Metoprolol Succinate(ER) & Amlodipine Besilate Tablets	Each film coated Bilayered tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Amlodipine Besilate Eq. to Amlodipine Excipients Approved colour used	IP IP	47.5 mg 50 mg 5 mg q.s.
349	Metoprolol Succinate(ER) & Amlodipine Besilate Tablets	Each film coated Bilayered tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Amlodipine Besilate Eq. to Amlodipine Excipients Approved colour used	IP IP	23.75 mg 25 mg 5 mg q.s.
350	Metoprolol SuccinateExtended release Tablets IP	Each film coated Extended release Tablet Contains Metoprolol succinate Equ. ToMetoprolol TartrateExcipients Colour:-Approved colour used	IP	11.875mg 12.5mg q.s.
351	Metronidazole Tablet IP	Each film coated Tablet Contains: Metronidazole Excipients Colour : Approved Coloured Used	IP	200mg q.s
352	Metronidazole Tablet IP	Each film coated Tablet Contains: Metronidazole Excipients Colour : Approved Coloured Used	IP	400mg q.s
353	Minocycline Hydrochloride Tablet	Each film coated Tablet Contains Minocycline Hydrochloride Equ. to Minocycline Excipients Colour : Approved Coloured Used	USP	100mg q.s
354	Minoxidil Tablets IP	Each Uncoated Tablet Contains: Minoxidil Excipients	IP	5mg q.s.
355	Minoxidil Tablets IP	Each uncoated tablet Contains: Minoxidil Excipients Approved colour used	IP	2.5mg q.s.
356	Montelukast & Doxophylline (SR) Tablets	Each uncoated tablet contains:- Montelukast Sodium Equivalent to Montelukast Doxophylline (AsSustained Release) Excipients Colour:-Approved colour used	IP IP	10 mg 400 mg q.s
357	Montelukast & Levocetirizine HCL Dispersible Tablets	Each uncoated dispersible tablet contains: Montelukast sodium Eq.to Montelukast Levocetirizine HCL Excipients Approved colour used	IP IP	4 mg 2.5 mg
358	Montelukast & Levocetirizine HCl Tablets	Each uncoated Bilayered Tablet Contains : Montelukast Sodium Equ. to Montelukast Levocetirizine Hydrochloride Excipients Approved colour used.	IP IP	10mg 5mg q.s.
359	Montelukast sodium & Bambuterol Hydrochloride Tablets	Each film coated Tablet contains: Montelukast sodium Equ. to Montelukast Bambuterol Hydrochloride Excipients Approved colour used	IP BP	10mg 10mg q.s.
360	Montelukast Sodium & Desloratadine Tablet	Each film coated Tablet Contains:- Montelukast Sodium Equivalent toMontelukast Desloratadine Excipients Approved colour used	IP BP	10 mg 5 mg q.s
361	Montelukast Sodium & Levocetirizine Dihydrochloride DispersibleTablets	Each Uncoated DispersibleTablet Contains: Montelukast Sodium Equ. To Montelukast LevocetirizineDihydrochloride Excipients Colour : Approved Coloured used	IP IP	5mg 2.5mg q.s.
362	Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP	Each UncoatedTablet Contains:- Montelukast Sodium eq. to Montelukast LevocetirizineDihydrochloride Excipients Approved colour used	IP IP	4mg 2.5mg q.s.
363	Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP	Each uncoated Tablet contains: Montelukast sodium Equ. to Montelukast LevocetirizineDihydrochloride Excipients Approved colour used.	IP IP	10mg 5mg q.s
364	Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP	Each Uncoated Tablet Contains:- Montelukast Sodium eq. to Montelukast Levocetirizine Hydrochloride Excipients Approved colour used	IP IP	4mg 2.5mg q.s.
365	Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP	Each film coated Tablet Contains:- Montelukast Sodium eq. to Montelukast Levocetirizine Hydrochloride Excipients Approved colour used	IP IP	10 mg 5mg q.s
366	Montelukast Sodium Chewable Tablets	Each UncoatedChewableTablet Contains: Montelukast sodium Equ. To Montelukast Excipients	IP	4mg q.s.
367	Montelukast Sodium Tablets IP	Each Film coated Tablet Contains : Montelukast Sodium Equ. to Montelukast Excipients Approved colour used	IP	10mg q.s.
368	Montelukast Sodium, Fexofenadine Hydrochloride and Sustained Release Acebrophylline Tablets	Each film coated Tablet contains: Montelukast sodium Equ. to Montelukast Fexofenadine Hydrochloride Acebrophylline (As sustainedrelease form) Excipients Approved colour used	IP IP	10mg 120mg 200mg q.s
369	Montelukast sodium, Levoceterizine dihydrochloride & Ambroxol hydrochloride Tablets	Each filmcoated tablets contains: Montelukast sodium Equivalent to Montelukast Levoceterizine dihydrochloride Ambroxol hydrochloride (As sustainedrelease) Excipients Approved colour used	IP IP IP	10 mg 5 mg 75 mg q.s.
370	Moxifloxacin Hydrochloride Tablets	Each Film coated Tablet Contains: Moxifloxacin Hydrochloride Equ. To Moxifloxacin Excipients Approved colour used.	IP	400mg q.s
371	Moxonidine Tablets	Each film coated tablet contains: Moxonidine Excipients Approved colour used	BP	0.2mg q.s.
372	Moxonidine Tablets	Each film coated tablet contains: Moxonidine Excipients Approved colour used	BP	0.3mg q.s.
373	Naproxen & Domperidone Tablets	Each film coated tablet contains: Naproxen Domperidone Excipients Approved colour used	IP IP	500mg 10mg q.s
374	Naproxen & Domperidone Tablets	Each Film coatedtablet contains: Naproxen Domperidone Excipients Approved colour used.	IP IP	250 mg 10 mg q.s
375	Naproxen Sodium & Domperidone Tablet	Each uncoated tablet contain: Naproxen Sodium Domperidone Excipients Approved colour used	IP IP	250 mg 10 mg q.s
376	Naproxen Sustained Release Tablets IP	Each uncoated sustained release tablet contains: Naproxen Excipients Approved colour used	IP	750mg q.s.
377	Naproxen Tablet IP	Each uncoated tablet contain: Naproxen Excipients Approved colour used	IP	250 mg q.s
378	Naproxen Tablet IP	Each uncoated tablet contain: Naproxen Excipients Approved colour used	IP	500 mg q.s
379	Nebivolol & Hydrochlorothiazid e Tablets	Each uncoated Tablets Contains: Nebivolol Hydrochloride Equ. to Nebivolol Hydrochlorothiazide Excipients Approved colour used.	IP IP	5mg 12.5mg q.s.
380	Nebivolol Hydrochloride Tablets IP	Each uncoated tablet contains: Nebivolol Hydrochloride Eq. to Nebivolol Excipients Approved colour used.	IP	5mg q.s.
381	Nicorandil Tablets IP	Each uncoated Tablets Contains: Nicorandil Excipients	IP	5mg
382	Nicorandil Tablets IP	Each uncoated Tablets Contains: Nicorandil Excipients	IP	10mg
383	Nifedipine Prolonged Release Tablets BP	Each Prolonged Release film coated tablet contains: Nifedipine Excipients Approved colour used.	BP	30mg q.s.
384	Nimesulide & Paracetamol Tablets	Each uncoated tablet contains: Nimesulide Paracetamol Excipients	BP IP	20 mg q.s.
385	Nimesulide & Paracetamol Tablets	Each uncoated Bilayered Tablet contains: Nimesulide Paracetamol Excipients Approved colour used.	BP IP	100mg 325mg q.s.
386	Nimesulide Mouth Dissolving Tablets	Each uncoated Mouth dissolving Tablet contains : Nimesulide Excipients Approved colour used.	BP	100mg q.s.
387	Nimesulide Tablets	Each uncoated tablet contains:- Nimesulide Excipients Colour:-Approved colour used	BP	100 mg q.s
388	Nimesulide, Paracetamol & Chlorzoxazone Tablets	Each film coated tablet contains: Nimesulide Paracetamol Chlorzoxazone Excipients Approved colour used	BP IP USP	100mg 325mg 250mg q.s
389	Nimesulide, Paracetamol, Phenylephrine HCl & Caffeine Tablets	Each uncoated Tablet Contains: Nimesulide Paracetamol Phenylephrine Hydrochloride Caffeine (anhydrous) Excipients	BP IP IP IP	100mg 325mg 10mg 25mg q.s.
390	Nimesulide, Paracetamol, Serratiopeptidase Tablets	Each film coated tablet contains : Nimesulide Paracetamol Serratiopeptidase ((Eq. to enzyme activityof 30000 units of enteric coated granules) Excipients Approved colour used.	BP IP IP	100mg 325mg 15mg
391	Nimesulide, Phenylephrine HCL, Cetirizine Dihydrochloride & Caffeine Tablets	Each uncoated tablet contains:- Nimesulide Phenylephrine Hydrochloride Cetirizine Dihydrochloride Caffeine (anhydrous) Excipients Colour:-Approved colour used	BP IP IP IP	100 mg 10 mg 5 mg 30 mg q.s.
392	Nimesulide, Phenylephrine HCl& Levocetirizine HCl Tablets	Each uncoated tablet contains: Nimesulide Phenylephrine HCl Levocetirizine HCl Excipients Approved Colour used	BP IP IP	100mg 5mg 5mg q.s.
393	Nimesulide, Phenylephrine Hydrochloride, Cetirizine Dihydrochloride & Caffeine Tablets	Each film Coated Tablet Contains : Nimesulide Phenylephrine Hydrochloride Cetirizine Dihydrochloride Caffeine ( Anhydrous) Excipients Approved colour Used.	BP IP IP IP	100mg 10mg 5mg 30mg q.s.
394	Nimodipine Tablets	Each Film coated Tablet Contains : Nimodipine Excipients Approved colour used.	IP	30mg q.s.
395	Nitrofurantoin SR Tablet	Each FilmCoated Sustained ReleaseTablet Contains Nitrofurantoin Excipients Colour :-Approved colour used	BP	100mg q.s.
396	Nitroglycerine Controlled Release Tablet	Each uncoated Tablet contains: Diluted Nitroglycerine Equ. to Nitroglycerin (as Controlled Release) Excipients Approved colour used	IP	2.6mg q.s.
397	Norfloxacin & TinidazoleTablets	Each film coated tablet contains:- Norfloxacin Tinidazole Excipients Colour:-Approved colour used	IP IP	400 mg 600 mg q.s.
398	Norfloxacin Tablets IP	Each film coated Tablet Contains: Norfloxacin Excipients Approved Colour Use	IP	400mg q.s
399	Nortriptyline & Gabapentin Tablets	Each Film coated Tablet Contains:- Nortriptyline Hydrochloride Equivalent to Nortriptyline Gabapentin Excipients Approved colour used	IP IP	10 mg 400 mg q.s.
400	Nortriptyline & PregabalineTablets	Each film coatedTablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabaline Excipients Approved colour used	IP IP	10 mg 75 mg q.s.
401	Nortriptyline, Pregabalin (SR) & Methylcobalamin Tablets	Each film coated Bilayered Tablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabalin (as Sustained Release) Methylcobalamin Excipient Approved colour used	IP IP IP	10 mg 75 mg 1500mcg q.s.
402	Nortriptyline, Pregabalin & Mecobalamin Tablets	Each film coatedTablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabalin Mecobalamin Excipient Approved colour used	IP IP IP	10 mg 75 mg 1500mcg q.s.
403	Nortriptyline, Pregabalin & Methylcobalamin Tablets	Each film coated Bilayered Tablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabalin Methylcobalamin Excipient Approved colour used	IP IP IP	10 mg 75 mg 1500mcg q.s.
404	Ofloxacin & Lactic Acid Bacillus Tablets	Each Film coated Tablet Contains : Ofloxacin Lactic Acid Bacillus Excipients Approved colour used.	IP	200mg 60 Million Spores q.s.
405	Ofloxacin & Ornidazole Tablet IP	Each FilmCoatedTabletContains: Ofloxacin Ornidazole Excipients Approved colour used	IP IP q.s.	200 mg 500 mg
406	Ofloxacin & TinidazoleTablets	Each film coated tablet contains: Ofloxacin Tinidazole Excipients Approved colour used.	IP IP	200mg 600mg q.s.
407	Ofloxacin Tablet IP	Each film coated tablet contains:- Ofloxacin Excipients Approved colour used	IP	400 mg q.s.
408	Ofloxacin Tablets IP	Each film coated tablet contains:- Ofloxacin Excipients Colour:-Approved colour used	IP	200 mg q.s.
409	OlanzapineTablet IP	Each film coated tablet contains: Olanzapine Excipients Approved colour used	IP	5mg q.s.
410	OlanzapineTablet IP	Each film coated tablet contains: Olanzapine Excipients Approved colour used	IP	2.5mg q.s.
411	OlanzapineTablet IP	Each film coated tablet contains: Olanzapine Excipients Approved colour used	IP	7.5 mg q.s.
412	OlanzapineTablets IP	Each film coated tablet contains: Olanzapine Excipients Approved colour used	IP	10 mg q.s.
413	Olmesartan & AmlodipineTablets		IP IP	20 mg 5 mg q.s
414	Olmesartan & Chlorthalidone Tablets	Each film coated tablet contains: Olmesartan Medoxomil Chlorthalidone Excipients Approved colour used	IP IP	20 mg 12.5 mg q.s
415	Olmesartan & Hydrochlorothiazid e Tablets	Each film coated tablet contains: Olmesartan Medoxomil Hydrochlorothiazide Excipients Approved colour used	IP IP	20 mg 12.5 mg q.s
416	Olmesartan & Metoprolol SuccinateTablets	Each film coated Bilayered tablet contains: Olmesartan Medoxomil Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Excipients Approved colour used	IP IP	20 mg 47.5 mg 50 mg q.s
417	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazid e Tablets	Each film coated Tablet Contains: Olmesartan Medoxomil AmlodipineBesylate Equ. To Amlodipine Hydrochlorothiazide Excipients ApprovedColour used.	IP IP IP	40mg 5mg 12.5mg q.s.
418	Olmesartan, Amlodipine & Hydrochlorothiazid e Tablets	Each film coated tablet contains: Olmesartan Medoxomil Amlodipine Besilate Eq. to Amlodipine Hydrochlorothiazide Excipients Approved colour used	IP IP IP	20 mg 5 mg 12.5 mg q.s
419	Olmesarton Medoxomil & Hydrochlorthiazide Tablet	Each film coated tablet contains: Olmesarton Medoxomil Hydrochlorthiazide Excipients Approved colour used	IP IP	40 mg 12.5 mg q.s.
420	Olmesarton Medoxomil Tablet IP	Each film coated tablet contains: Olmesarton Medoxomil Excipients Approved colour used	IP	20 mg q.s.
421	Olmesarton Medoxomil Tablet IP	Each film coated tablet contains: Olmesarton Medoxomil Excipients Approved colour used	IP	40 mg q.s.
422	Ondansetron Orally Disintegrating TabletsTablet IP	Each Uncoated OrallyDisintegrating Tablets Contains Ondansetron hydrochloride Equ. toOndansetron Excipients Approved colour used.	IP	4mg
423	Ondansetron Orally Disintegrating TabletsTablet IP	Each Uncoated OrallyDisintegrating Tablets Contains Ondansetron hydrochloride Equ. toOndansetron Excipients Approved colour used	IP	8mg
424	Ornidazole , Diloxanide & Simethicone Tablets	Each film coated tablet contains: Ornidazole Diloxanide furoate Simethicone Excipients Approved colour used.	IP IP IP	250mg 375mg 25mg q.s.
425	Ornidazole Tablets	Each Film coated Tablet Contains : Ornidazole Excipients Approved colour used.	IP	500mg q.s.
426	Pancreatin, Simethicone & Activated Charcoal Tablets	Each film coated Tablet Contains: Pancreatin Simethicone Activated Charcoal Excipients Approved colour used	IP IP IP	175mg 50mg 50mg q.s.
427	Pantoprazole Gastro-Resistant Tablets IP	Each enteric coated tablet contains:- Pantoprazole Sodium Eq. to Pantoprazole Excipients Colour:-Approved colour used	IP	40 mg q.s.
428	Pantoprazole Sodium & Domperidone Tablets	Each enteric coated tablet contains:- Pantoprazole Sodium Eq. to Pantoprazole Domperidone Excipients Colour:-Approved colour used	IP IP	40 mg 10 mg q.s.
429	Pantoprazole Tablets IP	Each enteric coated Tablet contains : Pantoprazole sodium sesquihydrate Equ. to Pantoprazole Excipients Approved colour used	IP	20mg q.s.
430	Paracetamol , Phenylephrine HCl & Cetirizine HCl, Tablets	Each uncoated tablet contains: Paracetamol Phenylephrine Hydrochloride Cetirizine Dihydrochloride Excipients Approved colour used. (Banned Drug 12/08/2024)	IP IP IP	325mg 5mg 5mg q.s.
431	Paracetamol (DT) Tablets BP	Each uncoated dispersible tablet contains: Paracetamol Excipients Approved colour used.	IP	650 mg q.s.
432	Paracetamol & Diclofenac Tablets IP	Each uncoated tablet contains:- Paracetamol Diclofenac Sodium Excipients Colour:-Approved colour used	IP IP	325 mg 50 mg q.s.
433	Paracetamol & Dicyclomine Hydrochloride Tablets	Each uncoated Tablet contains: Paracetamol Dicyclomine Hydrochloride Excipients	IP IP	325mg 20mg q.s.
434	Paracetamol & Domperidone Tablets	Each uncoatedtablet contains : Paracetamol Domperidone Excipients Approved colour used.	IP IP	325mg 10mg q.s.
435	Paracetamol and CaffeineTablets IP	Each uncoated Tablet contains: Paracetamol Caffeine Excipients	IP IP	650mg 50mg q.s.
436	Paracetamol and CaffeineTablets IP	Each Film Coated Tablet contains: Paracetamol Caffeine Excipients Approved Colour used.	IP IP	650mg 50mg q.s.
437	Paracetamol Bilayered Sustained Release Tablets	Each uncoated Bilayered Sustained Release Tablet contains : Paracetamol (As Immediate Release) Paracetamol (As Sustained Release) Excipients Approved Colour used.	IP IP	300mg 700mg q.s.
438	Paracetamol Tablets IP	Each uncoated tablet contains:- Paracetamol Excipients Colour:-Approved colour used	IP	650 mg q.s.
439	Paracetamol Tablets IP	Each uncoated tablet contains:- Paracetamol Excipients Approved colour used	IP	500 mg q.s.
440	Paracetamol, Cetirizine Dihydrochloride & Phenylephrine Hydrochloride Tablets	Each uncoated Tablet contains: Paracetamol Cetirizine Hydrochloride Phenylephrine Hydrochloride Excipients Approved colour used (Banned drug 12/08/2024)	IP IP IP	500mg 5mg 10mg q.s
441	Paracetamol, Phenylephrine HCL & Chlorpheniramine Maleate Tablets	Each uncoated tablet contains: Paracetamol Phenylephrine HCL Chlorpheniramine Maleate Excipients Approved colour used .	IP IP IP	500mg 10mg 2mg q.s.
442	Paracetamol, Phenylephrine HCl, Cetirizine Tablet	Each Uncoated Tablet Contains: Paracetamol Phenylephrine Hydrochloride Cetirizine Excipients Approved Colour Used (Banned drug 12/08/2024)	IP IP IP	325mg 10mg 5mg q.s
443	Paracetamol, Phenylephrine HCL,Caffeine , & Chlorpheniramine Maleate Tablets	Each uncoated tablet contains: Paracetamol Phenylephrine Hydrochloride Caffeine (Anhydrous) Chlorpheniramine Maleate Excipients Approved colour used	IP IP IP IP	500 mg 12.5 mg 30mg 2 mg q.s
444	Paracetamol, Phenylephrine Hydrochloride , Guaiphenesin, Cetirizine Hydrochloride & Ambroxol Hydrochloride Tablets	Each uncoated Tablet contains: Paracetamol Phenylephrine Hydrochloride Guaiphenesin Cetirizine Hydrochloride Ambroxol Hydrochloride Excipients Approved colour used.	IP IP IP IP IP	325mg 5mg 50mg 5mg 15mg q.s.
445	Paracetamol, Phenylephrine hydrochloride & Cetirizine hydrochloride Tablets	Each uncoated tablets contains: Paracetamol Phenylephrine hydrochloride Cetirizine hydrochloride Excipients Approved colour used (Banned drug 12/08/2024)	IP IP IP	500 mg 5 mg 5 mg q.s.
446	Paracetamol, Phenylephrine Hydrochloride & Levocetirizine Dihydrochloride Tablets	Each Uncoated Tablet Contains: Paracetamol Phenylephrine Hydrochloride LevocetirizineDihydrochloride Excipients (Banned drug 12/08/2024)	IP IP IP	325mg 5mg 5mg q.s.
447	Paracetamol, Phenylephrine Hydrochloride, Cetirizine Hydrochloride , Dextromethorphan Hydrobromide & Caffeine Tablets	Each uncoatedtablet contains : Paracetamol Phenylephrine Hydrochloride Cetirizine Hydrochloride Dextromethorphan Hydrobromide Caffeine (Anhydrous) Excipients Approved colour used.	IP IP IP IP IP	500mg 10mg 5mg 10mg 30mg q.s.
448	Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate &Caffeine Tablets	Each uncoated Tablet contains: Paracetamol Phenylephrine Hydrochloride Chlorpheniramine Maleate Caffeine (Anhydrous) Excipients Approved Colour Used.	IP IP IP IP	325mg 5mg 2mg 15mg q.s.
449	Paracetamol, Phenylephrine Hydrochloride, Diphenhydramine Hydrochloride & Caffeine (Anhydrous) Tablets	Each uncoated tablet contains:- Paracetamol Phenylephrine Hydrochloride Diphenhydramine Hydrochloride Caffeine (Anhydrous) Excipients Colour:-Approved colour used	IP IP IP IP	500 mg 5 mg 25 mg 30 mg q.s.
450	Paracetamol, Phenylpherine Hydrochloride , Caffeine & Diphenhydra mine Hydrochloride Tablets	Each uncoated tablet contains: Paracetamol Phenylpherine Hydrochloride Caffeine (Anhydrous) Diphenhydramine Hydrochloride Excipients Approved colour used.	IP IP IP IP	325mg 5mg 30mg 25mg q.s.
451	Paroxetine Hydrochloride Tablet	Each film coated Tablet Contains : Paroxetinehydrochloride Hemihydrate Equ. to Paroxetine Excipients Approved Colour used	IP	20mg q.s
452	Paroxetine Prolonged Release tablet	Each enteric–coated Bilayered prolonged release Tablet contains : Paroxetine Hydrochloride (as Hemihydrate) Equ. to Paroxetine Excipients Approved colour used	IP	12.5mg q.s
453	Paroxetine Prolonged- Release Tablets IP	Each enteric coated prolonged-release tablet contains: Paroxetine Hydrochloride Hemihydrate Eq.to Paroxetine Excipients Approved colour used	IP	12.5mg
454	Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide, Cetirizine Hydrochloride, Ambroxol Hydrochloride, Guaiphenesin Tablets	Each uncoated Tablet Contains : Phenylephrine Hydrochloride Dextromethorphan Hydrochloride Cetirizine Hydrochloride Ambroxol Hydrochloride Guaiphenesin Excipients Approved colour used.	IP IP IP IP IP	15mg 10mg 5mg 30mg 100mg q.s.
455	Phenytoin Tablets IP	Each film coated tablet contains:- Phenytoin Sodium Excipients Colour : Approved Coloured Used	IP	100 mg q.s.
456	Piracetam & CiticolineTablet s	Each film coatedtablet contain: Piracetam Citicoline Sodium Eq. to Citicoline Excipients Approved colour used	IP IP	400 mg 500 mg q.s.
457	Piracetam Tablets	Each film coated tablet contains: Piracetam Excipients Approved colour used	IP	800 mg q.s.
458	Piracetam Tablets IP	Each film coatedtablet contain: Piracetam Excipients Approved colour used	IP	400 mg q.s.
459	Piroxicame DispersibleTablets	Each uncoated dispersible tablet contains: Piroxicame Excipients Approved colour used	IP	20 mg q.s.
460	Prasugrel Hydrochloride Tablets	Each Film coated Tablet Contains : Prasugrel Hydrochloride Equ. to Prasugrel Excipients Approved colour used.		5mg q.s.
461	Prasugrel Hydrochloride Tablets	Each Film coated Tablet Contains : Prasugrel Hydrochloride Equ. to Prasugrel Excipients Approved colour used		10mg q.s.
462	Prazosin Tablets IP	Each uncoated tablet contains: Prazosin Hydrochloride Eq.to Prazosin Excipients Approved colour used.	IP	5mg q.s.
463	Prednisolone Tablet IP	Each uncoated Tablet contains: Prednisolone Excipients Colour : Approved Coloured Used	IP	5mg q.s
464	Prednisolone Tablet IP	Each uncoated Tablet contains: Prednisolone Excipients Colour : Approved Coloured Used	IP	10mg q.s
465	Prednisolone Tablet IP	Each uncoated Tablet contains Prednisolone Excipients Colour : Approved Coloured Used	IP	20mg q.s
466	Pregabalin (SR), Methylcobalamin & Nortriptyline Tablets	Each film coated Tablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabalin (as Sustained Release) Methylcobalamin Excipient Approved colour used	IP IP IP	10 mg 75 mg 1500mcg q.s.
467	Pregabalin (Sustained Release) & Methylcobalamin Tablets	Each film coated Bilayered Tablet Contains: Pregabalin ( As Sustained Release) Methylcobalamin Excipients Approved Colour Used.	IP IP	75mg 1500mcg q.s.
468	Pregabalin Sustained Release Tablet	Each Uncoated Sustained Release Tablet Contains : Pregabalin Excipients Approved colour used	IP	75mg q.s.
469	Pregabalin, Methylcobalamin, Alpha Lipoic Acid, Folic acid & Pyridoxine Tablets	Each film coated Tablet contains : Pregabalin Methylcobalamin Alpha Lipoic Acid Folic Acid Pyridoxine hydrochloride Excipients Approved colour used	IP IP USP IP IP	75mg 1500mcg 100mg 1.5mg 3mg q.s
470	Pregabalin( Sustained Release) & Methylcobalamin Tablets	Each film coatedTablet Contains: Pregabalin ( AsSustained Release) Methylcobalamin Excipients Approved Colour Used.	IP IP	75mg 1500mcg q.s.
471	Prochlorperazine Maleate Mouth Dissolving Tablets	Each uncoated Tablet contains: Prochlorperazine Maleate Excipients	IP	5mg q.s.
472	Propranolol Hydrochloride (SR) & Flunarizine Tablets	Each Uncoated Bilayered Tablet Contains: Propranolol Hydrochloride (as Sustained Release) Flunarizine Dihydrochloride Equ. To Flunarizine Excipients Approved colour used.	IP BP	40mg 10mg q.s.
473	Propranolol Hydrochloride Tablets	Each Uncoated Tablet Contains: Propranolol Hydrochloride Excipients	IP	40mg q.s.
474	Prulifloxacin Tablets	Each film coated Tablet Contains: Prulifloxacin Excipients Approved Colour used		600mg
475	Pyridoxine Hydrochloride Tablets IP	Each uncoated Tablet Contains: Pyridoxine Hydrochloride Excipients	IP	50mg q.s.
476	Rabeprazole & Domperidone Tablets	Each entericcoatedtablets contains: Rabeprazole Sodium Domperidone Excipients Colour:-Approved colour used	IP IP	20 mg 10 mg q.s
477	Rabeprazole Gastro- Resistant Tablets IP	Each entericcoatedtablets contains: Rabeprazole Sodium Excipients Colour:-Approved colour used	IP	20mg q.s
478	Ramipril & Hydrochlorothiazid e Tablets IP	Each uncoated Tablet Contains: Ramipril Hydrochlorthiazide Excipients Approved colour used	IP IP	2.5mg 12.5mg q.s.
479	Ramipril & Hydrochlorothiazid e Tablets IP	Each uncoated Tablet Contains: Ramipril Hydrochlorthiazide Excipients Approved colour used	IP IP	5mg 12.5mg q.s.
480	Ramipril Tablets IP	Each Uncoated Tablet Contains: Ramipril Excipients	IP	2.5mg q.s.
481	Ramipril Tablets IP	Each uncoated Tablet Contains: Ramipril Excipients Approved colour used	IP	1.25 mg q.s.
482	Ramipril Tablets IP	Each uncoated Tablet Contains: Ramipril Excipients Approved colour used	IP	5mg q.s.
483	Ranitidine Hydrochloride Tablets	Each film coated Tablet contains: Ranitidine Hydrochloride Equ. to Ranitidine Excipients Approved colour used	IP	150mg q.
484	Ranitidine Hydrochloride Tablets	Each film coated Tablet contains: Ranitidine Hydrochloride Equ. to Ranitidine Excipients Approved colour used.	IP	300mg q.s
485	Riboflavin , Folic Acid, Niacinamide & Lactic Acid Bacillus Tablets	Each Uncoated Tablet contains: Riboflavin Folic acid Niacinamide Lacticacid bacillus Excipients Colour: Tartrazine	IP IP IP	10mg 1.5mg 100mg 60Million Spores q.s
486	Riboflavin, Folic Acid, Niacinamide with Lactic Acid Bacillus Tablets	Each uncoated Tablet Contains: Riboflavin Folic Acid Niacinamide Lactic Acid Bacillus Excipients Approved colour used.	IP IP IP	10mg 1.5mg 50mg 120 Million spores q.s.
487	Rifaximin Tablets	Each filmcoatedtablets contains: Rifaximin Excipients Approved colour used		550 mg q.s.
488	Rifaximin Tablets	Each filmcoated tablets contains: Rifaximin Excipients Approved colour used		400 mg q.s.
489	RifaximineTablets	Each filmcoated tablets contains: Rifaximine Excipients Approved colour used		200 mg q.s.
490	Rosuvastatin & FenofibrateTablets	Each film coated Tablet Contains: Rosuvastatin Calcium Equ. to Rosuvastatin Fenofibrate Excipients Approved colour used	IP IP	20mg 160mg q.s.
491	Rosuvastatin & FinofibrateTablet IP	Each film coated tablet contains:- Rosuvastatin calcium Equ. toRosuvastatin Finofibrate Excipients Colour : Approved Coloured Used	IP IP	10mg 160mg q.s.
492	Rosuvastatin Tablet IP	Each film coated tablet Contains : Rosuvastatin Calcium Equ. to Rosuvastatin Excipients Approved Colour Used	IP	40mg
493	Rosuvastatin Tablets IP	Each filmcoated tablet contain Rosuvastatin Calcium Eq.to Rosuvastatin Excipients Approved colour used	IP	5 mg q.s.
494	Rosuvastatin Tablets IP	Each filmcoated tablet contain Rosuvastatin calcium Eq.to Rosuvastatin Excipients Approved colour used	IP	10 mg q.s.
495	Rosuvastatin Tablets IP	Each filmcoated tablet contain Rosuvastatin Calcium Eq.to Rosuvastatin Excipients Approved colour used	IP	20 mg q.s.
496	Roxithromycin & Ambroxol Tablets	Each film coatedtablet contain: Roxithromycin Ambroxol Hydrochloride Excipients Approved colour used	IP IP	150 mg 60 mg q.s
497	Roxithromycin Tablets	Each filmcoated tablets contains: Roxithromycin Excipients Approved colour used	IP	150 mg q.s.
498	Serratiopeptidase tablet IP	Each film coated tablet Contains:- Serratiopeptidase (Equ. toEnzyme activity20,000Units of enteric coated granules) Excipients Colour : ApprovedColour Used	IP	10mg q.s
499	Sertraline Hydrochloride Tablets IP	Each film coated Tablet Contains: Sertraline Hydrochloride Equ. To Sertraline Excipients ApprovedColour used.	IP	50mg q.s.
500	Sertraline Tablets IP	Each film coated tablets contains: Sertraline Hydrochloride Eq. to Sertraline Excipients Approved colour used.	IP	25mg q.s.
501	Sevelamer Carbonate Tablets	Each film coated Tablet Contains: Sevelamer Carbonate Excipients Approved colour used		400mg q.s.
502	Sildenafil Citrate Tablets IP	Each film coated tablet contains:- Sildenafil Citrate Eq. tosildenafil Excipients Colour:- Approved Colour used	IP	50 mg q.s
503	Sildenafil Citrate Tablets IP	Each film coated tablet contains:- Sildenafil Citrate Eq. tosildenafil Excipients Colour:- Approved Colour used	IP	100 mg q.s.
504	Sitagliptin Phosphate & Metformin Hydrochloride Tablets	Each film coated Tablets contains : Sitagliptin Phosphate Monohydrate Equ. to Sitagliptin Metformin Hydrochloride Excipients Approved colour used	IP	64.25mg 50mg 500mg q.s.
505	Sitagliptin Phosphate & Metformin Hydrochloride Tablets	Each film coated Tablets contains : Sitagliptin Phosphate Monohydrate Equ. to Sitagliptin Metformin Hydrochloride Excipients Approved colour used	IP	64.25mg 50mg 1000mg q.s.
506	Sitagliptin Phosphate & Metformin Hydrochloride Tablets	Each film coated Tablet Contains : Sitagliptin Phosphate Monohydrate Equ. to Sitagliptin Metformin Hydrochloride Excipients Approved colour used.	IP IP	64.25mg 50mg 850mg q.s.
507	Sitagliptin PhosphateTablet	Each film coated Tablet Contains : Sitagliptin phosphate Monohydrate Equ. to Sitagliptin Excipients Approved Colour used	IP	25mg q.s
508	Sitagliptin PhosphateTablet	Each film coated Tablet Contains : Sitagliptin phosphate Monohydrate Equ. to Sitagliptin Excipients Approved Colour used	IP	50mg q.s
509	Sitagliptin PhosphateTablet	Each film coated Tablet Contains : Sitagliptin phosphate Monohydrate Equ. to Sitagliptin Excipients Approved Colour used	IP	100mg q.s
510	Sodium Valproate & Valproic Acid Controlled ReleaseTablet	Each film coated controlledrelease tablet contains: Sodium Valproate Valproic Acid (Both together correspond tosodium valproate) Excipients Approved colour used	IP IP	133.5 mg 58 mg 200 mg q.s.
511	Sodium Valproate & Valproic Acid Controlled ReleaseTablet	Each film coated controlledrelease tablet contains: Sodium Valproate Valproic Acid (Both together correspond tosodium valproate) Excipients Approved colour used	IP IP	333 mg 145 mg 500 mg q.s.
512	Solifenacin Succinate Tablets IP	Each film coated tablet contains: Solifenacin Succinate Excipients Approved colour used.	IP	5mg q.s.
513	Spironolactone Tablets IP	Each Uncoated Tablet Contains: Spironolactone Excipients Approved colour used	IP	25mg q.s.
514	Spironolactone Tablets IP	Each Uncoated Tablet Contains: Spironolactone Excipients Approved colour used	IP	50mg q.s.
515	Spironolactone Tablets IP	Each Uncoated Tablet Contains: Spironolactone Excipients Approved colour used	IP	100mg q.s.
516	Sulfasalazine Gastro –Resistant Tablets IP	Each enteric coated tablet contains: Sulfasalazine Excipients Approved colour used.	IP	500mg q.s.
517	Sulfasalazine Gastro Resistant Tablets USP	Each Enteric Coated Tablet Contains: Sulfasalazine Excipients Approved colour used	USP	1000mg q.s.
518	Tablets of Biotin, N-Acetyl L- Cysteine, Vitamins & Minerals	Each film coated tablet contains: Biotin N-Acetyl L- Cysteine Calcium Pantothenate Sodium selenite eq.to elemental Selenium Cupric Oxide eq.to elemental Copper Zinc Oxide eq. to elemental Zinc Manganese Sulphate eq. to elemental Manganese Folic Acid Excipients Approved colour used. Appropriate overages of vitamins added to compensate Loss on storage For Therapeutic use only	IP BP IP BP IP BP IP	10mg 50mg 100mg 65mcg 3mg 25mg 1mg 1mg q.s.
519	Tadalafil Tablet IP	Each uncoated tablet contains: Tadalafil Excipients Approved colour used	IP	10 mg q.s
520	Tadalafil Tablet IP	Each uncoated tablet contains: Tadalafil Excipients Approved colour used	IP	20 mg q.s
521	Tamsulosin Hydrochloride (MR) & Dutasteride Tablets	Each film coated Tablet contains: Tamsulosin Hydrochloride (as modified release) Dutasteride Excipients Approved colour used.	IP IP	0.4 mg 0.5 mg q.s.
522	Tamsulosin Hydrochloride Modified Release Tablets	Each film coated Tablet contains: Tamsulosin Hydrochloride (as modified release) Excipients Approved colour used.	IP	0.4mg q.s.
523	Tapentadol Tablets	Each film coatedtablet contain: Tapentadol Hydrochloride Equivalent to Tapentadol Excipients Approved colour used	IP	50 mg q.s.
524	Tapentadol Tablets	Each film coatedtablet contain: Tapentadol Hydrochloride Equivalent to Tapentadol Excipients Approved colour used	IP	100 mg q.s.
525	Telmisartan & AmlodipineTablets	Each uncoated Bilayered Tablet Contains: Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Approved colour used	IP IP	80mg 5mg q.s.
526	Telmisartan & AmlodipineTablets IP	Each Uncoated Tablet Contains :- Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Colour: Approved Colour Used.	IP IP	40mg 5mg q.s.
527	Telmisartan & AmlodipineTablets IP	Each Uncoated Tablet Contains:- Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Colour: Approved Coloured Used	IP IP	80mg 10mg q.s
528	Telmisartan & AmlodipineTablets IP	Each Uncoated Tablet Contains :- Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Approved Colour Used.	IP IP	80mg 5mg q.s.
529	Telmisartan & AmlodipineTablets IP	Each Uncoated Bilayered Tablet Contains :- Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Colour: Approved Colour Used.	IP IP	40mg 5mg q.s.
530	Telmisartan & AmlodipineTablets IP	Each Uncoated Bilayered Tablet Contains:- Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Colour: Approved Coloured Used.	IP IP	80mg 10mg q.s
531	Telmisartan & Atorvastatin Tablets	Each film coated Tablet Contains : Telmisartan Atorvastatin Calcium Equ. to Atorvastatin. Excipients Approved colour used.	IP IP	40mg 10mg q.s.
532	Telmisartan & Chlorthalidone Tablets	Each uncoated Bilayered Tablet contains: Telmisartan Chlorthalidone Excipients Approved colour used	IP IP	40mg 12.5mg q.s.
533	Telmisartan & CilnidipineTablets	Each Film coated Tablet Contains : Telmisartan Cilnidipine Excipients Approved colour used.	IP IP	40mg 10mg q.s.
534	Telmisartan & Hydrochlorthiazide Tablet IP	Each Uncoated Tablet Contains:- Telmisartan Hydrochlorothiazide Excipients Colour: Approved Coloured Used.	IP IP	80mg 12.5mg q.s
535	Telmisartan & Metoprolol Succinate (ER) Tablets	Each uncoated bilayer tablet contain: Telmisartan Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Excipients Approved colour used	IP IP	40 mg 47.5 mg 50 mg q.s.
536	Telmisartan & Metoprolol Succinate (ER) Tablets	Each Uncoated Bilayered Tablet Contains: Telmisartan Metoprolol Succinate Equ. to Metoprolol Tartrate (as Extended Release ) Excipients Approved colour used	IP IP IP	40mg 23.75 25mg q.s.
537	Telmisartan and Hydrochlorothiazid e TabletsIP	Each Uncoated Tablet Contains:- Telmisartan Hydrochlorothiazide Excipients Colour: ApprovedColour Used.	IP IP	40mg 12.5mg q.s.
538	Telmisartan Tablet IP	Each Uncoated Tablet Contains:- Telmisartan Excipients Colour: Approved Colour Used.	IP	20mg q.s
539	Telmisartan Tablet IP	Each Uncoated Tablet Contains:- Telmisartan Excipients Colour: Approved Colour Used.	IP	40mg q.s
540	Telmisartan Tablet IP	Each Uncoated Tablet Contains:- Telmisartan Excipients Colour: Approved Colour Used.	IP	80mg q.s
541	Telmisartan, Amlodipine & Hydrochlorothiazid e	Each uncoated bilayer tablet contain: Telmisartan Amlodipine Besylate Eq.to Amlodipine Hydrochlorothiazide Excipients Approved colour used	IP IP IP	40 mg 5 mg 12.5 mg
542	Teneligliptin & Metformin hydrochloride Tablets	Each uncoated by-layered tablets contains: Teneligliptin hydrobromide hydrat Equivalent to Teneligliptin Metformin hydrochloride (As Extended release) Excipients Approved colour used	IP	20 mg 500 mg q.s.
543	Teneligliptin & Metformin Hydrochloride Tablets	Each uncoated bilayered tablet contains: Teneligliptin Hydrobromide hydrate Equivalent to Teneligliptin Metformin hydrochloride (As Extended release) Excipients Approved colour used	IP	20 mg 1000 mg q.s.
544	Terbinafine hydrochloride Tablets IP	Each filmcoated tablets contains: Terbinafine hydrochloride Equivalent to Terbinafine Excipients Approved colour used	IP	250 mg q.s.
545	Terbinafine hydrochloride Tablets IP	Each film coated tablets contains: Terbinafine hydrochloride Equivalent to Terbinafine Excipients Approved colour used	IP	500 mg q.s.
546	Thiamine Hydrochloride Tablets IP	Each film coated Tablet Contains: Thiamine Hydrochloride Excipients Approved colour used	IP	100mg q.s.
547	Thiamine Tablets IP	Each uncoated Tablet Contains Thiamine Hydrochloride Excipients Colour :- Approved colour used	IP	50mg q.s
548	Thyroxine Tablet IP	Each Uncoated Tablet Contains Thyroxine sodium (as anhydrous) Excipients Colour : Approved Coloured Used	IP	12.5mcg q.s
549	Thyroxine Tablet IP	Each Uncoated Tablet Contains Thyroxine sodium (as anhydrous) Excipients Colour : Approved Coloured Used	IP	25mcg q.s
550	Thyroxine Tablet IP	Each Uncoated Tablet Contains Thyroxine sodium (as anhydrous) Excipients Colour : Approved Coloured Used	IP	50mcg q.s
551	Thyroxine Tablet IP	Each Uncoated Tablet Contains Thyroxine sodium (as anhydrous) Excipients Colour : Approved Coloured Used	IP	75mcg q.s
552	Thyroxine Tablet IP	Each Uncoated Tablet Contains Thyroxine sodium (as anhydrous) Excipients Colour : Approved Coloured Used	IP	100 mcg q.s
553	Ticagrelor Tablets	Each film coated tablet contains: Ticagrelor Excipients Approved colour used	IP	90mg q.s
554	Tolperisone Hydrochloride & Diclofenac Sodium Tablets	Each Film coated Tablets Contains : Tolperisone Hydrochloride Diclofenac Sodium Excipients Approved colour used	IP IP	150mg 50mg q.s.
555	Tolperisone Hydrochloride & Paracetamol Tablet	Each film coated Tablet Contains: Tolperisone hydrochloride Paracetamol Excipients Approved colour Used	JP IP	150mg 325mg
556	Tolperisone Hydrochloride Sustained Release Tablet	Each film coated sustained Release Tablet Contains: Tolperisone Hydrochloride Excipients Approved Colour Used	JP	450mg
557	Tolperisone Hydrochloride Tablet	Each film coated Tablet Contains: Tolperisone Hydrochloride Excipients Approved colour used	JP	150mg q.s
558	Torsemide & Spironolactone Tablets	Each uncoated tablet contain: Torsemide Spironolactone Excipients Approved colour used	IP IP	10 mg 50 mg q.s.
559	Torsemide & Spironolactone Tablets	Each uncoated tablet contain: Torsemide Spironolactone Excipients Approved colour used	IP IP	20 mg 50 mg q.s.
560	Torsemide & Spironolactone Tablets	Each uncoated tablet contains: Torsemide Spironolactone Excipients Approved colour used	IP IP	5 mg 50 mg q.s.
561	Torsemide Tablets IP	Each uncoated tablet contain: Torsemide Excipients Approved colour used	IP	10 mg q.s.
562	Torsemide Tablets IP	Each uncoated tablet contain: Torsemide Excipients Approved colour used	IP	20 mg q.s.
563	Torsemide Tablets IP	Each uncoated tablet contain: Torsemide Excipients Approved colour used	IP	5 mg q.s.
564	Torsemide Tablets IP	Each uncoated tablet contain: Torsemide Excipients Approved colour used	IP	100 mg q.s.
565	Tramadol & ParacetamolTablet	Each Film Coated Tablet Contains: Paracetamol Tramadol Hydrochloride Excipients Approved Colour Used	IP IP	325mg 37.5mg q.s
566	Tramadol Hydrochloride Prolonged Release Tablet IP	Each film coated sustainedrelease tablet contain: Tramadol Hydrochloride Excipients Approved colour used	IP	100mg q.s
567	Tramadol Hydrochloride Tablet IP	Each film coatedtablet contain: Tramadol Hydrochloride Excipients Approved colour used	IP	100mg q.s
568	Tranexamic Acid & Ethamsylate Tablets	Each film coated Tablet contains: Tranexamic Acid Ethamsylate Excipients Approved colour used.	IP BP	250mg 250mg q.s.
569	Tranexamic Acid Tablets	Each film coated Tablet Contains: Tranexamic Acid Excipients Colour : Approved Coloured Used	BP	250mg q.s
570	Tranexamic Acid Tablets IP	Each film coated Tablet Contains: Tranexamic Acid Excipients Approved Colour Used.	IP	500mg
571	Tranexamic Acid Tablets IP	Each film coated Tablet Contains: Tranexamic Acid Excipients Colour : Approved Coloured Used	IP	250mg q.s
572	TranexamicAcid& Mefenamic Acid Tablets	Each filmcoated tablets contains: Tranexamic Acid Mefenamic Acid Excipients Approved colour used	IP IP	500 mg 250 mg q.s.
573	Trifluoperazine Hydrochloride Tablets IP	Each film coated Tablet contains: Trifluoperazine Hydrochloride Excipients Approved colour used	IP	5mg q.s
574	Trypsin – Chymotrypsin Tablets	Each enteric - coated tablet contains: 2,00,000 Armour Units of Enzymatic Activity* *Supplied by a purified Concentrate which has Specific Trypsin and Chymotrypsin Activity in a Ratio of Approximately Six to One. Excipients Approved colour used.		2,00,000 AU q.s.
575	Trypsin , Bromelain and Rutoside Trihydrate Tablets	Each Enteric coated tablet contains: Trypsin Bromelain RutosideTrihydrate Excipients Approved colour used.	BP BP	96mg 180mg 200mg q.s.
576	Trypsin- Chymotrypsin Tablets	Each entericcoated Tablet contains: 1,00,000 Armour units of enzymaticactivity *Supplied by a purified concentrate which has specific Trypsin & Chymotrypsin activityin aratio of Approximately six to one. Excipients Approved colour used.	q.s.
577	Trypsin-Chymotrypsin, Aceclofenac & Paracetamol Tablets	Each film coated tablet contains: Aceclofenac Paracetamol Trypsin-Chymotrypsin Of enzyme activity (as enteric coated granules) Excipients Approved colour used.	I.P. I.P.	100mg 325mg 150,000AU q.s.
578	Trypsin, Bromelain & Rutoside Trihydrate Tablets	Each Enteric coatedTablet Contains:- Trypsin Bromelain RutosideTrihydrate Equivalent toRutoside (anhydrous) Excipients Approved colour used	BP BP	48 mg 90 mg 100 mg q.s.
579	Trypsin, Bromelain, Rutoside Trihydrate & Diclofenac Sodium Tablets	Each Enteric coatedTablet Contains: Trypsin Bromelain Rutoside Trihydrate Diclofenac Sodium Excipients Approved Colour Used	BP BP IP	48mg 90mg 100mg 50mg q.s.
580	Trypsin, Bromelain, Rutoside Trihydrate and Aceclofenac Tablets	Each enteric coated Tablet contains : Trypsin Bromelain Rutoside Trihydrate Aceclofenac Excipients Approved colour used	IP BP IP	48mg 90mg 100mg 100mg q.s
581	Ursodeoxycholic Acid Tablets IP	Each filmcoated tablets contains: Ursodeoxycholic Acid Excipients Approved colour used	IP	300 mg q.s.
582	Ursodeoxycholic Acid Tablets IP	Each film coated tablets contains: Ursodeoxycholic Acid Excipients Approved colour used	IP	150 mg q.s.
583	Vildagliptin & Metformin Hydrochloride Tablet	Each film coated tablet contains: Vildagliptin Metformin Hydrochloride Excipients Approved colour used	IP	50 mg 500 mg q.s.
584	Vildagliptin & Metformin Hydrochloride Tablet	Each film coated tablet contains: Vildagliptin Metformin Hydrochloride Excipients Approved colour used	IP	50 mg 1000 mg q.s.
585	Vildagliptin Tablet	Each uncoatedtablet contains: Vildagliptin Excipients Approved colour used		50 mg q.s.
586	Vitamin E Acetate & Levocarnitine Tablets	Each film coated tablet contains: Tocopheryl Acetate (as 50% powder) L- Carnitine –L – Tartrate Eq. to Levocarnitine Appropriate overages added Excipients Approved colour used.	IP USP	200mg 150mg q.s
587	Voglibose & Metformin Hydrochloride (Sustained Release) Tablet	Each uncoated Bilayered tablet contains: Voglibose Metformin Hydrochloride (As Sustained Release) Excipients Approved colour used	IP IP	0.2 mg 500 mg q.s.
588	Voglibose & Metformin Hydrochloride (Sustained Release) Tablet	Each uncoated Bilayered tablet contains: Voglibose Metformin Hydrochloride (As Sustained Release) Excipients Approved colour used	IP IP	0.3 mg 500 mg q.s.
589	Voglibose Dispersible Tablet IP	Each uncoated tablet contains: Voglibose Excipients Approved colour used	IP	0.2 mg q.s.
590	Voglibose Dispersible Tablet IP	Each uncoated tablet contains: Voglibose Excipients Approved colour used	IP	0.3 mg q.s.
591	Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablet	Each uncoated Bilayered tablet contains: Voglibose Glimepiride Metformin Hydrochloride (As Sustained Release) Excipients Approved colour used	IP IP IP	0.2 mg 1 mg 500mg q.s.
592	Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablet	Each uncoated Bilayered tablet contains: Voglibose Glimepiride Metformin Hydrochloride (As Sustained Release) Excipients Approved colour used	IP IP IP	0.2 mg 2 mg 500mg q.s.
593	Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablet	Each uncoated Bilayered tablet contains: Voglibose Glimepiride Metformin Hydrochloride (As Sustained Release) Excipients Approved colour used	IP IP IP	0.3 mg 2 mg 500 mg q.s.
594	Voriconazole Tablet IP	Each film coated Tablet Contains: Voriconazole Excipients Approved Colour Used.	IP	200 mg q.s
595	Warfarin Sodium Tablets IP 1mg	Each uncoated tablet contains: Warfarin Sodium Clathrate Eq. to Warfarin Sodium (anhydrous) Excipients ApprovedColour used	IP	1mg q.s.
596	Warfarin Sodium Tablets IP 3mg	Each uncoated tablet contains: Warfarin Sodium Clathrate Eq. to Warfarin Sodium (anhydrous) Excipients Approved Colour used	IP	3mg q.s.
597	Warfarin Sodium Tablets IP 5mg	Each uncoated tablet contains: Warfarin Sodium Clathrate Eq. to Warfarin Sodium (anhydrous) Excipients Approved Colour used	IP	5mg q.s.
598	Zinc Acetate Tablets	Each Enteric coated Tablet Contains: Zinc Acetate(as dihydrate) Equ. toElemental Zinc Excipients Approved Colour Used	USP	50mg q.s

Toothpaste

S.No.	Product Name	Composition	Packing	Strength
1	Potassium Nitrate & Sodium Monofluorophosph ate Toothpaste	Composition : Potassium Nitrate Sodium Monofluorophosphate In a Pleasantly Flavoured Base Colour :Brilliant Blue FCF	BP USP	5.0%w/w 0.7%w/w q.s